<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="b2ff2ca2-6f3a-437b-ba56-990563159d2d" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;issue:issue:pii\:S0092867419X00136;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text;article:article:pii\:S0092867420301471">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(20)30147-1">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/566e6cd1-6733-4396-8509-c361b873cc99/fx1.jpg">
    


        <meta property="og:description" content="Although enhanced blood vessel formation is thought to drive cancer via nutrient delivery,
tumor-associated vasculature can directly regulate tumor cell growth via pericyte-derived
“pericrine” signals without affecting blood vessel function.">
    











        <meta name="twitter:title" content="Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/566e6cd1-6733-4396-8509-c361b873cc99/fx1.jpg">
    


        <meta name="twitter:description" content="Although enhanced blood vessel formation is thought to drive cancer via nutrient delivery,
tumor-associated vasculature can directly regulate tumor cell growth via pericyte-derived
“pericrine” signals without affecting blood vessel function.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells"> <meta name="citation_date" content="2020/06/11"> <meta name="citation_online_date" content="2020/05/29"> <meta name="citation_volume" content="181"> <meta name="citation_issue" content="6"> <meta name="citation_firstpage" content="1346"> <meta name="citation_lastpage" content="1363.e21"> <meta name="citation_pmid" content="32473126"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867420301471"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867420301471"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867420301471"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2020.02.003"> <meta name="citation_pmid" content="32473126"> <meta name="citation_author" content="Ping-Pui Wong"><meta name="citation_author_email" content="huangbp3@mail.sysu.edu.cn"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="José M. Muñoz-Félix"><meta name="citation_author_email" content="j.munoz-felix@qmul.ac.uk"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Maruan Hijazi"><meta name="citation_author_institution" content="Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Hyojin Kim"><meta name="citation_author_institution" content="The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK"><meta name="citation_author" content="Stephen D. Robinson"><meta name="citation_author_institution" content="Gut Microbes and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK"><meta name="citation_author_institution" content="School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK"><meta name="citation_author" content="Beatriz De Luxán-Delgado"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Irene Rodríguez-Hernández"><meta name="citation_author_institution" content="Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Oscar Maiques"><meta name="citation_author_institution" content="Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Ya-Ming Meng"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Qiong Meng"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Natalia Bodrug"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Matthew Scott Dukinfield"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Louise E. Reynolds"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="George Elia"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Andrew Clear"><meta name="citation_author_institution" content="Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Catherine Harwood"><meta name="citation_author_institution" content="Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK"><meta name="citation_author" content="Yu Wang"><meta name="citation_author_institution" content="ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA"><meta name="citation_author" content="James J. Campbell"><meta name="citation_author_institution" content="ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA"><meta name="citation_author" content="Rajinder Singh"><meta name="citation_author_institution" content="ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA"><meta name="citation_author" content="Penglie Zhang"><meta name="citation_author_institution" content="ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA"><meta name="citation_author" content="Thomas J. Schall"><meta name="citation_author_institution" content="ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA"><meta name="citation_author" content="Kylie P. Matchett"><meta name="citation_author_institution" content="Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, Edinburgh EH16 4TJ, UK"><meta name="citation_author" content="Neil C. Henderson"><meta name="citation_author_institution" content="Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, Edinburgh EH16 4TJ, UK"><meta name="citation_author" content="Peter W. Szlosarek"><meta name="citation_author_institution" content="Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Sally A. Dreger"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Sally Smith"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="J. Louise Jones"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="John G. Gribben"><meta name="citation_author_institution" content="Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Pedro R. Cutillas"><meta name="citation_author_institution" content="Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Pascal Meier"><meta name="citation_author_institution" content="The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK"><meta name="citation_author" content="Victoria Sanz-Moreno"><meta name="citation_author_institution" content="Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_author" content="Kairbaan M. Hodivala-Dilke"><meta name="citation_author_email" content="k.hodivala-dilke@qmul.ac.uk"><meta name="citation_author_institution" content="Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK"><meta name="citation_keywords" content="mural cell; β3-integrin; paracrine"><meta name="citation_reference" content="citation_title=A CXCL1 paracrine network links cancer chemoresistance and metastasis; citation_author=S. Acharyya; citation_author=T. Oskarsson; citation_author=S. Vanharanta; citation_author=S. Malladi; citation_author=J. Kim; citation_author=P.G. Morris; citation_author=K. Manova-Todorova; citation_author=M. Leversha; citation_author=N. Hogg; citation_author=V.E. Seshan; citation_author=et al.; citation_journal_title=Cell; citation_volume=150; citation_firstpage=165; citation_lastpage=178; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Pericytes: developmental, physiological, and pathological perspectives, problems, and promises; citation_author=A. Armulik; citation_author=G. Genové; citation_author=C. Betsholtz; citation_journal_title=Dev. Cell; citation_volume=21; citation_firstpage=193; citation_lastpage=215; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A; citation_author=I. Arozarena; citation_author=B. Sanchez-Laorden; citation_author=L. Packer; citation_author=C. Hidalgo-Carcedo; citation_author=R. Hayward; citation_author=A. Viros; citation_author=E. Sahai; citation_author=R. Marais; citation_journal_title=Cancer Cell; citation_volume=19; citation_firstpage=45; citation_lastpage=57; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis; citation_author=S. Batista; citation_author=E. Maniati; citation_author=L.E. Reynolds; citation_author=B. Tavora; citation_author=D.M. Lees; citation_author=I. Fernandez; citation_author=G. Elia; citation_author=O. Casanovas; citation_author=C. Lo Celso; citation_author=T. Hagemann; citation_author=K. Hodivala-Dilke; citation_journal_title=Nat. Commun.; citation_volume=5; citation_firstpage=5054; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium; citation_author=D.M. Brantley-Sieders; citation_author=C.M. Dunaway; citation_author=M. Rao; citation_author=S. Short; citation_author=Y. Hwang; citation_author=Y. Gao; citation_author=D. Li; citation_author=A. Jiang; citation_author=Y. Shyr; citation_author=J.Y. Wu; citation_author=J. Chen; citation_journal_title=Cancer Res.; citation_volume=71; citation_firstpage=976; citation_lastpage=987; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Requirement of vascular integrin alpha v beta 3 for angiogenesis; citation_author=P.C. Brooks; citation_author=R.A. Clark; citation_author=D.A. Cheresh; citation_journal_title=Science; citation_volume=264; citation_firstpage=569; citation_lastpage=571; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels; citation_author=P.C. Brooks; citation_author=A.M. Montgomery; citation_author=M. Rosenfeld; citation_author=R.A. Reisfeld; citation_author=T. Hu; citation_author=G. Klier; citation_author=D.A. Cheresh; citation_journal_title=Cell; citation_volume=79; citation_firstpage=1157; citation_lastpage=1164; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin; citation_author=P.C. Brooks; citation_author=S. Strömblad; citation_author=R. Klemke; citation_author=D. Visscher; citation_author=F.H. Sarkar; citation_author=D.A. Cheresh; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=96; citation_firstpage=1815; citation_lastpage=1822; citation_publication_date=1995; "><meta name="citation_reference" content="citation_title=Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance; citation_author=Z. Cao; citation_author=B.S. Ding; citation_author=P. Guo; citation_author=S.B. Lee; citation_author=J.M. Butler; citation_author=S.C. Casey; citation_author=M. Simons; citation_author=W. Tam; citation_author=D.W. Felsher; citation_author=K. Shido; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=25; citation_firstpage=350; citation_lastpage=365; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells; citation_author=Z. Cao; citation_author=J.M. Scandura; citation_author=G.G. Inghirami; citation_author=K. Shido; citation_author=B.S. Ding; citation_author=S. Rafii; citation_journal_title=Cancer Cell; citation_volume=31; citation_firstpage=110; citation_lastpage=126; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes; citation_author=E.M. Caspani; citation_author=P.H. Crossley; citation_author=C. Redondo-Garcia; citation_author=S. Martinez; citation_journal_title=PLoS ONE; citation_volume=9; citation_firstpage=e101402; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Akt fine-tunes NF-κB-dependent gene expression during T&nbsp;cell activation; citation_author=J. Cheng; citation_author=B. Phong; citation_author=D.C. Wilson; citation_author=R. Hirsch; citation_author=L.P. Kane; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=286; citation_firstpage=36076; citation_lastpage=36085; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Targeting the tumour vasculature: insights from physiological angiogenesis; citation_author=A.S. Chung; citation_author=J. Lee; citation_author=N. Ferrara; citation_journal_title=Nat. Rev. Cancer; citation_volume=10; citation_firstpage=505; citation_lastpage=514; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway; citation_author=V.G. Cooke; citation_author=V.S. LeBleu; citation_author=D. Keskin; citation_author=Z. Khan; citation_author=J.T. O’Connell; citation_author=Y. Teng; citation_author=M.B. Duncan; citation_author=L. Xie; citation_author=G. Maeda; citation_author=S. Vong; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=21; citation_firstpage=66; citation_lastpage=81; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Targeted In-Depth Quantification of Signaling Using Label-Free Mass Spectrometry; citation_author=P.R. Cutillas; citation_journal_title=Methods Enzymol.; citation_volume=585; citation_firstpage=245; citation_lastpage=268; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Akt-dependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK; citation_author=H.C. Dan; citation_author=M.J. Cooper; citation_author=P.C. Cogswell; citation_author=J.A. Duncan; citation_author=J.P. Ting; citation_author=A.S. Baldwin; citation_journal_title=Genes Dev.; citation_volume=22; citation_firstpage=1490; citation_lastpage=1500; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=A third-generation lentivirus vector with a conditional packaging system; citation_author=T. Dull; citation_author=R. Zufferey; citation_author=M. Kelly; citation_author=R.J. Mandel; citation_author=M. Nguyen; citation_author=D. Trono; citation_author=L. Naldini; citation_journal_title=J.&nbsp;Virol.; citation_volume=72; citation_firstpage=8463; citation_lastpage=8471; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms; citation_author=W.B. Fang; citation_author=I. Jokar; citation_author=A. Zou; citation_author=D. Lambert; citation_author=P. Dendukuri; citation_author=N. Cheng; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=287; citation_firstpage=36593; citation_lastpage=36608; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly; citation_author=S.S. Foo; citation_author=C.J. Turner; citation_author=S. Adams; citation_author=A. Compagni; citation_author=D. Aubyn; citation_author=N. Kogata; citation_author=P. Lindblom; citation_author=M. Shani; citation_author=D. Zicha; citation_author=R.H. Adams; citation_journal_title=Cell; citation_volume=124; citation_firstpage=161; citation_lastpage=173; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate; citation_author=M. Furuhashi; citation_author=T. Sjöblom; citation_author=A. Abramsson; citation_author=J. Ellingsen; citation_author=P. Micke; citation_author=H. Li; citation_author=E. Bergsten-Folestad; citation_author=U. Eriksson; citation_author=R. Heuchel; citation_author=C. Betsholtz; citation_author=et al.; citation_journal_title=Cancer Res.; citation_volume=64; citation_firstpage=2725; citation_lastpage=2733; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation; citation_author=B. Garmy-Susini; citation_author=H. Jin; citation_author=Y. Zhu; citation_author=R.J. Sung; citation_author=R. Hwang; citation_author=J. Varner; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=115; citation_firstpage=1542; citation_lastpage=1551; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment; citation_author=M. Georgouli; citation_author=C. Herraiz; citation_author=E. Crosas-Molist; citation_author=B. Fanshawe; citation_author=O. Maiques; citation_author=A. Perdrix; citation_author=P. Pandya; citation_author=I. Rodriguez-Hernandez; citation_author=K.M. Ilieva; citation_author=G. Cantelli; citation_author=et al.; citation_journal_title=Cell; citation_volume=176; citation_firstpage=757; citation_lastpage=774.e23; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=The perivascular niche regulates breast tumour dormancy; citation_author=C.M. Ghajar; citation_author=H. Peinado; citation_author=H. Mori; citation_author=I.R. Matei; citation_author=K.J. Evason; citation_author=H. Brazier; citation_author=D. Almeida; citation_author=A. Koller; citation_author=K.A. Hajjar; citation_author=D.Y. Stainier; citation_author=et al.; citation_journal_title=Nat. Cell Biol.; citation_volume=15; citation_firstpage=807; citation_lastpage=817; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties; citation_author=P. Ghiabi; citation_author=J. Jiang; citation_author=J. Pasquier; citation_author=M. Maleki; citation_author=N. Abu-Kaoud; citation_author=S. Rafii; citation_author=A. Rafii; citation_journal_title=PLoS ONE; citation_volume=9; citation_firstpage=e112424; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=DNA damage-mediated induction of a chemoresistant niche; citation_author=L.A. Gilbert; citation_author=M.T. Hemann; citation_journal_title=Cell; citation_volume=143; citation_firstpage=355; citation_lastpage=366; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway; citation_author=A. Gruhler; citation_author=J.V. Olsen; citation_author=S. Mohammed; citation_author=P. Mortensen; citation_author=N.J. Faergeman; citation_author=M. Mann; citation_author=O.N. Jensen; citation_journal_title=Mol. Cell. Proteomics; citation_volume=4; citation_firstpage=310; citation_lastpage=327; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer; citation_author=J.L. Guan; citation_journal_title=IUBMB Life; citation_volume=62; citation_firstpage=268; citation_lastpage=276; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer; citation_author=B.S. Guerrouahen; citation_author=J. Pasquier; citation_author=N.A. Kaoud; citation_author=M. Maleki; citation_author=M.C. Beauchamp; citation_author=A. Yasmeen; citation_author=P. Ghiabi; citation_author=R. Lis; citation_author=F. Vidal; citation_author=A. Saleh; citation_author=et al.; citation_journal_title=Mol. Cancer Ther.; citation_volume=13; citation_firstpage=3123; citation_lastpage=3136; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes; citation_author=D. Hanahan; citation_journal_title=Nature; citation_volume=315; citation_firstpage=115; citation_lastpage=122; citation_publication_date=1985; "><meta name="citation_reference" content="citation_title=Hallmarks of cancer: the next generation; citation_author=D. Hanahan; citation_author=R.A. Weinberg; citation_journal_title=Cell; citation_volume=144; citation_firstpage=646; citation_lastpage=674; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Targeting the PDGF signaling pathway in tumor treatment; citation_author=C.H. Heldin; citation_journal_title=Cell Commun. Signal.; citation_volume=11; citation_firstpage=97; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Myosin phosphatase: structure, regulation and function; citation_author=M. Ito; citation_author=T. Nakano; citation_author=F. Erdodi; citation_author=D.J. Hartshorne; citation_journal_title=Mol. Cell. Biochem.; citation_volume=259; citation_firstpage=197; citation_lastpage=209; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2; citation_author=D. Keskin; citation_author=J. Kim; citation_author=V.G. Cooke; citation_author=C.C. Wu; citation_author=H. Sugimoto; citation_author=C. Gu; citation_author=M. De Palma; citation_author=R. Kalluri; citation_author=V.S. LeBleu; citation_journal_title=Cell Rep.; citation_volume=10; citation_firstpage=1066; citation_lastpage=1081; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in&nbsp;vitro; citation_author=K.E. LaBarbera; citation_author=R.D. Hyldahl; citation_author=K.S. O’Fallon; citation_author=P.M. Clarkson; citation_author=S. Witkowski; citation_journal_title=Physiol. Rep.; citation_volume=3; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns; citation_author=M.R. Larsen; citation_author=T.E. Thingholm; citation_author=O.N. Jensen; citation_author=P. Roepstorff; citation_author=T.J. Jørgensen; citation_journal_title=Mol. Cell. Proteomics; citation_volume=4; citation_firstpage=873; citation_lastpage=886; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1; citation_author=J. Lu; citation_author=X. Ye; citation_author=F. Fan; citation_author=L. Xia; citation_author=R. Bhattacharya; citation_author=S. Bellister; citation_author=F. Tozzi; citation_author=E. Sceusi; citation_author=Y. Zhou; citation_author=I. Tachibana; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=23; citation_firstpage=171; citation_lastpage=185; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation; citation_author=C. Mas-Moruno; citation_author=F. Rechenmacher; citation_author=H. Kessler; citation_journal_title=Anticancer. Agents Med. Chem.; citation_volume=10; citation_firstpage=753; citation_lastpage=768; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma; citation_author=W.P. Mason; citation_journal_title=Neuro-oncol.; citation_volume=17; citation_firstpage=634; citation_lastpage=635; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL; citation_author=S. McComb; citation_author=J. Aguadé-Gorgorió; citation_author=L. Harder; citation_author=B. Marovca; citation_author=G. Cario; citation_author=C. Eckert; citation_author=M. Schrappe; citation_author=M. Stanulla; citation_author=A. von Stackelberg; citation_author=J.P. Bourquin; citation_author=B.C. Bornhauser; citation_journal_title=Sci. Transl. Med.; citation_volume=8; citation_firstpage=339ra70; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Characterization of a TiO2 enrichment method for label-free quantitative phosphoproteomics; citation_author=A. Montoya; citation_author=L. Beltran; citation_author=P. Casado; citation_author=J.C. Rodríguez-Prados; citation_author=P.R. Cutillas; citation_journal_title=Methods; citation_volume=54; citation_firstpage=370; citation_lastpage=378; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit; citation_author=E.A. Morgan; citation_author=J.G. Schneider; citation_author=T.E. Baroni; citation_author=O. Uluçkan; citation_author=E. Heller; citation_author=M.A. Hurchla; citation_author=H. Deng; citation_author=D. Floyd; citation_author=A. Berdy; citation_author=J.L. Prior; citation_author=et al.; citation_journal_title=FASEB J.; citation_volume=24; citation_firstpage=1117; citation_lastpage=1127; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes; citation_author=M.B. O’Keeffe; citation_author=A.H. Devlin; citation_author=A.J. Burns; citation_author=T.A. Gardiner; citation_author=I.D. Logan; citation_author=D.G. Hirst; citation_author=S.R. McKeown; citation_journal_title=Oncol. Res.; citation_volume=17; citation_firstpage=93; citation_lastpage=101; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Myosin II reactivation and cytoskeletal remodelling as a hallmark and a vulnerability in melanoma resistance; citation_author=J.L. Orgaz; citation_author=E. Crosas-Molist; citation_author=A. Sadok; citation_author=A. Perdrix-Rosell; citation_author=O. Maiques; citation_author=J. Monger; citation_author=I. Rodriguez-Hernandez; citation_author=S. Mele; citation_author=M. Georgouli; citation_author=V. Bridgeman; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=37; citation_firstpage=85; citation_lastpage=103.e9; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions; citation_author=A.R. Pedrosa; citation_author=A. Trindade; citation_author=C. Carvalho; citation_author=J. Graça; citation_author=S. Carvalho; citation_author=M.C. Peleteiro; citation_author=R.H. Adams; citation_author=A. Duarte; citation_journal_title=Oncotarget; citation_volume=6; citation_firstpage=24404; citation_lastpage=24423; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=The diverse and complex roles of NF-κB subunits in cancer; citation_author=N.D. Perkins; citation_journal_title=Nat. Rev. Cancer; citation_volume=12; citation_firstpage=121; citation_lastpage=132; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Probability-based protein identification by searching sequence databases using mass spectrometry data; citation_author=D.N. Perkins; citation_author=D.J. Pappin; citation_author=D.M. Creasy; citation_author=J.S. Cottrell; citation_journal_title=Electrophoresis; citation_volume=20; citation_firstpage=3551; citation_lastpage=3567; citation_publication_date=1999; "><meta name="citation_reference" content="citation_title=Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy; citation_author=K. Pietras; citation_author=K. Rubin; citation_author=T. Sjöblom; citation_author=E. Buchdunger; citation_author=M. Sjöquist; citation_author=C.H. Heldin; citation_author=A. Ostman; citation_journal_title=Cancer Res.; citation_volume=62; citation_firstpage=5476; citation_lastpage=5484; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=NF-kappaB functions as a tumour promoter in inflammation-associated cancer; citation_author=E. Pikarsky; citation_author=R.M. Porat; citation_author=I. Stein; citation_author=R. Abramovitch; citation_author=S. Amit; citation_author=S. Kasem; citation_author=E. Gutkovich-Pyest; citation_author=S. Urieli-Shoval; citation_author=E. Galun; citation_author=Y. Ben-Neriah; citation_journal_title=Nature; citation_volume=431; citation_firstpage=461; citation_lastpage=466; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Endothelial-specific inhibition of NF-κB enhances functional haematopoiesis; citation_author=M.G. Poulos; citation_author=P. Ramalingam; citation_author=M.C. Gutkin; citation_author=M. Kleppe; citation_author=M. Ginsberg; citation_author=M.J.P. Crowley; citation_author=O. Elemento; citation_author=R.L. Levine; citation_author=S. Rafii; citation_author=J. Kitajewski; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=7; citation_firstpage=13829; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Pericytes and vessel maturation during tumor angiogenesis and metastasis; citation_author=A. Raza; citation_author=M.J. Franklin; citation_author=A.Z. Dudek; citation_journal_title=Am. J. Hematol.; citation_volume=85; citation_firstpage=593; citation_lastpage=598; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins; citation_author=L.E. Reynolds; citation_author=L. Wyder; citation_author=J.C. Lively; citation_author=D. Taverna; citation_author=S.D. Robinson; citation_author=X. Huang; citation_author=D. Sheppard; citation_author=R.O. Hynes; citation_author=K.M. Hodivala-Dilke; citation_journal_title=Nat. Med.; citation_volume=8; citation_firstpage=27; citation_lastpage=34; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice; citation_author=A.R. Reynolds; citation_author=L.E. Reynolds; citation_author=T.E. Nagel; citation_author=J.C. Lively; citation_author=S.D. Robinson; citation_author=D.J. Hicklin; citation_author=S.C. Bodary; citation_author=K.M. Hodivala-Dilke; citation_journal_title=Cancer Res.; citation_volume=64; citation_firstpage=8643; citation_lastpage=8650; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors; citation_author=A.R. Reynolds; citation_author=I.R. Hart; citation_author=A.R. Watson; citation_author=J.C. Welti; citation_author=R.G. Silva; citation_author=S.D. Robinson; citation_author=G. Da Violante; citation_author=M. Gourlaouen; citation_author=M. Salih; citation_author=M.C. Jones; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=15; citation_firstpage=392; citation_lastpage=400; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Dual role of pericyte α6β1-integrin in tumour blood vessels; citation_author=L.E. Reynolds; citation_author=G. D’Amico; citation_author=T. Lechertier; citation_author=A. Papachristodoulou; citation_author=J.M. Muñoz-Félix; citation_author=A. De Arcangelis; citation_author=M. Baker; citation_author=B. Serrels; citation_author=K.M. Hodivala-Dilke; citation_journal_title=J.&nbsp;Cell Sci.; citation_volume=130; citation_firstpage=1583; citation_lastpage=1595; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=NIH Image to ImageJ: 25 years of image analysis; citation_author=C.A. Schneider; citation_author=W.S. Rasband; citation_author=K.W. Eliceiri; citation_journal_title=Nat. Methods; citation_volume=9; citation_firstpage=671; citation_lastpage=675; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102; citation_author=B. Sennino; citation_author=B.L. Falcón; citation_author=D. McCauley; citation_author=T. Le; citation_author=T. McCauley; citation_author=J.C. Kurz; citation_author=A. Haskell; citation_author=D.M. Epstein; citation_author=D.M. McDonald; citation_journal_title=Cancer Res.; citation_volume=67; citation_firstpage=7358; citation_lastpage=7367; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients; citation_author=D. Sinha; citation_author=L. Chong; citation_author=J. George; citation_author=H. Schluter; citation_author=S. Monchgesang; citation_author=S. Mills; citation_author=J. Li; citation_author=C. Parish; citation_author=D. Bowtell; citation_author=P. Kaur; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=22; citation_firstpage=1813; citation_lastpage=1824; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice; citation_author=V. Steri; citation_author=T.S. Ellison; citation_author=A.M. Gontarczyk; citation_author=K. Weilbaecher; citation_author=J.G. Schneider; citation_author=D. Edwards; citation_author=M. Fruttiger; citation_author=K.M. Hodivala-Dilke; citation_author=S.D. Robinson; citation_journal_title=Circ. Res.; citation_volume=114; citation_firstpage=79; citation_lastpage=91; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation; citation_author=A.N. Stratman; citation_author=K.M. Malotte; citation_author=R.D. Mahan; citation_author=M.J. Davis; citation_author=G.E. Davis; citation_journal_title=Blood; citation_volume=114; citation_firstpage=5091; citation_lastpage=5101; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Integrin inhibitors reaching the clinic; citation_author=R. Stupp; citation_author=C. Ruegg; citation_journal_title=J.&nbsp;Clin. Oncol.; citation_volume=25; citation_firstpage=1637; citation_lastpage=1638; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway; citation_author=C.H. Tang; citation_author=C.C. Tsai; citation_journal_title=Biochem. Pharmacol.; citation_volume=83; citation_firstpage=335; citation_lastpage=344; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy; citation_author=B. Tavora; citation_author=L.E. Reynolds; citation_author=S. Batista; citation_author=F. Demircioglu; citation_author=I. Fernandez; citation_author=T. Lechertier; citation_author=D.M. Lees; citation_author=P.P. Wong; citation_author=A. Alexopoulou; citation_author=G. Elia; citation_author=et al.; citation_journal_title=Nature; citation_volume=514; citation_firstpage=112; citation_lastpage=116; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Does cilengitide deserve another chance?; citation_author=M. Tucci; citation_author=S. Stucci; citation_author=F. Silvestris; citation_journal_title=Lancet Oncol.; citation_volume=15; citation_firstpage=e584; citation_lastpage=e585; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells; citation_author=P.V. Usatyuk; citation_author=P. Fu; citation_author=V. Mohan; citation_author=Y. Epshtein; citation_author=J.R. Jacobson; citation_author=J. Gomez-Cambronero; citation_author=K.K. Wary; citation_author=V. Bindokas; citation_author=S.M. Dudek; citation_author=R. Salgia; citation_author=et al.; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=289; citation_firstpage=13476; citation_lastpage=13491; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility; citation_author=E. Vial; citation_author=E. Sahai; citation_author=C.J. Marshall; citation_journal_title=Cancer Cell; citation_volume=4; citation_firstpage=67; citation_lastpage=79; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Non-muscle myosin II takes centre stage in cell adhesion and migration; citation_author=M. Vicente-Manzanares; citation_author=X. Ma; citation_author=R.S. Adelstein; citation_author=A.R. Horwitz; citation_journal_title=Nat. Rev. Mol. Cell Biol.; citation_volume=10; citation_firstpage=778; citation_lastpage=790; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=2016 update of the PRIDE database and its related tools; citation_author=J.A. Vizcaíno; citation_author=A. Csordas; citation_author=N. del-Toro; citation_author=J.A. Dianes; citation_author=J. Griss; citation_author=I. Lavidas; citation_author=G. Mayer; citation_author=Y. Perez-Riverol; citation_author=F. Reisinger; citation_author=T. Ternent; citation_author=et al.; citation_journal_title=Nucleic Acids Res.; citation_volume=44; citation_number=D1; citation_firstpage=D447; citation_lastpage=D456; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Emerging roles of PDGF-D signaling pathway in tumor development and progression; citation_author=Z. Wang; citation_author=A. Ahmad; citation_author=Y. Li; citation_author=D. Kong; citation_author=A.S. Azmi; citation_author=S. Banerjee; citation_author=F.H. Sarkar; citation_journal_title=Biochim. Biophys. Acta; citation_volume=1806; citation_firstpage=122; citation_lastpage=130; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Single-vector inducible lentiviral RNAi system for oncology target validation; citation_author=D. Wiederschain; citation_author=S. Wee; citation_author=L. Chen; citation_author=A. Loo; citation_author=G. Yang; citation_author=A. Huang; citation_author=Y. Chen; citation_author=G. Caponigro; citation_author=Y.M. Yao; citation_author=C. Lengauer; citation_author=et al.; citation_journal_title=Cell Cycle; citation_volume=8; citation_firstpage=498; citation_lastpage=504; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Endothelial Notch1 Activity Facilitates Metastasis; citation_author=E. Wieland; citation_author=J. Rodriguez-Vita; citation_author=S.S. Liebler; citation_author=C. Mogler; citation_author=I. Moll; citation_author=S.E. Herberich; citation_author=E. Espinet; citation_author=E. Herpel; citation_author=A. Menuchin; citation_author=J. Chang-Claude; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=31; citation_firstpage=355; citation_lastpage=367; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability; citation_author=E.H. Wilkes; citation_author=P. Casado; citation_author=V. Rajeeve; citation_author=P.R. Cutillas; citation_journal_title=Mol. Cell. Proteomics; citation_volume=16; citation_firstpage=1694; citation_lastpage=1704; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread; citation_author=P.P. Wong; citation_author=F. Demircioglu; citation_author=E. Ghazaly; citation_author=W. Alrawashdeh; citation_author=M.R. Stratford; citation_author=C.L. Scudamore; citation_author=B. Cereser; citation_author=T. Crnogorac-Jurcevic; citation_author=S. McDonald; citation_author=G. Elia; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=27; citation_firstpage=123; citation_lastpage=137; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Pericytes limit tumor cell metastasis; citation_author=X. Xian; citation_author=J. Håkansson; citation_author=A. Ståhlberg; citation_author=P. Lindblom; citation_author=C. Betsholtz; citation_author=H. Gerhardt; citation_author=H. Semb; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=116; citation_firstpage=642; citation_lastpage=651; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Metabolic reprogramming of the tumour microenvironment; citation_author=Y. Xing; citation_author=S. Zhao; citation_author=B.P. Zhou; citation_author=J. Mi; citation_journal_title=FEBS J.; citation_volume=282; citation_firstpage=3892; citation_lastpage=3898; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients; citation_author=Y. Yonenaga; citation_author=A. Mori; citation_author=H. Onodera; citation_author=S. Yasuda; citation_author=H. Oe; citation_author=A. Fujimoto; citation_author=T. Tachibana; citation_author=M. Imamura; citation_journal_title=Oncology; citation_volume=69; citation_firstpage=159; citation_lastpage=166; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function; citation_author=W.K. You; citation_author=F. Yotsumoto; citation_author=K. Sakimura; citation_author=R.H. Adams; citation_author=W.B. Stallcup; citation_journal_title=Angiogenesis; citation_volume=17; citation_firstpage=61; citation_lastpage=76; citation_publication_date=2014; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Enhanced blood vessel (BV) formation is thought to drive tumor growth through elevated nutrient delivery. However, this observation has overlooked potential roles for mural cells in directly affecting tumor growth independent of BV function. Here we provide clinical data correlating high percentages of mural-β3-integrin-negative tumor BVs with increased tumor sizes but no effect on BV numbers. Mural-β3-integrin loss also enhances tumor growth in implanted and autochthonous mouse tumor models with no detectable effects on BV numbers or function. At a molecular level, mural-cell β3-integrin loss enhances signaling via FAK-p-HGFR-p-Akt-p-p65, driving CXCL1, CCL2, and TIMP-1 production. In particular, mural-cell-derived CCL2 stimulates tumor cell MEK1-ERK1/2-ROCK2-dependent signaling and enhances tumor cell survival and tumor growth. Overall, our data indicate that mural cells can control tumor growth via paracrine signals regulated by β3-integrin, providing a previously unrecognized mechanism of cancer growth control.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=5006&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1&amp;be=3685&amp;fe=4866&amp;dc=4833&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749586678935,%22n%22:0,%22f%22:2947,%22dn%22:2948,%22dne%22:2948,%22c%22:2948,%22s%22:2948,%22ce%22:2948,%22rq%22:2948,%22rp%22:3660,%22rpe%22:4619,%22dl%22:3665,%22di%22:4774,%22ds%22:4832,%22de%22:4849,%22dc%22:4865,%22l%22:4865,%22le%22:4893%7D,%22navigation%22:%7B%7D%7D&amp;fp=4172&amp;fcp=4172&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><style>stream {
  position: relative;
  display: block;
}
</style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(20)30147-1"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-301502" aria-expanded="false" aria-controls="login-links-301502" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-301502" id="login-links--301502" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-301502" data-opens="#links-dialog-301502" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-301502" aria-modal="true"><button data-closes="#links-dialog-301502" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930147-1" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2020.02.003">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(20)30147-1" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(19)X0013-6"><span>Volume 181</span>, <span>Issue 6</span></a></span><span class="meta-panel__pages"><span>p1346-1363.e21</span></span><span class="meta-panel__onlineDate">June 11, 2020</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=181&amp;issue=6&amp;pii=S0092-8674%2819%29X0013-6" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Ping-Pui</span> <span property="familyName">Wong</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ping-Pui</span> <span property="familyName">Wong</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:huangbp3@mail.sysu.edu.cn" property="email" title="Send email to Ping-Pui Wong">huangbp3@mail.sysu.edu.cn</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Wong/Ping-Pui" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">13</a></sup> <a id="eadd0010" href="mailto:huangbp3@mail.sysu.edu.cn" property="email" title="Send email to Ping-Pui Wong">huangbp3@mail.sysu.edu.cn</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">José M.</span> <span property="familyName">Muñoz-Félix</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">José M.</span> <span property="familyName">Muñoz-Félix</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:j.munoz-felix@qmul.ac.uk" property="email" title="Send email to José M. Muñoz-Félix">j.munoz-felix@qmul.ac.uk</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Mu%C3%B1oz-F%C3%A9lix/Jos%C3%A9+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">13</a></sup> <a id="eadd0015" href="mailto:j.munoz-felix@qmul.ac.uk" property="email" title="Send email to José M. Muñoz-Félix">j.munoz-felix@qmul.ac.uk</a></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Maruan</span> <span property="familyName">Hijazi</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Maruan</span> <span property="familyName">Hijazi</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Hijazi/Maruan" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Hyojin</span> <span property="familyName">Kim</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Hyojin</span> <span property="familyName">Kim</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Kim/Hyojin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Stephen D.</span> <span property="familyName">Robinson</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Stephen D.</span> <span property="familyName">Robinson</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Gut Microbes and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Robinson/Stephen+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Beatriz</span> <span property="familyName">De Luxán-Delgado</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Beatriz</span> <span property="familyName">De Luxán-Delgado</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/De+Lux%C3%A1n-Delgado/Beatriz" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Irene</span> <span property="familyName">Rodríguez-Hernández</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Irene</span> <span property="familyName">Rodríguez-Hernández</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Rodr%C3%ADguez-Hern%C3%A1ndez/Irene" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Oscar</span> <span property="familyName">Maiques</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Oscar</span> <span property="familyName">Maiques</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Maiques/Oscar" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Ya-Ming</span> <span property="familyName">Meng</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ya-Ming</span> <span property="familyName">Meng</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Meng/Ya-Ming" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Qiong</span> <span property="familyName">Meng</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Qiong</span> <span property="familyName">Meng</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Meng/Qiong" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Natalia</span> <span property="familyName">Bodrug</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Natalia</span> <span property="familyName">Bodrug</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Bodrug/Natalia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Matthew Scott</span> <span property="familyName">Dukinfield</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Matthew Scott</span> <span property="familyName">Dukinfield</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Dukinfield/Matthew+Scott" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Louise E.</span> <span property="familyName">Reynolds</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Louise E.</span> <span property="familyName">Reynolds</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Reynolds/Louise+E" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">George</span> <span property="familyName">Elia</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">George</span> <span property="familyName">Elia</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Elia/George" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Andrew</span> <span property="familyName">Clear</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Andrew</span> <span property="familyName">Clear</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Clear/Andrew" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Catherine</span> <span property="familyName">Harwood</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Catherine</span> <span property="familyName">Harwood</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Harwood/Catherine" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Yu</span> <span property="familyName">Wang</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yu</span> <span property="familyName">Wang</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wang/Yu" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">James J.</span> <span property="familyName">Campbell</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">James J.</span> <span property="familyName">Campbell</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Campbell/James+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Rajinder</span> <span property="familyName">Singh</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Rajinder</span> <span property="familyName">Singh</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Singh/Rajinder" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Penglie</span> <span property="familyName">Zhang</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Penglie</span> <span property="familyName">Zhang</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zhang/Penglie" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Thomas J.</span> <span property="familyName">Schall</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Thomas J.</span> <span property="familyName">Schall</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Schall/Thomas+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Kylie P.</span> <span property="familyName">Matchett</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kylie P.</span> <span property="familyName">Matchett</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, Edinburgh EH16 4TJ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Matchett/Kylie+P" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Neil C.</span> <span property="familyName">Henderson</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Neil C.</span> <span property="familyName">Henderson</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, Edinburgh EH16 4TJ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Henderson/Neil+C" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Peter W.</span> <span property="familyName">Szlosarek</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Peter W.</span> <span property="familyName">Szlosarek</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Szlosarek/Peter+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Sally A.</span> <span property="familyName">Dreger</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sally A.</span> <span property="familyName">Dreger</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Dreger/Sally+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Sally</span> <span property="familyName">Smith</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sally</span> <span property="familyName">Smith</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Smith/Sally" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">J. Louise</span> <span property="familyName">Jones</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">J. Louise</span> <span property="familyName">Jones</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Jones/J+Louise" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au28" aria-controls="axel_author_au28"><span property="givenName">John G.</span> <span property="familyName">Gribben</span></a><div id="au28" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">John G.</span> <span property="familyName">Gribben</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Gribben/John+G" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au29" aria-controls="axel_author_au29"><span property="givenName">Pedro R.</span> <span property="familyName">Cutillas</span></a><div id="au29" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Pedro R.</span> <span property="familyName">Cutillas</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Cutillas/Pedro+R" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au30" aria-controls="axel_author_au30"><span property="givenName">Pascal</span> <span property="familyName">Meier</span></a><div id="au30" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Pascal</span> <span property="familyName">Meier</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Meier/Pascal" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au31" aria-controls="axel_author_au31"><span property="givenName">Victoria</span> <span property="familyName">Sanz-Moreno</span></a><div id="au31" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Victoria</span> <span property="familyName">Sanz-Moreno</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Sanz-Moreno/Victoria" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au32" aria-controls="axel_author_au32"><span property="givenName">Kairbaan M.</span> <span property="familyName">Hodivala-Dilke</span></a><div id="au32" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kairbaan M.</span> <span property="familyName">Hodivala-Dilke</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0020" href="mailto:k.hodivala-dilke@qmul.ac.uk" property="email" title="Send email to Kairbaan M. Hodivala-Dilke">k.hodivala-dilke@qmul.ac.uk</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">14</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Hodivala-Dilke/Kairbaan+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">14</a></sup> <a id="eadd0020" href="mailto:k.hodivala-dilke@qmul.ac.uk" property="email" title="Send email to Kairbaan M. Hodivala-Dilke">k.hodivala-dilke@qmul.ac.uk</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Gut Microbes and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">ChemoCentryx Inc., 850 Maude Ave., Mountain View, CA 94043, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh BioQuarter, University of Edinburgh, Edinburgh EH16 4TJ, UK</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">13</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">14</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received May 17, 2018</span>; <span>Revised November 21, 2019</span>; <span>Accepted January 31, 2020</span>; <span>Published online May 29, 2020</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2020.02.003" property="sameAs" target="_blank">10.1016/j.cell.2020.02.003 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867420301471" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2020 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2020.02.003" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(19)X0013-6"><img src="/cms/asset/693aff61-b843-4e36-9d8c-1f1580f96ce7/cov200h.gif" alt="Cover Image - Cell, Volume 181, Issue 6"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2820%2930147-1" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical Abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental Information (2)</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930147-1" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.02.003">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2820%2930147-1" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2020.02.003&amp;pii=S0092-8674%2820%2930147-1" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930147-1" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.02.003">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2020.02.003" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867420301471&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867420301471&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=181&amp;issue=6&amp;pii=S0092-8674%2819%29X0013-6" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(20)30553-5" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(20)30559-6" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract" aria-current="true">Highlights</a></li><li><a href="#author-abstract" aria-current="false">Summary</a></li><li><a href="#graphical-abstract" aria-current="false">Graphical Abstract</a></li><li><a href="#keywords" aria-current="false">Keywords</a></li><li><a href="#sec-1" aria-current="false">Introduction</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li><a href="#sec-4" aria-current="false">STAR★Methods</a></li><li><a href="#acknowledgments" aria-current="false">Acknowledgments</a></li><li><a href="#supplementary-material" aria-current="false">Supplemental Information (2)</a></li><li><a href="#references" aria-current="false">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Low mural-β3-integrin in tumor BVs is associated with poor prognosis in human cancers</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">Mural-β3-integrin loss enhances tumor growth in tumor models without vascular changes</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Mural-β3-integrin loss upregulates FAK-p-HGFR-p-Akt-p-p65-driven cytokine production</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Mural cell-derived CCL2 activates MEK1-ROCK2-dependent tumor growth</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Enhanced blood vessel (BV) formation is thought to drive tumor growth through elevated nutrient delivery. However, this observation has overlooked potential roles for mural cells in directly affecting tumor growth independent of BV function. Here we provide clinical data correlating high percentages of mural-β3-integrin-negative tumor BVs with increased tumor sizes but no effect on BV numbers. Mural-β3-integrin loss also enhances tumor growth in implanted and autochthonous mouse tumor models with no detectable effects on BV numbers or function. At a molecular level, mural-cell β3-integrin loss enhances signaling via FAK-p-HGFR-p-Akt-p-p65, driving CXCL1, CCL2, and TIMP-1 production. In particular, mural-cell-derived CCL2 stimulates tumor cell MEK1-ERK1/2-ROCK2-dependent signaling and enhances tumor cell survival and tumor growth. Overall, our data indicate that mural cells can control tumor growth via paracrine signals regulated by β3-integrin, providing a previously unrecognized mechanism of cancer growth control.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical Abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/7cab77a5-b364-48b0-aea7-762c3e4b051c/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2020.02.003/asset/566e6cd1-6733-4396-8509-c361b873cc99/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/7cab77a5-b364-48b0-aea7-762c3e4b051c/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;mural+cell&quot;" alt="Search on this keyword" rel="nofollow">mural cell</a></li><li><a href="/action/doSearch?AllField=&quot;%CE%B23-integrin&quot;" alt="Search on this keyword" rel="nofollow">β3-integrin</a></li><li><a href="/action/doSearch?AllField=&quot;paracrine&quot;" alt="Search on this keyword" rel="nofollow">paracrine</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0030" role="paragraph">The precise mechanisms underlying the role of tumor stromal cells in cancer growth are still unclear. In solid cancers, blood vessels are essential for the delivery of nutrients and oxygen (<span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Hanahan and Weinberg, 2011</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Hanahan, D. ∙ Weinberg, R.A.</div><div><strong>Hallmarks of cancer: the next generation</strong></div><div><em>Cell.</em> 2011; <strong>144</strong>:646-674</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79952284127" target="_blank" aria-label="Open Scopus in new tab">Scopus (49637)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21376230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2011.02.013&amp;pmid=21376230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Formation of new tumor blood vessels, tumor angiogenesis, involves enhanced proliferation and migration of endothelial cells, development of a vessel basement membrane, and subsequent recruitment of supporting mural cells including pericytes (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Chung et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Chung, A.S. ∙ Lee, J. ∙ Ferrara, N.</div><div><strong>Targeting the tumour vasculature: insights from physiological angiogenesis</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:505-514</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2868" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77953988924" target="_blank" aria-label="Open Scopus in new tab">Scopus (660)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20574450/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2868&amp;pmid=20574450" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These cellular processes are thought to require changes in cell adhesion. The cell adhesion receptor integrin αvβ3 is upregulated in nascent tumor blood vessels in both endothelial cells and pericytes, suggesting a functional role of this integrin in tumor angiogenesis. Importantly, despite strong preclinical data and the fact that potent β3-integrin inhibitors are now under development, previous strategies to target β3-integrin as anti-angiogenic and anti-cancer strategies have failed in clinical trials (<span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib38 bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Mason, 2015; Tucci et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Mason, W.P.</div><div><strong>End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma</strong></div><div><em>Neuro-oncol.</em> 2015; <strong>17</strong>:634-635</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/neuonc/nov018" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84928911049" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25681307/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fneuonc%2Fnov018&amp;pmid=25681307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Tucci, M. ∙ Stucci, S. ∙ Silvestris, F.</div><div><strong>Does cilengitide deserve another chance?</strong></div><div><em>Lancet Oncol.</em> 2014; <strong>15</strong>:e584-e585</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1470-2045%2814%2970462-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1470-2045%2814%2970462-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84925228193" target="_blank" aria-label="Open Scopus in new tab">Scopus (33)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25456376/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2814%2970462-0&amp;pmid=25456376" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This is most likely because a deeper understanding of the&nbsp;role of this integrin in tumor blood vessels and tumor biology is still required. Although β3-integrin in endothelial cells has been studied extensively (<span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib6 bib7 bib8 bib51 bib53 bib59 bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Brooks et&nbsp;al., 1994a, 1994b, 1995; Reynolds et&nbsp;al., 2002, 2009;Steri et&nbsp;al., 2014; Stupp and Ruegg, 2007</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Brooks, P.C. ∙ Clark, R.A. ∙ Cheresh, D.A.</div><div><strong>Requirement of vascular integrin alpha v beta 3 for angiogenesis</strong></div><div><em>Science.</em> 1994; <strong>264</strong>:569-571</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.7512751" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0028362876" target="_blank" aria-label="Open Scopus in new tab">Scopus (2823)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7512751/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.7512751&amp;pmid=7512751" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Brooks, P.C. ∙ Montgomery, A.M. ∙ Rosenfeld, M. ...</div><div><strong>Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels</strong></div><div><em>Cell.</em> 1994; <strong>79</strong>:1157-1164</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2F0092-8674%2894%2990007-8&amp;cf=abstract&amp;site=cell-site">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2F0092-8674%2894%2990007-8&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0028670833" target="_blank" aria-label="Open Scopus in new tab">Scopus (2216)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7528107/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0092-8674%2894%2990007-8&amp;pmid=7528107" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Brooks, P.C. ∙ Strömblad, S. ∙ Klemke, R. ...</div><div><strong>Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1995; <strong>96</strong>:1815-1822</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI118227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0028972105" target="_blank" aria-label="Open Scopus in new tab">Scopus (766)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7560073/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI118227&amp;pmid=7560073" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Reynolds, L.E. ∙ Wyder, L. ∙ Lively, J.C. ...</div><div><strong>Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins</strong></div><div><em>Nat. Med.</em> 2002; <strong>8</strong>:27-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm0102-27" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0036152857" target="_blank" aria-label="Open Scopus in new tab">Scopus (566)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11786903/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm0102-27&amp;pmid=11786903" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Reynolds, A.R. ∙ Hart, I.R. ∙ Watson, A.R. ...</div><div><strong>Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors</strong></div><div><em>Nat. Med.</em> 2009; <strong>15</strong>:392-400</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.1941" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-64149106522" target="_blank" aria-label="Open Scopus in new tab">Scopus (405)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19305413/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.1941&amp;pmid=19305413" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Steri, V. ∙ Ellison, T.S. ∙ Gontarczyk, A.M. ...</div><div><strong>Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice</strong></div><div><em>Circ. Res.</em> 2014; <strong>114</strong>:79-91</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/CIRCRESAHA.114.301591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84892931092" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24103390/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FCIRCRESAHA.114.301591&amp;pmid=24103390" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Stupp, R. ∙ Ruegg, C.</div><div><strong>Integrin inhibitors reaching the clinic</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2007; <strong>25</strong>:1637-1638</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2006.09.8376" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-34249113455" target="_blank" aria-label="Open Scopus in new tab">Scopus (113)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17470853/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2006.09.8376&amp;pmid=17470853" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), its role in pericytes still remains unknown.</div><div id="p0035" role="paragraph">Pericytes are generally recognized for being able to cross-talk with endothelial cells and regulate blood vessel leakage (<span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib2 bib50 bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Armulik et&nbsp;al., 2011; Raza et&nbsp;al., 2010; Stratman et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Armulik, A. ∙ Genové, G. ∙ Betsholtz, C.</div><div><strong>Pericytes: developmental, physiological, and pathological perspectives, problems, and promises</strong></div><div><em>Dev. Cell.</em> 2011; <strong>21</strong>:193-215</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.devcel.2011.07.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.devcel.2011.07.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79961230399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1996)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21839917/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2011.07.001&amp;pmid=21839917" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Raza, A. ∙ Franklin, M.J. ∙ Dudek, A.Z.</div><div><strong>Pericytes and vessel maturation during tumor angiogenesis and metastasis</strong></div><div><em>Am. J. Hematol.</em> 2010; <strong>85</strong>:593-598</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ajh.21745" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77955496673" target="_blank" aria-label="Open Scopus in new tab">Scopus (307)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20540157/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fajh.21745&amp;pmid=20540157" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Stratman, A.N. ∙ Malotte, K.M. ∙ Mahan, R.D. ...</div><div><strong>Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation</strong></div><div><em>Blood.</em> 2009; <strong>114</strong>:5091-5101</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2009-05-222364" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-73949086144" target="_blank" aria-label="Open Scopus in new tab">Scopus (448)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19822899/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2009-05-222364&amp;pmid=19822899" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, the correlation of pericyte abundance in controlling cancer growth and progression is still unclear (<span class="dropBlock reference-citations"><a id="body-ref-sref58-1" href="#" role="doc-biblioref" data-xml-rid="bib11 bib14 bib20 bib42 bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-1" aria-controls="sref58-1">Caspani et&nbsp;al., 2014; Cooke et&nbsp;al., 2012; Furuhashi et&nbsp;al., 2004; O’Keeffe et&nbsp;al., 2008; Sinha et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref58-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Caspani, E.M. ∙ Crossley, P.H. ∙ Redondo-Garcia, C. ...</div><div><strong>Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e101402</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0101402" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84904512087" target="_blank" aria-label="Open Scopus in new tab">Scopus (98)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25032689/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0101402&amp;pmid=25032689" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cooke, V.G. ∙ LeBleu, V.S. ∙ Keskin, D. ...</div><div><strong>Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:66-81</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84855912001" target="_blank" aria-label="Open Scopus in new tab">Scopus (440)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22264789/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2011.11.024&amp;pmid=22264789" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Furuhashi, M. ∙ Sjöblom, T. ∙ Abramsson, A. ...</div><div><strong>Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate</strong></div><div><em>Cancer Res.</em> 2004; <strong>64</strong>:2725-2733</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-03-1489" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-16544382996" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15087386/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-03-1489&amp;pmid=15087386" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>O’Keeffe, M.B. ∙ Devlin, A.H. ∙ Burns, A.J. ...</div><div><strong>Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes</strong></div><div><em>Oncol. Res.</em> 2008; <strong>17</strong>:93-101</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3727/096504008785055530" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-47549086341" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18669161/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3727%2F096504008785055530&amp;pmid=18669161" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Sinha, D. ∙ Chong, L. ∙ George, J. ...</div><div><strong>Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:1813-1824</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-15-1931" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84964329283" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26589433/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-15-1931&amp;pmid=26589433" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, the molecular mechanisms behind the regulation of tumor progression by pericytes are still largely unknown. Recent studies have revealed that tumor endothelial cells can produce angiocrine factors, endothelium-derived factors that can regulate tumor growth and chemosensitivity (<span class="dropBlock reference-citations"><a id="body-ref-sref73" href="#" role="doc-biblioref" data-xml-rid="bib1 bib5 bib9 bib10 bib23 bib24 bib25 bib36 bib44 bib64 bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73" aria-controls="sref73">Acharyya et&nbsp;al., 2012; Brantley-Sieders et&nbsp;al., 2011; Cao et&nbsp;al., 2014, 2017; Ghajar et&nbsp;al., 2013; Ghiabi et&nbsp;al., 2014; Gilbert and Hemann, 2010; Lu et&nbsp;al., 2013; Pedrosa et&nbsp;al., 2015; Tavora et&nbsp;al., 2014; Wieland et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref73"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Acharyya, S. ∙ Oskarsson, T. ∙ Vanharanta, S. ...</div><div><strong>A CXCL1 paracrine network links cancer chemoresistance and metastasis</strong></div><div><em>Cell.</em> 2012; <strong>150</strong>:165-178</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84863625224" target="_blank" aria-label="Open Scopus in new tab">Scopus (880)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22770218/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2012.04.042&amp;pmid=22770218" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Brantley-Sieders, D.M. ∙ Dunaway, C.M. ∙ Rao, M. ...</div><div><strong>Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium</strong></div><div><em>Cancer Res.</em> 2011; <strong>71</strong>:976-987</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-10-3396" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79551567742" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21148069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-10-3396&amp;pmid=21148069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Cao, Z. ∙ Ding, B.S. ∙ Guo, P. ...</div><div><strong>Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:350-365</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2014.02.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2014.02.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84896098492" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24651014/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.02.005&amp;pmid=24651014" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Cao, Z. ∙ Scandura, J.M. ∙ Inghirami, G.G. ...</div><div><strong>Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells</strong></div><div><em>Cancer Cell.</em> 2017; <strong>31</strong>:110-126</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2016.11.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2016.11.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85008402585" target="_blank" aria-label="Open Scopus in new tab">Scopus (102)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27989801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.11.010&amp;pmid=27989801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Ghajar, C.M. ∙ Peinado, H. ∙ Mori, H. ...</div><div><strong>The perivascular niche regulates breast tumour dormancy</strong></div><div><em>Nat. Cell Biol.</em> 2013; <strong>15</strong>:807-817</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncb2767" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84880332704" target="_blank" aria-label="Open Scopus in new tab">Scopus (857)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23728425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncb2767&amp;pmid=23728425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Ghiabi, P. ∙ Jiang, J. ∙ Pasquier, J. ...</div><div><strong>Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e112424</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0112424" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84911395686" target="_blank" aria-label="Open Scopus in new tab">Scopus (67)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25380486/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0112424&amp;pmid=25380486" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Gilbert, L.A. ∙ Hemann, M.T.</div><div><strong>DNA damage-mediated induction of a chemoresistant niche</strong></div><div><em>Cell.</em> 2010; <strong>143</strong>:355-366</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77958501473" target="_blank" aria-label="Open Scopus in new tab">Scopus (362)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21029859/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2010.09.043&amp;pmid=21029859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Lu, J. ∙ Ye, X. ∙ Fan, F. ...</div><div><strong>Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1</strong></div><div><em>Cancer Cell.</em> 2013; <strong>23</strong>:171-185</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2012.12.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2012.12.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84873728505" target="_blank" aria-label="Open Scopus in new tab">Scopus (363)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23375636/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.12.021&amp;pmid=23375636" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Pedrosa, A.R. ∙ Trindade, A. ∙ Carvalho, C. ...</div><div><strong>Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions</strong></div><div><em>Oncotarget.</em> 2015; <strong>6</strong>:24404-24423</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.18632/oncotarget.4380" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84943408033" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26213336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.18632%2Foncotarget.4380&amp;pmid=26213336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Wieland, E. ∙ Rodriguez-Vita, J. ∙ Liebler, S.S. ...</div><div><strong>Endothelial Notch1 Activity Facilitates Metastasis</strong></div><div><em>Cancer Cell.</em> 2017; <strong>31</strong>:355-367</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2017.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2017.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85013625323" target="_blank" aria-label="Open Scopus in new tab">Scopus (222)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28238683/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2017.01.007&amp;pmid=28238683" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For example, nuclear factor κB (NF-κB) signaling and its control of endothelial cell-derived cytokine production has been implicated in cancer progression and chemosensitivity (<span class="dropBlock reference-citations"><a id="body-ref-sref64-2" href="#" role="doc-biblioref" data-xml-rid="bib1 bib9 bib10 bib25 bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-2" aria-controls="sref64-2">Acharyya et&nbsp;al., 2012; Cao et&nbsp;al., 2014, 2017; Gilbert and Hemann, 2010; Tavora et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Acharyya, S. ∙ Oskarsson, T. ∙ Vanharanta, S. ...</div><div><strong>A CXCL1 paracrine network links cancer chemoresistance and metastasis</strong></div><div><em>Cell.</em> 2012; <strong>150</strong>:165-178</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84863625224" target="_blank" aria-label="Open Scopus in new tab">Scopus (880)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22770218/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2012.04.042&amp;pmid=22770218" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Cao, Z. ∙ Ding, B.S. ∙ Guo, P. ...</div><div><strong>Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:350-365</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2014.02.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2014.02.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84896098492" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24651014/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.02.005&amp;pmid=24651014" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Cao, Z. ∙ Scandura, J.M. ∙ Inghirami, G.G. ...</div><div><strong>Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells</strong></div><div><em>Cancer Cell.</em> 2017; <strong>31</strong>:110-126</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2016.11.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2016.11.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85008402585" target="_blank" aria-label="Open Scopus in new tab">Scopus (102)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27989801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.11.010&amp;pmid=27989801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Gilbert, L.A. ∙ Hemann, M.T.</div><div><strong>DNA damage-mediated induction of a chemoresistant niche</strong></div><div><em>Cell.</em> 2010; <strong>143</strong>:355-366</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77958501473" target="_blank" aria-label="Open Scopus in new tab">Scopus (362)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21029859/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2010.09.043&amp;pmid=21029859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Similar roles for paracrine signals derived from pericytes were hitherto less well studied.</div><div id="p0040" role="paragraph">Our findings suggest a concept where direct cross-talk between mural cells and tumor cells promotes cancer growth and that this is controlled by mural cell-β3-integrin.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>In Human Cancers, High Percentages of Tumor Blood Vessels that Are Mural-β3-Integrin Negative Correlate with Increased Tumor Size and Enhanced Disease Progression</h3><div id="p0045" role="paragraph">Here we show that mural cell-β3-integrin was expressed only in a subset of blood vessels and that mural-β3-integrin-negative blood vessels were evident. The range of percentages of blood vessels that were mural-β3-integrin negative across individual patient samples was wide in human cutaneous melanoma (mean value, 41%), diffuse large B cell lymphoma (mean value, 49%) and endoplasmic reticulum (ER)+ breast cancer (mean value, 57%) (<a id="crosref0235" href="#fig1">Figure&nbsp;1</a>A; <a id="crosref0240" href="#figs1">Figures S1</a>A–S1D). A high percentage of mural-β3-integrin-negative blood vessels (i.e., when more than the mean number of tumor blood vessels are mural-β3-integrin negative) correlated significantly with patients stratified into those with increased (1) tumor burden in human cutaneous melanoma (identified by increased Breslow thickness), (2) tumor cell proliferation in human cutaneous melanoma (<a id="crosref0245" href="#fig1">Figure&nbsp;1</a>B; <a id="crosref0250" href="#figs1">Figure&nbsp;S1</a>E), and (3) tumor size in human diffuse large B cell lymphoma and human ER+ breast cancer (<a id="crosref0255" href="#fig1">Figure&nbsp;1</a>B) but not with a change in blood vessel density (<a id="crosref0260" href="#fig1">Figure&nbsp;1</a>C). Importantly, a high proportion of mural-β3-integrin-negative blood vessels correlated with patients with (1) elevated metastasis incidence (<a id="crosref0265" href="#fig1">Figure&nbsp;1</a>D), (2) increased disease progression stage (<a id="crosref0270" href="#fig1">Figure&nbsp;1</a>E), (3) elevated incidence of relapse (<a id="crosref0275" href="#fig1">Figure&nbsp;1</a>F), and (4) advanced aggressive cancer phenotype (<a id="crosref0280" href="#fig1">Figure&nbsp;1</a> G) in primary human cutaneous melanoma, diffuse large B cell lymphoma, ER+ breast cancer, and mesothelioma, respectively. Together, these clinical data indicate that a high percentage of blood vessels that are mural-β3-integrin negative correlate with enhanced tumor size and progression with no apparent effect on blood vessel density.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/3c25bf3a-b886-43f0-97dc-45e5786ac148/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2020.02.003/asset/2cb90f37-4ea3-424d-8369-6aaa079c7ec0/main.assets/gr1.jpg" height="959" width="689" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/3c25bf3a-b886-43f0-97dc-45e5786ac148/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">High Percentages of Tumor Blood Vessels That Are Mural-β3-Integrin Negative Correlate with Increased Tumor Size and Enhanced Disease Progression in Human Cancers</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Human cutaneous melanoma (n&nbsp;= 52), human diffuse large B-cell lymphoma (DLCBL) (n&nbsp;= 54), and human breast cancer (n&nbsp;= 80) sections double-immunostained for β3-integrin and α-SMA. Representative images of melanoma sections. Arrows, β3-integrin<b>-</b>negative blood vessels. Bar charts, percentage of blood vessels that are mural β3-integrin negative for individual patients.</div><div id="fspara0020" role="paragraph">(B) Violin plots, individual tumor sizes (n&nbsp;= 49 cutaneous melanoma patients; n&nbsp;= 54 DLCBL patients; n&nbsp;= 80 breast cancer patients).</div><div id="fspara0025" role="paragraph">(C) CD31 immunostaining and blood vessel density.</div><div id="fspara0030" role="paragraph">(D) Cutaneous melanoma patients with more than the mean percentage (&gt;41%) of tumor blood vessels that are mural-β3-integrin negative associated significantly with increased metastasis incidence (n&nbsp;= 50 patient samples).</div><div id="fspara0035" role="paragraph">(E) Lymphoma patients with more than the mean (49%) percentage of mural−β3-integrin-negative tumor blood vessels (tumor blood vessels that are mural-β3-integrin negative) associated with advanced disease (stages II–IV) (n&nbsp;= 103 patient samples).</div><div id="fspara0040" role="paragraph">(F) Breast cancer patients with more than the mean percentage (57%) of tumor blood vessels that are mural-β3-integrin negative stratified into those with an increase in relapse incidence (n&nbsp;= 63 tumor samples).</div><div id="fspara0045" role="paragraph">(G) Human mesothelioma patients with a high percentage of mural-β3-integrin-negative blood vessels (&gt;51% of tumor blood vessels that are mural-β3-integrin negative) were significantly associated with advanced, aggressive types of mesothelioma including biphasic and sarcomatoid mesothelioma (n&nbsp;= 22 patient samples).</div><div id="fspara0050" role="paragraph">Each sample on the violin plots represent individual patient data. Means ± SEM are given. <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. N.S., no significant difference. Scale bar in (A), 25&nbsp;μm. (B), (C), (E), and (G), Student’s t test. (D) and (F), Chi-square test.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/b3783937-17f2-4c16-8419-8d998100b99f/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2020.02.003/asset/82373254-e6cb-4254-b2ac-ab44f02f9fe3/main.assets/figs1.jpg" height="861" width="678" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/b3783937-17f2-4c16-8419-8d998100b99f/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Representative Images of Mural β3-Integrin-Negative and Positive Human Tumor Blood Vessels, Related to <a id="crosref0860" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0325" role="paragraph">Representative images of double immunostained tumor sections for β3-integrin and α-SMA. Mural β3-integrin negative and β3-integrin positive vessels are given in melanoma (A), human lymphoma (B), human ER+ breast cancer (C) and mesothelioma (D). Yellow signal identifies β3-integrin and α-SMA co-staining. (E) In human melanoma, tumor cell proliferation is enhanced, indicating enhanced tumor growth, in patients where more than the mean (41) % of blood vessels are mural-β3-integrin negative (n=54-65 fields of view). Scale bars (A-D) 100&nbsp;μm, (E) 50&nbsp;μm.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>Generation and Characterization of <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> Mice</h3><div id="p0050" role="paragraph">In order to elucidate the possible mechanisms by which pericyte-β3-integrin loss could regulate cancer growth and progression, we generated a mouse model of <i>pdgfrβcre-</i>driven β3-integrin deficiency, where β3-integrin deficiency was confirmed in tumor pericytes. Mendelian ratios, male:female ratios, and average mouse weights were all normal for mice born to <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> × <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0285" href="#figs2">Figures S2</a>A–S2D). <i>Pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice showed no apparent defects in non-tumor-burdened tissues (<a id="crosref0290" href="#figs2">Figure&nbsp;S2</a>E), with poor cre-activity in pericytes of unchallenged skin but good cre activity in tumor pericytes (<a id="crosref0295" href="#figs2">Figure&nbsp;S2</a>F; <span class="dropBlock reference-citations"><a id="body-ref-sref54-1" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-1" aria-controls="sref54-1">Reynolds et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref54-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Reynolds, L.E. ∙ D’Amico, G. ∙ Lechertier, T. ...</div><div><strong>Dual role of pericyte α6β1-integrin in tumour blood vessels</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2017; <strong>130</strong>:1583-1595</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.197848" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85018256546" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28289267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.197848&amp;pmid=28289267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Mural cell purity was established (<a id="crosref0900" href="#figs2">Figure S2</a>G), and cell survival was not affected by loss of β3-integrin (<a id="crosref0305" href="#figs2">Figure&nbsp;S2</a>H). Loss of β3-integrin, but not β1 or β5 subunits, was evident only in pericytes isolated from <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0310" href="#figs2">Figure&nbsp;S2</a>I). Pericyte specificity of deletion was supported by expression of β3-integrin in endothelial cells and fibroblasts from <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0315" href="#figs2">Figures S2</a>J and S2K). These data indicate good specificity of β3-integrin deletion in tumor-associated pericytes from <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice in the systems tested.</div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/30e4124a-e00f-4f01-83be-e9810de1170d/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2020.02.003/asset/0522b333-2d4c-437d-bb7f-309299627726/main.assets/figs2.jpg" height="942" width="670" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/30e4124a-e00f-4f01-83be-e9810de1170d/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Characterization of pdgfrβcre-;β3<sup>fl/fl</sup> and pdgfrβcre+;β3<sup>fl/fl</sup> mice, Related to <a id="crosref0865" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0335" role="paragraph">(A) Crossing <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice produced litters in which the numbers of <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were born at predicted Mendelian ratios (n=95-100 mice per genotype). (B) Gender ratios of <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were normal (n=95-100 mice per genotype). (C) Mouse weights at 3&nbsp;months old. No differences were observed in the weights of sex-matched mice between the two genotypes (n=7-21 mice per genotype). (D) All mice were analyzed by PCR genotyping. <i>β3-integrin-floxed</i> PCR identifying homozygous <i>β3-integrin floxed</i> (<i>β3fl/fl</i>) (270&nbsp;bp), <i>WT non-floxed</i> (<i>β3-integrin wt</i>) (182&nbsp;bp) and <i>pdgfrβcre</i> PCR shows a product identifying <i>pdgfrβcre</i> at 669&nbsp;bp. (E) Representative H&amp;E stained sections of heart, liver lung, kidney and spleen from 12&nbsp;week old <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. No gross morphological defects were observed. (F) <i>Upper panels</i>, Unchallenged adult skin from <i>pdgfrβcre-</i>;<i>TdTom</i> immunostained for endomucin and PDGFRβ shows weak PDGFRβ expression in mural cells in 76.6% dermal vessels. No <i>TdTom</i> signal was observed in <i>pdgfrβcre-</i>;<i>TdTom skin (data not shown).</i> Unchallenged adult skin from <i>pdgfrβcre+</i>;<i>TdTom</i> shows TdTom reporter signal in only 32.6% of dermal blood vessels. <i>Arrows</i>, PDGFRβ−positive or TdTom-positive vessels. <i>Arrowheads,</i> PDGFRβ-negative or TdTom-negative vessels. <i>Lower panels, pdgfrβcre-</i> and <i>pdgfrβcre+</i> mice were bred with <i>mTmG</i> reporter mice, producing both <i>pdgfrβcre-;mTmG</i> and <i>pdgfrβcre+;mTmG</i> mice. B16F0s were subcutaneously inoculated into mice. Tumor blood vessels were examined for expression of both membrane-targeted tandem dimer Tomato (mT) (red), observed in host tissue, and membrane-targeted green fluorescent protein (GFP) (mG) (green), which is observed only after Cre excision. GFP expression was found exclusively in mural cells surrounding blood vessels in <i>pdgfrβcre+;mTmG</i> mice only. (G) Flow cytometry of pericytes isolated from <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> mice show that the purity of pericyte preparation is high. Pericyte preparations showed good expression of NG2, PDGFRβ and CD146 (all pericyte markers) and low levels of CD31 (endothelial cell marker), Mac1 (macrophage marker) and PDGFRα (fibroblast marker). Median values are given (n=3 experimental repeats). Negative controls (blue peaks), target signals (orange peaks). (H) MTS cell survival assay showing WT and β3-integrin-null pericytes relative cell survival (n= 8 replicates per group). (I) Western blot analysis revealed that pericytes isolated from <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> mice expressed β3-integrin whereas pericytes isolated from <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice did not. Both genotypes expressed equal levels of β1-integrin, β5-integrin, PDGFRβ and NG2. Hsc70 acted as a loading control. Densitometric values are given (n=3 experimental repeats). (J) Western blots. Endothelial cells isolated from <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice showed no deletion in β3-integrin, and expressed the endothelial marker endomucin but not the pericyte marker NG2. Densitometric values are given, n=5 experimental repeats). (K) Western blots. Fibroblasts isolated from <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice also expressed β3-integrin. Densitometric values are given. Bar charts represent means ± s.e.m. (n=5 experimental repeats). These data further support that loss of β3-integrin was not found in endothelial cells or fibroblasts but only in pericytes isolated from <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. (L) Double immunofluorescence staining for β3-integrin and α-SMA demonstrated that pericytes in B16F0 subcutaneous tumors grown in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice had reduced β3-integrin expression levels. Magnified regions show β3-integrin-positive pericytes (yellow signal) on <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> tumor blood vessels, but β3-integrin-negative pericytes on <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> tumor blood vessels. Bar chart represents mean pixel intensity of β3-integrin expression in α-SMA positive cells ± s.e.m (n=5 tumors analyzed per genotype). (M) Ki67 endomucin double staining and Ki67 positive cell analysis in the perivascular areas (<i>dotted line</i>) of B16F0-tumors grown in <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> mice and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. Enhanced tumor cell proliferation in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice acts as an indicator of enhanced tumor growth. (N) <i>Pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> mice and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were injected with 0.5 x 10<sup>6</sup> CMPTX labelled B16F10 melanoma cells via the tail vein. Mice were sacrificed and lungs harvested 2 and 48&nbsp;hr after the injection. The number of CMPTX positive cells in the lungs was not different between genotypes (n=9-10 lungs analyzed per group). (O) E0771 cells co-injected into the mammary fat pad in <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice, culled when tumors reached 600&nbsp;mm<sup>3</sup> and subsequent lung metastases assessed by analysis of H&amp;E stained sections. Results showed that although no changes in the numbers of metastases were observed, metastases were larger in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (n=6 mice per group). H&amp;E stained section images in (O) were taken by using Panoramic scanner and Panoramic viewer 3D HISTECH software. The scanner produced images by tiling high resolution sections together. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&lt;0.001. (C-O) Student’s <i>t</i> test. Scale bar (E) 50&nbsp;μm, (F) 100&nbsp;μm, (L) 100&nbsp;μm, (M) 25&nbsp;μm, (O) 50&nbsp;μm, (N) 500&nbsp;μm,</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Loss of Pericyte-β3-Integrin Enhances Tumor Growth in Mice</h3><div id="p0055" role="paragraph">To examine the effect of pericyte-β3-integrin loss on tumor growth, <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were injected subcutaneously with syngeneic mouse melanoma B16F0 and Lewis lung carcinoma (LLC) cells. Immunofluorescence analysis confirmed reduced β3-integrin expression in platelet-derived growth factor receptor β (PDGFRβ)-positive and α-SMA-positive tumor blood vessel pericytes only in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0320" href="#fig2">Figure&nbsp;2</a>A; <a id="crosref0325" href="#figs2">Figure&nbsp;S2</a>L). B16F0 tumor growth and tumor cell proliferation (Ki67) were enhanced significantly in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0330" href="#fig2">Figure&nbsp;2</a>B; <a id="crosref0335" href="#figs2">Figure&nbsp;S2</a>M). The increase in tumor growth was confirmed using LLC tumor cells in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0340" href="#fig2">Figure&nbsp;2</a>C). In a second experimental setting, B16F10 or LLC cells were injected via the tail vein, and lung tumor burden was measured by microCT imaging. No differences in the number of CMTPX-labeled tumor cell homing (2&nbsp;h after tail vein injection) or seeding (48&nbsp;h after injections) were observed between the lungs of each genotype (<a id="crosref0345" href="#figs2">Figure&nbsp;S2</a>N). However, at 16&nbsp;days after inoculation, enhanced tumor burden was observed in the lungs of <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0350" href="#fig2">Figures 2</a>D and 2E). This correlated with an increase in the number and size of B16F10 and LLC lung nodules in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0355" href="#fig2">Figures 2</a>F and 2G). Orthotopic growth of syngeneic mammary E0771 tumor cells was also enhanced in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0360" href="#fig2">Figure&nbsp;2</a>H). However, although no difference in the number of&nbsp;spontaneous lung metastases was observed, the size of E0771 lung metastases was significantly increased in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0365" href="#figs2">Figure&nbsp;S2</a>O). Corroborating these results at 13&nbsp;weeks of age, spontaneous pancreatic tumor growth was significantly enhanced in <i>RIPtag-2</i>+;<i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice compared with <i>RIPtag-2+</i>;<i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0370" href="#fig2">Figure&nbsp;2</a>I). Together, these data suggest that loss of pericyte-β3-integrin is sufficient to enhance tumor growth at primary and secondary sites.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/58568896-52b0-48b3-8351-b28c03d33a60/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2020.02.003/asset/216dc664-19c8-4d9a-a337-5ed793e445e6/main.assets/gr2.jpg" height="952" width="715" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/58568896-52b0-48b3-8351-b28c03d33a60/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Pericyte-β3-Integrin Deletion Increases Tumor Growth</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0060" role="paragraph">(A) Double immunofluorescence staining for β3-integrin in B16F0 subcutaneous tumors in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre−;β3</i><sup><i>fl/fl</i></sup> mice.</div><div id="fspara0065" role="paragraph">(B and C) B16F0 (B) and LLC tumor growth (C) in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre−;β3</i><sup><i>fl/fl</i></sup> mice (n=10-14 mice per group). Representative images of B16F0 and LLC tumors are given.</div><div id="fspara0070" role="paragraph">(D and E) <i>Pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were injected with either B16F10 melanoma (D) or LLC cells (E) via the tail vein. Representative high-resolution microCT images of lung capacity 16&nbsp;days post-tumor-cell inoculation are given. Red signal represents air in lungs. Graphs represent lung capacity and % loss of lung capacity (n&nbsp;= 4–6 mice imaged per group).</div><div id="fspara0075" role="paragraph">(F and G) Loss of pericyte β3-integrin expression significantly increased the number and size of lung nodules in both B16F10 (F) and LLC (G). Bar charts represent means ± SEM (n&nbsp;= 7–9 mice per group). Representative images of tumor burdened lungs and their hematoxylin and eosin (H&amp;E)-stained sections are given.</div><div id="fspara0080" role="paragraph">(H) Orthotopic E0771 tumor growth. (n&nbsp;= 6 mice per group).</div><div id="fspara0085" role="paragraph">(I) Tumor size in 13-week-old <i>RIPtag-2;pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> and <i>RIPtag-2;pdgfrβcre−;β3</i><sup><i>fl/fl</i></sup> mice (n&nbsp;= 8–10 mice per group). H&amp;E of pancreatic tumor sections provided. All H&amp;E stained section images were taken by Panoramic scanner and Panoramic viewer 3D HISTECH software. The scanner produced images by tiling high resolution fields together.</div><div id="fspara0090" role="paragraph"><sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. (B)–(E) and (H), Two-way ANOVA test. (F), (G), and (I), Student’s t test. Scale bars in (A), 100&nbsp;μm; (B)–(E), 5&nbsp;mm; (F) and (G) gross lung, 1.0&nbsp;cm and H&amp;E sections, 500&nbsp;μm; (I), 200&nbsp;μm.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-4"><h3>Pericyte-β3-Integrin Deletion Does Not Cause Gross Changes in Tumor Blood Vessel Numbers or Function</h3><div id="p0060" role="paragraph">The effect of pericyte-β3-integrin loss on vascular properties was examined next. Blood vessel density, detected by immunostaining for endomucin, was not significantly different in B16F0, B16F10, LLC, or E0771 tumors in <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice or spontaneous pancreatic tumors in <i>RIPtag-2</i>+;<i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> and <i>RIPtag-2</i>+;<i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0375" href="#fig3">Figures 3</a>A and 3B; <a id="crosref0380" href="#figs3">Figures S3</a>A–S3D). The percentage of blood vessels lacking mural cells was not significantly changed between genotypes (<a id="crosref0385" href="#fig3">Figures 3</a>A and 3B; <a id="crosref0390" href="#figs3">Figures S3</a>E and S3G). No differences between the percentage of tumor blood vessels perfused (<a id="crosref0395" href="#fig3">Figure&nbsp;3</a>C; <a id="crosref0400" href="#figs3">Figures S3</a>F) and the percentage of tumor blood vessels with basement membrane collagen IV in <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> or <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were detected (<a id="crosref0405" href="#fig3">Figure&nbsp;3</a>D; <a id="crosref0410" href="#figs3">Figure&nbsp;S3</a>H). Blood vessel leakage, tumor hypoxia, and blood flow were also not changed between genotypes (<a id="crosref0415" href="#fig3">Figures 3</a>E and 3F; <a id="crosref0420" href="#figs3">Figures S3</a>I and S3J). Last, unchallenged skin of <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice showed no difference in blood vessel density, percentage of αSMA-negative vessels (pericyte coverage), or vessel leakage (<a id="crosref0425" href="#figs3">Figure&nbsp;S3</a>K), most likely because previous reports and our own data indicate that <i>pdgfrβ</i> promoter activity is low in mural cells of normal quiescent vessels (<a id="crosref0430" href="#figs2">Figure&nbsp;S2</a>F; <span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib31 bib47 bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Heldin, 2013; Pietras et&nbsp;al., 2002; Wang et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Heldin, C.H.</div><div><strong>Targeting the PDGF signaling pathway in tumor treatment</strong></div><div><em>Cell Commun. Signal.</em> 2013; <strong>11</strong>:97</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1478-811X-11-97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84890467312" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24359404/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1478-811X-11-97&amp;pmid=24359404" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Pietras, K. ∙ Rubin, K. ∙ Sjöblom, T. ...</div><div><strong>Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy</strong></div><div><em>Cancer Res.</em> 2002; <strong>62</strong>:5476-5484</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12359756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=12359756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Wang, Z. ∙ Ahmad, A. ∙ Li, Y. ...</div><div><strong>Emerging roles of PDGF-D signaling pathway in tumor development and progression</strong></div><div><em>Biochim. Biophys. Acta.</em> 2010; <strong>1806</strong>:122-130</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20434526/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=20434526" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Together, these data suggest that the enhanced tumor growth in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice is not associated with any gross effect on tumor blood vessel number, maturation, perfusion, or flow functions and led us to investigate whether a possible paracrine effect of β3-null pericytes on tumor cells could affect tumor growth directly.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/39b4eae0-22e6-4d86-ba7d-b3df50e1f5cd/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2020.02.003/asset/a92528ce-fcb8-498b-b12c-22479360130c/main.assets/gr3.jpg" height="950" width="645" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/39b4eae0-22e6-4d86-ba7d-b3df50e1f5cd/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Tumor Blood-Vessel Density, Perfusion, Pericyte Coverage, Leakage, and Blood Flow Are Not Affected by Pericyte-β3-Integrin Loss</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0100" role="paragraph">Midline sections of (A) B16F0 subcutaneous tumors and (B) primary <i>RIPtag-2</i> tumors immunostained for endomucin to detect blood vessels (n= 4–9 mice per group) or double immunostained for endomucin and α-SMA for percentage of pericyte-free vessel analysis.</div><div id="fspara0105" role="paragraph">(C) Mice injected antemortem via the tail vein with a PE-PECAM antibody (red) to detect perfused blood vessels. Tumor sections subsequently immunostained for endomucin to detect all blood vessels (green) and the percentage of perfused blood vessel assessed by counting the percentage of endomucin positive blood vessels that displayed PE-PECAM. (n&nbsp;= 4–5 tumors per group).</div><div id="fspara0110" role="paragraph">(D) Tumour sections double-immunostained for basement membrane marker collagen IV (green) and CD31 (red). Bar charts, percentage of blood vessels with associated collagen IV expression (n&nbsp;= 5–8 B16F0 tumors per group) (n&nbsp;= 11–12 <i>RIPtag-2</i> tumors per group).</div><div id="fspara0115" role="paragraph">(E) For blood vessel leakage mice were injected via the tail vein, in an antemortem process, with PE-PECAM ab (red) and Hoechst dye (blue). Relative area of Hoechst dye uptake into perivascular tumor cells to area of PE-PECAM provides an indication of vessel leakage. Bar charts, means ± SEM (n&nbsp;= 4–11 tumors analyzed per group).</div><div id="fspara0120" role="paragraph">(F) Doppler ultrasonography in live mice provides relative blood flow, tumor perfusion, and tumor blood volume in subcutaneous B16F0 tumors. Representative ultrasound images. Bar charts, quantitation across the whole tumors (n&nbsp;= 4 tumors analyzed per group). </div><div id="fspara0125" role="paragraph">N.S., no significant difference. (A)–(F), Student’s t test. Scale bars in (A)–(C), 50&nbsp;μm; (D), 100&nbsp;μm; (E), 25&nbsp;μm; (F), 5&nbsp;mm.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/14107f96-10f0-4080-ba3f-56de8984222e/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2020.02.003/asset/443dc136-10f9-429d-aa4b-19ebb2aaf45d/main.assets/figs3.jpg" height="952" width="689" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/14107f96-10f0-4080-ba3f-56de8984222e/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Tumor Blood Vessel Density, Pericyte Coverage, and Leakiness Is Not Affected by Pericyte-β3-Integrin Deletion, Related to <a id="crosref0870" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0345" role="paragraph">Sections of: (A) LLC subcutaneous, (B) B16F10 lung nodules, (C) LLC lung nodule and (D) E0771 orthotopic mammary tumors were stained for endomucin, and the number of vessels per mm<sup>2</sup> counted. Quantitation shows that the number of vessels per mm<sup>2</sup> was not affected in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. (E) Sections of LLC subcutaneous tumors were double immunostained for endomucin and α-SMA and the percentage of vessels with associated pericytes counted. Quantitation shows that the percentage of α-SMA-positive tumor blood vessels was not affected in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. (n=7-9 subcutaneous tumors analyzed per group). (F) Sections from subcutaneous LLC tumors from mice that had been injected via the tail vein with PE-PECAM ab (red), to detect perfused vessels, were immunostained for endomucin (green). Bar charts indicate that percentage of PE-PECAMab perfused endomucin-positive vessels. (G) Sections of E0771 orthotopic mammary tumors were double immunostained for endomucin and α-SMA and the percentage of vessels with associated pericytes counted. Quantitation shows that the percentage of α-SMA-positive tumor blood vessels was not affected in <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. (n=7-9 subcutaneous tumors analyzed per group). (H) Sections from subcutaneous LLC tumors were double immunostained for basement membrane marker collagen IV (green) and CD31 as an endothelium marker (red). Bar charts indicate that the percentage of blood vessels with collagen IV expression in LLC tumor vascular basement membranes was unchanged between genotypes (n=9-10 tumors analyzed per group). (I) Relative area of perivascular Hoechst dye leakage (blue): PE-PECAM ab (red) in LLC tumors grown in <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice after ante-mortem intravenous injection of Hoechst dye. No significant change in perivascular leakage between <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup><i>and pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice was observed. Bar charts represent means ± s.e.m. (n=4-5 tumors analyzed per group). (J) Tumor hypoxia. Immunodetection of the hypoxia marker pimonidazole shows no significant difference between genotypes in tumor hypoxia in both B16F0 and LLC tumors grown in <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> after ante-mortem administration of PE-PECAM ab to detect perfused vessels and pimonidazole to detect hypoxia. Bar charts represent means ± s.e.m. (n=4-5 tumors analyzed per group). (K) Unchallenged skin from <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were sectioned and double immunostained for endomucin and α-SMA. Quantitation of blood vessel density; pericyte association with blood vessels and vascular leakage, using Hoechst as above, was unchanged between genotypes. Bar charts represent means ± s.e.m. (n=3-5 mice per group). N.S., no significant difference. (A-K) Student’s <i>t</i> test. Scale bars in (A-F) 50&nbsp;μm, (G, I, J) 50&nbsp;μm, (H) 100&nbsp;μm.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-5"><h3>Deletion of Mural Cell-β3-Integrin Increases Tumor Cell Growth Independent of Effects on Tumor Blood Vessels</h3><div id="p0065" role="paragraph">To test the paracrine effect of β3-null mural cells on tumor growth, we developed experiments where wild-type C57BL/6 mice were co-injected with tumor cells and either wild-type (WT) or β3-null pericytes and the resulting tumors analyzed. Subcutaneous co-injection of B16F0 with β3-null pericytes (1:8) showed enhanced tumor growth compared with co-injection of WT pericytes with B16F0 cells (<a id="crosref0435" href="#fig4">Figure&nbsp;4</a>A; <a id="crosref0440" href="#figs4">Figure&nbsp;S4</a>A). No differences in tumor blood vessel density or pericyte coverage were observed between these groups (<a id="crosref0445" href="#fig4">Figure&nbsp;4</a>B). In a second model, co-injection of B16F10 cells with β3-null pericytes via the tail vein of WT C57BL/6 mice increased the number of B16F10 lung nodules and relative nodule size above that of WT pericytes at both 1:4 and 1:8 ratios (<a id="crosref0450" href="#fig4">Figure&nbsp;4</a>C; <a id="crosref0455" href="#figs4">Figure&nbsp;S4</a>B). Using CMTPX-tagged pericytes, the survival of WT and β3-null pericytes after injection in C57BL/6 mice was not different <i>in&nbsp;vivo</i> (<a id="crosref0460" href="#fig4">Figure&nbsp;4</a>D), suggesting that changes in tumor burden were not affected by differential pericyte survival. Furthermore, blood vessel density and pericyte coverage of blood vessels were not altered (<a id="crosref0465" href="#fig4">Figure&nbsp;4</a>E; <a id="crosref0470" href="#figs4">Figure&nbsp;S4</a>C). B16F0 cell invasion was similar when B16F0 cells were incubated with conditioned medium from WT or β3-null pericytes, suggesting that tumor cell invasion is not affected by paracrine signals generated from β3-null pericytes (<a id="crosref0475" href="#fig4">Figure&nbsp;4</a>F). In another model, although the number of spontaneous E0771 lung metastases was similar between groups, the size of metastases was elevated in mice that were co-injected with β3-null pericytes (<a id="crosref0480" href="#fig4">Figure&nbsp;4</a>G; <a id="crosref0485" href="#figs4">Figure&nbsp;S4</a>D). <i>In&nbsp;vitro</i>, conditioned medium from β3-null pericytes was able to significantly enhance tumor cell numbers, indicating that a paracrine signal from pericytes controlled malignant cell growth (<a id="crosref0490" href="#fig4">Figure&nbsp;4</a>H). These data, together with the evidence showing that tumor cell homing and seeding in the lungs are not affected by loss of pericyte-β3-integrin, suggested that tumor growth, either at primary or secondary sites, was enhanced by loss of pericyte-β3-integrin, pointing toward a possible paracrine mechanism of pericyte-tumor cell cross-talk that is regulated by pericyte-β3-integrin.</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/6553f85f-9ccd-46d4-a29b-1a47d21115ee/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2020.02.003/asset/ffc25762-52a2-4bc1-a3b4-170a5fe525f9/main.assets/gr4.jpg" height="943" width="693" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/6553f85f-9ccd-46d4-a29b-1a47d21115ee/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">β3-Integrin-Deficient Pericytes Enhance Tumor Cell Growth Independent of the Tumor Vasculature</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0135" role="paragraph">(A) Tumour growth in WT mice injected subcutaneously with either B16F0 cells plus WT pericytes, or B16F0 plus β3-null pericytes at 1:8 ratios. (n&nbsp;= 10 tumors per group).</div><div id="fspara0140" role="paragraph">(B) Blood vessel density and the percentage of vessels without associated α-SMA-positive pericyte coverage (n&nbsp;= 5–8 tumors per group).</div><div id="fspara0145" role="paragraph">(C) B16F10 tumor growth in lungs of wildtype mice injected via the tail vein with either B16F10 cells plus WT pericytes or B16F10 cells plus β3-null pericytes at 1:4 or 1:8 ratios at 21&nbsp;days post-injection. Gross tumor burdened lungs and H&amp;E stained images are given (n&nbsp;= 3–5 mice per group).</div><div id="fspara0150" role="paragraph">(D) WT mice injected with either 0.5&nbsp;× 10<sup>6</sup> CMTPX labelled WT pericytes or β3-null pericytes and lungs harvested at 2&nbsp;h and 48&nbsp;h after the injection. Representative stereomicroscopic images of fresh lungs from both genotypes (n&nbsp;= 5 lungs per group).</div><div id="fspara0155" role="paragraph">(E) Quantitation showed no difference in blood vessel density across any of the groups (detailed in [C]). Bar charts, means ± SEM (n&nbsp;= 3–5 tumor-burdened lungs analyzed per group).</div><div id="fspara0160" role="paragraph">(F) Transwell cell invasion assay showed no significant difference in invasion between B16F0 cells treated with conditioned medium from either WT pericytes or β3-null pericytes (n&nbsp;= 9–11 technical repeats).</div><div id="fspara0165" role="paragraph">(G) E0771 cells were co-injected with WT- or β3-null pericytes into the mammary fat pad of C75BL/6 mice. Mice were culled when tumors reached 600&nbsp;mm<sup>3</sup> and lung metastases assessed (n&nbsp;= 8 mice per group). Representative images of H&amp;E stained sections are given.</div><div id="fspara0170" role="paragraph">(H) Conditioned medium from WT or β3-null pericytes was applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assays. All H&amp;E-stained section images were taken by Panoramic scanner and Panoramic viewer 3D HISTECH software. The scanner produced images by tiling high-resolution fields together.</div><div id="fspara0175" role="paragraph">Results are means ± SEM relative to tumor cells treated with conditioned media from WT pericytes (n&nbsp;= 3 experimental repeats). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. N.S., no significant difference. PC, pericytes. (A), Two-way ANOVA test. (B)–(H), Student’s t test. Scale bars in (B) and (G), 50&nbsp;μm; (C) gross lung, 1.0&nbsp;cm and H&amp;E sections, 500&nbsp;μm; (D), 500&nbsp;μm; (G), 50&nbsp;μm.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/94e000cf-008e-48b5-a0cd-7aaada7231e3/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2020.02.003/asset/2b806d41-0630-483f-982c-0b76302911b7/main.assets/figs4.jpg" height="887" width="675" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/94e000cf-008e-48b5-a0cd-7aaada7231e3/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">β3-Integrin-Deficient Pericytes Enhance Tumor Cell Growth Independent of the Tumor Vasculature, Related to <a id="crosref0875" href="#fig4">Figure&nbsp;4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0355" role="paragraph">Schematic representation of the protocol for co-injection of B16F0 tumor cells with WT or β3-integrin null pericytes either (A) subcutaneously or (B) via the tail vein. (C) Immunofluorescence images of endomucin and α-SMA double immunostaining in sections of the lung nodules described in main <a id="crosref0880" href="#fig4">Figure&nbsp;4</a>C. Quantitation shows no difference in blood vessel density or percentage of pericyte-free tumor blood vessels across any of the groups, demonstrating that elevated tumor growth in the presence of β3-null pericytes is independent of blood vessel numbers and mural cell support. Bar charts represent means ± s.e.m. (n=3-5) tumor burdened lungs analyzed per group. (D) Schematic representation of the protocol for the orthotopic co-injection of E0771 tumor cells and WT or β3-integrin null pericytes into female C57BL/6 mice. N.S., no significant difference. PC, pericytes. N.S., no significant difference. (C) Student’s <i>t</i> test. Scale bars in (C) 50&nbsp;μm.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-6"><h3>Increased Focal Adhesion Kinase (FAK)-p-HGFR-p-Akt-NF-κB Signaling and Subsequent Chemokine Production in β3-Deficient Pericytes Enhances Tumor Cell ROCK2 Signaling and Tumor Cell Survival</h3><div id="p0070" role="paragraph">Next, the molecular mechanisms underlying pericyte-β3-integrin-tumor cell crosstalk were explored. Unbiased proteomics analysis of WT and β3-null pericytes identified increased expression of multiple candidates in β3-null pericytes. These included FAK, a major known regulator of integrin signaling (<span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Guan, 2010</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Guan, J.L.</div><div><strong>Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer</strong></div><div><em>IUBMB Life.</em> 2010; <strong>62</strong>:268-276</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/iub.311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77951125212" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20101634/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fiub.311&amp;pmid=20101634" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0500" href="#fig5">Figure&nbsp;5</a>A; <a id="crosref0505" href="#figs5">Figure&nbsp;S5</a>A). <i>Proteome-Profiler</i> tyrosine kinase and receptor tyrosine kinase arrays identified that β3-null pericytes also had significantly elevated levels of p-HGFR, p-Akt (S473), and p-Akt (T308) compared with WT pericytes (<a id="crosref0510" href="#fig5">Figure&nbsp;5</a>B). The enhancement of Akt signaling was further supported by increased expression of phospho-Akt1 (S122) and phospho-Akt1 (S129) in β3-null pericytes (<a id="crosref0515" href="#figs5">Figure&nbsp;S5</a>A). Previous studies have shown that elevated HGFR phosphorylation can activate Akt activity (<span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">Usatyuk et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Usatyuk, P.V. ∙ Fu, P. ∙ Mohan, V. ...</div><div><strong>Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2014; <strong>289</strong>:13476-13491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M113.527556" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84900465261" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24634221/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M113.527556&amp;pmid=24634221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which has been recognized previously to regulate angiocrine signaling from endothelial cells (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Guerrouahen et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Guerrouahen, B.S. ∙ Pasquier, J. ∙ Kaoud, N.A. ...</div><div><strong>Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer</strong></div><div><em>Mol. Cancer Ther.</em> 2014; <strong>13</strong>:3123-3136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1535-7163.MCT-13-1053" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84917705793" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25319392/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1535-7163.MCT-13-1053&amp;pmid=25319392" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). At a molecular level, Akt activity is also known to regulate NF-κB-mediated signaling (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib12 bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Cheng et&nbsp;al., 2011; Dan et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Cheng, J. ∙ Phong, B. ∙ Wilson, D.C. ...</div><div><strong>Akt fine-tunes NF-κB-dependent gene expression during T&nbsp;cell activation</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2011; <strong>286</strong>:36076-36085</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M111.259549" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-80053909808" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21862580/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M111.259549&amp;pmid=21862580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Dan, H.C. ∙ Cooper, M.J. ∙ Cogswell, P.C. ...</div><div><strong>Akt-dependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK</strong></div><div><em>Genes Dev.</em> 2008; <strong>22</strong>:1490-1500</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1662308" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-44849117768" target="_blank" aria-label="Open Scopus in new tab">Scopus (512)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18519641/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1662308&amp;pmid=18519641" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Western blot analysis confirmed that, in addition to increased phospho-hepatocyte growth factor receptor (p-HGFR) expression, phosphorylation of both Akt (at S473) and the NF-kB subunit p65 (at S536) was elevated in β3-null pericytes (<a id="crosref0530" href="#fig5">Figure&nbsp;5</a>C). The upregulation of activated p65 was confirmed by increased nuclear localization of p-p65 in β3-null pericytes (<a id="crosref0535" href="#figs5">Figure&nbsp;S5</a>B). Pharmacological inhibition of β3-integrin using cilengitide (<span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Mas-Moruno et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Mas-Moruno, C. ∙ Rechenmacher, F. ∙ Kessler, H.</div><div><strong>Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation</strong></div><div><em>Anticancer. Agents Med. Chem.</em> 2010; <strong>10</strong>:753-768</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2174/187152010794728639" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79952741178" target="_blank" aria-label="Open Scopus in new tab">Scopus (512)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21269250/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2174%2F187152010794728639&amp;pmid=21269250" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) in WT pericytes also enhanced the levels of phospho-HGFR, -Akt, and -p65 (<a id="crosref0545" href="#figs5">Figure&nbsp;S5</a>C). Activation of p65 has been associated with upregulation of cytokine production (<span class="dropBlock reference-citations"><a id="body-ref-sref64-3" href="#" role="doc-biblioref" data-xml-rid="bib49 bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-3" aria-controls="sref64-3">Poulos et&nbsp;al., 2016; Tavora et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Poulos, M.G. ∙ Ramalingam, P. ∙ Gutkin, M.C. ...</div><div><strong>Endothelial-specific inhibition of NF-κB enhances functional haematopoiesis</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:13829</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms13829" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85006954187" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28000664/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms13829&amp;pmid=28000664" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Here, β3-null pericytes produced significantly elevated levels of cytokine-related factors, including sICAM-1, interleukin-1β (IL-1β), CXCL1, CCL2, and TIMP-1 compared with WT pericytes (<a id="crosref0550" href="#fig5">Figure&nbsp;5</a>D). The clinical relevance of the enhanced levels of p-Akt and nuclear p65 were supported by the significant upregulation of p-Akt (<a id="crosref0555" href="#fig5">Figure&nbsp;5</a>E; <a id="crosref0560" href="#figs5">Figures S5</a>D and S5E) and nuclear p65 (<a id="crosref0565" href="#fig5">Figure&nbsp;5</a>F) in mural cells of human cancers where more than the mean percentage of blood vessels were mural-β3-integrin negative.</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/bed39d45-1136-4f1e-b54c-e0b71b3dc1e6/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2020.02.003/asset/986f651e-d443-4896-b67e-ca391618b281/main.assets/gr5.jpg" height="940" width="703" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/bed39d45-1136-4f1e-b54c-e0b71b3dc1e6/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Loss of Pericyte-β3-Integrin Expression Significantly Increases FAK-pHGFR-pAkt-p-p65-Dependent Cytokine Production</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0185" role="paragraph">(A) Volcano plot of phosphoproteomic analysis shows significant enhancement of several phosphoproteins including FAK in β3-null versus WT pericytes.</div><div id="fspara0190" role="paragraph">(B) Analysis of receptor tyrosine kinase (RTK) arrays or tyrosine kinase (TK) arrays shows a significant increase in p-HGFR, p-Akt (S473), and p-Akt (T308) levels in β3-null pericytes compared with WT pericytes (n&nbsp;= 4 dots from 2 experimental repeats).</div><div id="fspara0195" role="paragraph">(C) Western blot analysis of WT and β3-null pericyte lysates. Bar charts represent densitometric values of phospho-proteins relative to total protein values ± SEM (n&nbsp;= 5 experimental repeats). Hsc70, loading control.</div><div id="fspara0200" role="paragraph">(D–F) Protein-profiler cytokine array analysis of fold increase in cytokine expression between WT and β3-null pericytes (n&nbsp;= 4 dots from 2 experimental repeats) (D). Representative images of the relevant dots from the cytokine arrays are given. Human cutaneous melanoma, lymphoma, and ER+ breast cancer samples were double immunostained for the mural cell marker α-SMA and for either p-Akt (E) or nuclear p65 (F). High proportions of mural-β3-integrin-negative blood vessels are associated with elevated levels of p-Akt and nuclear p65 in all human cancers (n&nbsp;= 5–6 patient samples). Representative images of double immunostained sections from each cancer type for α-SMA and with either p-Akt or p65 are given. Arrows highlight p-Akt (E) or nuclear p65 (F) staining. Each sample in the violin plots given represents individual tumors from separate patients. Means ± SEM are given.</div><div id="fspara0205" role="paragraph">(G–I) Western blot analysis of β3-null pericytes after treatment with vehicle alone (DMSO) or FAK inhibitor (PF573228 10&nbsp;μM). Bar charts, average densitometric analysis relative to loading controls (=3 experimental repeats). β3-null pericytes were treated with either vehicle alone (DMSO), HGFR-inhibitor (H), or Akt-inhibitor (I) for 10, 30, and 60&nbsp;min. Western blot analysis of DMSO-, HGFR-inhibitor-, or Akt-inhibitor-treated β3-null pericytes.</div><div id="fspara0210" role="paragraph">Bar charts represent densitometric values of phospho-proteins relative to total protein means ± SEM (n&nbsp;= 3 experimental repeats). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. N.S., no significant difference. (B)–(I), Student’s t test. Scale bars in (E) and (F), 100&nbsp;μm.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/b57e4a22-c3f8-48dd-bcd4-32fd48d367aa/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2020.02.003/asset/46ed39ae-5d39-42df-a8f3-52faa54c849a/main.assets/figs5.jpg" height="787" width="678" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/b57e4a22-c3f8-48dd-bcd4-32fd48d367aa/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Loss of β3 Expression or Function Enhances Alternative Signalling Pathways, Related to <a id="crosref0885" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0365" role="paragraph">(A) Phosphoproteomic analysis identified levels of FAK1 and phosphorylated Akt1 (Ser122) and Akt1 (Ser129) in WT and β3-integrin null pericytes. Bar charts represent ppm units of 3 different samples per group. (B) WT and β3-null pericytes were immunostained for p-p65 and DAPI. Quantitation revealed that nuclear p-p65 was enhanced significantly in β3-null pericytes. Bar charts represent means ± s.e.m. (n=3 experimental repeats). (C) Western blot analysis of p-HGFR (Tyr1234/1235), HGFR, p-Akt (S473), total Akt, p-p65 (S536) and total p65 from WT pericytes treated with either placebo or the β3-integrin inhibitor, cilengitide. Bar charts represent densitometric values ± s.e.m (n=3 experimental repeats). Hsc70 acts as a loading control. (D, E) Triple immunostaining of p-Akt, α-SMA and β3-integrin in human breast cancer. Low power (D), and high power (E). αSMA positive mural cells with low p-AKT and high β3-integrin or high p-AKT and low β3-integrin. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. (A-C) Student’s <i>t</i> test. Scale bars in (B, D) 50&nbsp;μm, (E) 25&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0075" role="paragraph">In intervention studies, FAK inhibitor (PF573228) treatment reduced the expression of pY397-FAK and also the levels of p-HGFR, p-Akt, and p-p65 in β3-null pericytes (<a id="crosref0570" href="#fig5">Figure&nbsp;5</a>G). Second, treatment with the HGFR inhibitor PHA-665752 reduced HGFR phosphorylation, p-Akt, and subsequent p-p65 levels in β3-null pericytes (<a id="crosref0575" href="#fig5">Figure&nbsp;5</a>H). Third, treatment with the Akt inhibitor LY294002 reduced both p-Akt and p-p65 levels (<a id="crosref0580" href="#fig5">Figure&nbsp;5</a>I). Together, these data demonstrate that the elevated p-HGFR levels observed in β3-null pericytes lead to an increase in Akt phosphorylation and subsequent p65 phosphorylation.</div><div id="p0080" role="paragraph">The functional relevance of the molecular changes in p-HGFR, p-Akt, and p-p65 in β3-null pericytes were then evaluated. CRISPR-Cas9 gene editing of Akt in β3-null pericytes (β3-null;Akt<sup>KO</sup> pericytes [PCs]) resulted in a reduction in phosphorylation and expression of total Akt as well as a reduction in p-HGFR but not total HGFR (<a id="crosref0585" href="#fig6">Figure&nbsp;6</a>A). CRISPR-Cas9 ablation of HGFR in β3-null PCs (β3-null;HGFR<sup>KO</sup> PCs) showed a reduction in the expression total HGFR and modest reduction in p-HGFR as well as a reduction in p-Akt but not total Akt (<a id="crosref0590" href="#fig6">Figure&nbsp;6</a>A). Together, these data indicate cross-regulation of p-Akt and p-HGFR in β3-null PCs. Downstream of this, Akt or HGFR deletion resulted in a reduction in downstream p-p65 (but not total p65), TIMP-1, and CCL2. Furthermore, exposure of B16F0 cells to conditioned medium from β3-null;Akt<sup>KO</sup> or β3-null;HGFR<sup>KO</sup> PCs resulted in significantly reduced tumor cell survival compared with B16F0 cells exposed to conditioned medium from Cas9 control-transfected β3-null PCs (β3 null;Cas9) (<a id="crosref0595" href="#fig6">Figure&nbsp;6</a>B). Although gene-edited PCs showed similar cell survival levels as controls (<a id="crosref0600" href="#figs6">Figure&nbsp;S6</a>A), co-injection of β3-null;Akt<sup>KO</sup> pericytes with B16F0 cells reduced the enhanced tumor growth observed in mice co-injected with B16F0 and β3-null;Cas9 PC controls (<a id="crosref0605" href="#fig6">Figure&nbsp;6</a>C). Together, these data indicate a functional role of PC Akt and HGFR in enhanced tumor cell survival induced by loss of PC-β3-integrin.</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/e7712134-cb4a-4ddb-ad67-64652009f3be/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2020.02.003/asset/dcb777de-4a15-4a2e-af6a-b2c41c16fa2a/main.assets/gr6.jpg" height="754" width="767" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/e7712134-cb4a-4ddb-ad67-64652009f3be/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Deletion of Pericyte-β3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0220" role="paragraph">(A) Western blot analysis of β3-null pericytes with CRISPR-Cas9 deletion of Akt1 (β3-null;Akt<sup>KO</sup> PC) or HGFR (β3-null;HGFR<sup>KO</sup> PC) compared with β3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n&nbsp;= 3 experimental repeats).</div><div id="fspara0225" role="paragraph">(B) B16F0 cell survival after exposure to conditioned media from β3-null;Akt<sup>KO</sup>, β3-null;HGFR<sup>KO</sup>, or β3-null;Cas9 pericytes (n&nbsp;= 16 technical replicates for 2 separate experiments).</div><div id="fspara0230" role="paragraph">(C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus β3-null;Cas9 pericytes or B16F0 plus β3-null;Akt<sup>KO</sup> pericytes at 1:8 ratio (n&nbsp;= 10 per group).</div><div id="fspara0235" role="paragraph">(D) Western blot analysis using mock- and Iκ-Bα-SR-transfected WT or β3-null pericyte lysates. HSC70, loading control.</div><div id="fspara0240" role="paragraph">(E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Iκ-Bα-SR-transfected β3-null pericytes (n&nbsp;= 4 dots from 2 independent experiments).</div><div id="fspara0245" role="paragraph">(F) Conditioned media from mock- and Iκ-Bα-SR-transfected β3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected β3-null pericytes (n&nbsp;= 3 experimental repeats).</div><div id="fspara0250" role="paragraph">(G) WT mice were injected via the tail vein with either B16F10 cells and mock-transfected β3-null pericytes or B16F10 cells and Iκ-Bα-SR-transfected β3-null pericytes and lungs harvested for lung nodule analysis at 21&nbsp;days post-injection with representative gross lung and H&amp;E stained sections (n&nbsp;= 3 mice per group). All H&amp;E-stained section images were taken by Panoramic scanner and Panoramic viewer 3D HISTECH software. The scanner produced images by tiling high-resolution sections together. Bar charts, means ± SEM for numbers of lung nodules and sizes of lung nodules across all groups.</div><div id="fspara0255" role="paragraph">(H) Western blot confirmed the CRISPR-Cas9 depletion of CXCL1, CCL2, or TIMP-1 in β3-null pericytes back to WT;Cas9 levels. Bar charts, densitometric analysis.</div><div id="fspara0260" role="paragraph">(I) MTS cell survival of B16F0 cells exposed to conditioned medium from Cas9-control transfected β3-null pericytes (β3-null;Cas9) or CRISPR-knockout CXCL1, TIMP-1, or CCL2 β3-null pericytes (namely, β3-null;CXCL1<sup>KO</sup>, β3-null;TIMP-1<sup>KO</sup>, β3-null;CCL2<sup>KO</sup>, respectively). Results are means ± SEM relative to tumor cells treated with conditioned media from β3-null;Cas9.</div><div id="fspara0265" role="paragraph">(J) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus β3-null;Cas9 pericytes or B16F0 plus β3-null;CXCL1<sup>KO</sup>, β3-null;TIMP-1<sup>KO</sup>, or β3-null;CCL2<sup>KO</sup> pericytes (n&nbsp;= 8–9 mice per group).</div><div id="fspara0270" role="paragraph">Bar charts, means ± SEM <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. N.S., no significant difference. (A), (B), (E)–(G), and (I), Student’s t test. (C) and (J), Two-way ANOVA test. Scale bar in (G) gross lung, 1.0&nbsp;cm and H&amp;E sections, 500&nbsp;μm.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/cab1a7a4-75f0-4b19-bd58-8ad5389ab5f2/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2020.02.003/asset/206153ef-28e1-4868-9c94-019b2be8656c/main.assets/figs6.jpg" height="865" width="662" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/cab1a7a4-75f0-4b19-bd58-8ad5389ab5f2/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Deletion of Pericyte-β3-Integrin Increases Tumor Cell Growth via Pericyte-CCL2 and Tumor Cell-MEK1 and ROCK2 Pathways, Related to <a id="crosref0890" href="#fig6">Figures 6</a> and <a id="crosref0895" href="#fig7">7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0375" role="paragraph">(A) MTS assays showing no differences in cell survival between WT;Cas9, β3-null;Cas9, β3-null;Akt<sup>KO</sup> and β3-null;HGFR<sup>KO</sup> pericytes (PC). (B) MTS assays showing no difference in cell survival between mock transfected and Iκ-BαSR-transfected β3-null pericytes. (C) MTS cell survival of B16F0 tumour cells treated with CM from b3-null pericytes with vehicle or CCR2-inhibitor. (D) Phosphoproteomic analysis identifies enrichment of phosphorylated residues in B16F0 cells exposed to CM from β3-null pericytes compared with WT pericytes. (E) Characterization of B16F0;ROCK2<sup>KO</sup> cells. Western blot analysis of ROCK2, p-MLC2, MLC2 and Hsc70 used as loading control. (F) MTS assay shows no significant difference in cell survival between B16F0;ROCK<sup>WT</sup> and B16F0;ROCK<sup>KO</sup> cells. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. N.S. No significant difference. (A, B, C and F) Student’s <i>t</i> test.</div></div></div></div></figcaption></figure></div><div id="p0085" role="paragraph">The functional consequence of inactivation of NF-κB signaling in β3-null PCs was next assessed in rescue of PC cytokine production and tumor cell growth control. β3-null PCs were transfected with the super-repressor, non-phosphorylatable mutant form of Iκ-Bα, Iκ-BαSR, which has been reported to repress the NF-κB pathway (<span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Pikarsky et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Pikarsky, E. ∙ Porat, R.M. ∙ Stein, I. ...</div><div><strong>NF-kappaB functions as a tumour promoter in inflammation-associated cancer</strong></div><div><em>Nature.</em> 2004; <strong>431</strong>:461-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02924" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-4644324186" target="_blank" aria-label="Open Scopus in new tab">Scopus (2241)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15329734/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02924&amp;pmid=15329734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). β3-null PC transfection with Iκ-BαSR was sufficient to reduce p-p65 levels back to WT PC levels (<a id="crosref0615" href="#fig6">Figure&nbsp;6</a>D) and significantly reduce the expression levels of CXCL1, CCL2, and TIMP-1 (<a id="crosref0620" href="#fig6">Figure&nbsp;6</a>E), indicating that NF-κB signaling was involved in the regulation of these secreted factors. Furthermore, exposure of tumor cells to conditioned medium from Iκ-BαSR-transfected β3-null PCs reduced the enhanced survival of B16F0, B16F10, and LLC cells compared with exposure to conditioned medium from mock-transfected β3-null PCs (<a id="crosref0625" href="#fig6">Figure&nbsp;6</a>F). <i>In&nbsp;vivo</i>, co-injection of B16F10 cells with Iκ-BαSR-transfected β3-null pericytes via the tail vein into C57BL/6 mice significantly decreased the number of lung nodules and relative nodule size compared with mice co-injected with B16F10 cells and mock-transfected β3-null PCs (<a id="crosref0630" href="#fig6">Figure&nbsp;6</a>G). No change in cell survival was observed between mock-transfected or Iκ-BαSR-transfected β3-null PCs (<a id="crosref0635" href="#figs6">Figure&nbsp;S6</a>B), suggesting that altered cell survival was unlikely to be responsible for the altered tumor growth in <a id="crosref0640" href="#fig6">Figure&nbsp;6</a>G. Together, these data indicate a functional role of NF-κB signaling in β3-null PC control of tumor growth.</div><div id="p0090" role="paragraph">To test the functional relevance of the enhanced levels of β3-null PC-derived CXCL1, CCL2, and TIMP-1 on enhanced tumor cell survival and tumor growth, β3-null PC with CRISPR-Cas9 depletion of CXCL1, CCL2, or TIMP-1 (β3-null;CXCL1<sup>KO</sup>, β3-null;CCL2<sup>KO</sup> and β3-null;TIMP-1<sup>KO</sup>, respectively) were generated, and target-protein depletion was confirmed by western blotting (<a id="crosref0645" href="#fig6">Figure&nbsp;6</a>H). Similar to the effect of deletion of Akt and HGFR in β3-null PCs, exposure of B16F0 cells to conditioned medium from β3-null;CXCL1<sup>KO</sup>, β3-null;CCL2<sup>KO</sup> and β3-null;TIMP-1<sup>KO</sup> PCs reduced B16F0 cell survival significantly compared with enhanced survival induced by exposure to conditioned medium from β3-null;Cas9 PCs (<a id="crosref0650" href="#fig6">Figure&nbsp;6</a>I). This effect on enhancing tumor cell survival was corroborated <i>in&nbsp;vivo</i>,&nbsp;where tumor growth was reduced when co-injecting B16F0 cells with either β3-null;CXCL1<sup>KO</sup>, β3-null;CCL2<sup>KO</sup>, or β3-null;TIMP-1<sup>KO</sup> PCs compared with co-injection of B16F0 cells with β3-null;Cas9 PCs (<a id="crosref0655" href="#fig6">Figure&nbsp;6</a>J). Together, these data suggest that depletion of these factors in β3-null PCs is sufficient to reduce the enhanced tumor growth observed and implicates them functionally, downstream of NFκB activity, as PC-derived paracrine signals that regulate tumor growth.</div><div id="p0095" role="paragraph">Because the fold expression increase in β3-null PC cytokine expression was highest for CCL2 (4-fold increase compared with WT PCs; <a id="crosref0660" href="#fig5">Figure&nbsp;5</a>D) and that Iκ-BαSR transfection of β3-null cells reduced CCL2 expression the most (4-fold decrease compared with mock-transfected PCs; <a id="crosref0665" href="#fig6">Figure&nbsp;6</a>E), we examined whether tumor cell CCR2, the receptor for CCL2, is involved in the enhanced tumor cell survival phenotype. B16F0 cells were exposed to conditioned media from WT and β3-null PCs and also treated with the CCR2<i>i</i> inhibitor or vehicle alone. Inhibition of CCR2 was sufficient to reduce the enhanced tumor cell survival observed after exposure to β3-null PC conditioned medium, suggesting that CCR2 is involved in tumor cell survival after exposure to β3-null PC conditioned medium (<a id="crosref0670" href="#figs6">Figure&nbsp;S6</a>C).</div><div id="p0100" role="paragraph">Using phosphoproteomics analysis of malignant cells, the molecular mechanism underlying the enhanced tumor cell survival and growth after exposure to β3-null PCs was examined. Kinase substrate enrichment analysis of the phosphoproteomics data identified that the ROCK2 signaling pathway was the most significantly enriched pathway in tumor cells exposed to β3-null PC conditioned medium compared with tumor cells exposed to WT PC conditioned medium (<a id="crosref0675" href="#fig7">Figure&nbsp;7</a>A). The phosphorylation levels of a number of proteins involved in tumor cell survival and progression support the notion that paracrine signals from β3-null PCs enhanced cell survival based signaling in tumor cells (<a id="crosref0680" href="#figs6">Figure&nbsp;S6</a>D).</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.003/asset/1ae8da14-5c87-4323-bcf0-f5e9bee6a7f6/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2020.02.003/asset/e9aca48a-d787-426b-bf36-ed59766db2f6/main.assets/gr7.jpg" height="812" width="754" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/1ae8da14-5c87-4323-bcf0-f5e9bee6a7f6/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Deletion of Pericyte-β3-Integrin Increases Tumor Cell Growth via Pericyte-CCL2 and Tumor Cell-MEK1 and ROCK2 Pathways</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0280" role="paragraph">(A) KSEA analysis of phosphoproteomics identifies kinase substrate pathway enrichment in B16F0 cells exposed to conditioned medium from β3-null pericytes compared with B16F0 cells exposed to conditioned medium from WT pericytes.</div><div id="fspara0285" role="paragraph">(B) Phospho-MLC2 immunohistochemical staining and signal intensity maps. Bar chart, H-score of mean signal intensity ± SEM in B16F0 tumors co-injected with WT or β3-null pericytes.</div><div id="fspara0290" role="paragraph">(C) Western blot analysis in B16F0 cells exposed to conditioned medium from β3-null;Cas9 or β3-null:CCL2<sup>KO</sup> pericytes.</div><div id="fspara0295" role="paragraph">(D) Phospho-MLC2 staining and intensity maps in B16F0 tumors co-injected with WT;Cas9, β3-null;Cas9, or β3-null;CCL2<sup>KO</sup> pericytes (n&nbsp;= 4–5 sections per sample). Bar chart, H-score of mean signal intensity ± SEM.</div><div id="fspara0300" role="paragraph">(E) Western blot analysis of B16F0 cells treated with MEK1 inhibitor U0126 indicating inhibition of the MEK effector ERK1/2 and of p-MLC2 in B16F0 cells treated with the ROCK2 inhibitor GSK269962A indicating inhibition of activity of the ROCK effector MLC2.</div><div id="fspara0305" role="paragraph">(F) B16F0 cells were exposed to conditioned medium from WT or β3-null pericytes in combination with either vehicle, MEK1 inhibitor, U0126, or ROCK2 inhibitor, GSK269962A, and B16F0 cell survival measured in MTS assay (n&nbsp;= 16 technical repeats per test).</div><div id="fspara0310" role="paragraph">(G) B16F0;ROCK2<sup>KO</sup> and B16F0;ROCK2<sup>WT</sup> cells were injected subcutaneously into <i>pdgfrβcre−;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. Once tumors were established, mice were treated with doxycycline to induce ROCK2 deletion in B16F0 cells <i>in&nbsp;vivo</i> (n&nbsp;= 5–9 mice per group).</div><div id="fspara0315" role="paragraph">Line graph, tumor growth, bar chart, mean end tumor volume ± SEM. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001. N.S., no significant difference. (B), (D), (F), (G), and bar chart, Student’s t test. (G) and line graph, Two-way ANOVA test. Scale bar in (B) and (D), 100&nbsp;μm.</div></div></div></div></figcaption></figure></div><div id="p0105" role="paragraph">Non-muscle Myosin II has contractile properties and is regulated by phosphorylation of its light and heavy chains (<span class="dropBlock reference-citations"><a id="body-ref-sref68-1" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68-1" aria-controls="sref68-1">Vicente-Manzanares et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref68-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Vicente-Manzanares, M. ∙ Ma, X. ∙ Adelstein, R.S. ...</div><div><strong>Non-muscle myosin II takes centre stage in cell adhesion and migration</strong></div><div><em>Nat. Rev. Mol. Cell Biol.</em> 2009; <strong>10</strong>:778-790</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrm2786" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-70350454867" target="_blank" aria-label="Open Scopus in new tab">Scopus (1461)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19851336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrm2786&amp;pmid=19851336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Importantly, a key phospho-substrate for many of the kinases arising from phosphoproteomics analysis was Myosin Light Chain 2 (MLC2, MYL12b, and MYL9). Myosin II-driven contractility relies on multiple kinases. Among them, previously published work has shown that Rho-kinase (ROCK) inactivates the myosin light chain 2 (MLC2) phosphatase, which leads to increased phosphorylation of MLC2 (p-MLC2) and activity of Myosin II (<span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Ito et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Ito, M. ∙ Nakano, T. ∙ Erdodi, F. ...</div><div><strong>Myosin phosphatase: structure, regulation and function</strong></div><div><em>Mol. Cell. Biochem.</em> 2004; <strong>259</strong>:197-209</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1023/B:MCBI.0000021373.14288.00" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-1942538405" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15124925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1023%2FB%3AMCBI.0000021373.14288.00&amp;pmid=15124925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). MLC2 is also directly phosphorylated by ROCK (<span class="dropBlock reference-citations"><a id="body-ref-sref68-2" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68-2" aria-controls="sref68-2">Vicente-Manzanares et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref68-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Vicente-Manzanares, M. ∙ Ma, X. ∙ Adelstein, R.S. ...</div><div><strong>Non-muscle myosin II takes centre stage in cell adhesion and migration</strong></div><div><em>Nat. Rev. Mol. Cell Biol.</em> 2009; <strong>10</strong>:778-790</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrm2786" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-70350454867" target="_blank" aria-label="Open Scopus in new tab">Scopus (1461)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19851336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrm2786&amp;pmid=19851336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Importantly, tumors arising from C57BL/6 mice injected with B16F0 melanoma cells plus β3-null PCs showed increased levels of p-MLC2 protein (a direct substrate of ROCK) compared with B16F0s co-injected with WT PCs (<a id="crosref0700" href="#fig7">Figure&nbsp;7</a>B). These data indicate that tumors with β3-null PCs grow with higher levels of actomyosin contractility, a feature associated with faster tumor growth <i>in&nbsp;vivo</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Georgouli et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Georgouli, M. ∙ Herraiz, C. ∙ Crosas-Molist, E. ...</div><div><strong>Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment</strong></div><div><em>Cell.</em> 2019; <strong>176</strong>:757-774.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2018.12.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2018.12.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85061010359" target="_blank" aria-label="Open Scopus in new tab">Scopus (103)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30712866/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.12.038&amp;pmid=30712866" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Given that previous reports have demonstrated that MEK1 and mitogen-activated protein kinase (MAPK) cascade signaling pathways are downstream of CCL2/CCR2-stimulated signaling (<span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib18 bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Fang et&nbsp;al., 2012; Tang and Tsai, 2012</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Fang, W.B. ∙ Jokar, I. ∙ Zou, A. ...</div><div><strong>CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2012; <strong>287</strong>:36593-36608</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M112.365999" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84867771909" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22927430/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M112.365999&amp;pmid=22927430" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Tang, C.H. ∙ Tsai, C.C.</div><div><strong>CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway</strong></div><div><em>Biochem. Pharmacol.</em> 2012; <strong>83</strong>:335-344</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bcp.2011.11.013" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84455202302" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22138288/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bcp.2011.11.013&amp;pmid=22138288" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we examined whether loss of β3-null PC-derived CCL2 was responsible for the enhancement of MEK1 and ROCK2 signaling pathways in B16F0. Western blot analysis showed reduced levels of p-MEK1/2, pERK1/2, and p-MLC2 in B16F0 cells exposed to conditioned medium from β3 null;CCL2<sup>KO</sup> PCs compared with B16F0 cells exposed to β3-null;Cas9 PC conditioned medium (<a id="crosref0710" href="#fig7">Figure&nbsp;7</a>C). These data suggest that CCL2 was involved in enhanced MEK1 and ROCK2 activity in tumor cells. Additionally, B16F0 tumors co-injected with β3-null;CCL2<sup>KO</sup> PCs showed a decrease in p-MLC2 levels, further linking a role of CCL2 to enhanced ROCK2-Myosin II activation <i>in&nbsp;vivo</i> (<a id="crosref0715" href="#fig7">Figure&nbsp;7</a>D).</div><div id="p0110" role="paragraph">To test the functional role of ROCK2 and MEK1 in enhancing tumor cell survival, tumor cells were treated with a MEK1 inhibitor (U0126) or ROCK inhibitor (GSK269962A) after exposure to β3-null PCs. Reduced Myosin II or ERK1/2 activity was confirmed after treatment (<a id="crosref0720" href="#fig7">Figure&nbsp;7</a>E). B16F0 cells pre-treated with the U0126 MEK1 inhibitor or the GSK269962A ROCK inhibitor displayed reduced tumor cell survival after exposure to β3-null PC conditioned medium compared with WT PC conditioned medium (<a id="crosref0725" href="#fig7">Figure&nbsp;7</a>F). Short hairpin RNA (shRNA) knockdown of ROCK2 in B16F0 cells resulted in reduced Myosin II activity (<a id="crosref0730" href="#figs6">Figure&nbsp;S6</a>E). Although B16F0;ROCK2<sup>KO</sup> cells did not have compromised growth <i>in&nbsp;vitro</i> (<a id="crosref0735" href="#figs6">Figure&nbsp;S6</a>F), depletion of ROCK2 in B16F0 cells was sufficient to reduce tumor growth in <i>pdgfrβcre+:β3</i><sup><i>fl/fl</i></sup> mice back to that observed in B16F0;ROCK2<sup>WT</sup> or B16F0;ROCK2<sup>KO</sup> tumor growth in <i>pdgfrβcre-:β3</i><sup><i>fl/fl</i></sup> mice (<a id="crosref0740" href="#fig7">Figure&nbsp;7</a>G). These data confirm that the enhanced B16F0 tumor growth observed in the absence of PC β3-integrin is dependent on B16F0 ROCK2 activity. The relationship between MEK1 and ROCK2 activation has been reported previously (<span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib3 bib67 bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Arozarena et&nbsp;al., 2011; Vial et&nbsp;al., 2003; Orgaz et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Arozarena, I. ∙ Sanchez-Laorden, B. ∙ Packer, L. ...</div><div><strong>Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A</strong></div><div><em>Cancer Cell.</em> 2011; <strong>19</strong>:45-57</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2010.10.029&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2010.10.029&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-78651457445" target="_blank" aria-label="Open Scopus in new tab">Scopus (183)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21215707/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.10.029&amp;pmid=21215707" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Orgaz, J.L. ∙ Crosas-Molist, E. ∙ Sadok, A. ...</div><div><strong>Myosin II reactivation and cytoskeletal remodelling as a hallmark and a vulnerability in melanoma resistance</strong></div><div><em>Cancer Cell.</em> 2020; <strong>37</strong>:85-103.e9</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2019.12.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2019.12.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85077365737" target="_blank" aria-label="Open Scopus in new tab">Scopus (95)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31935375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2019.12.003&amp;pmid=31935375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Vial, E. ∙ Sahai, E. ∙ Marshall, C.J.</div><div><strong>ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility</strong></div><div><em>Cancer Cell.</em> 2003; <strong>4</strong>:67-79</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1535-6108%2803%2900162-4&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1535-6108%2803%2900162-4&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0042349229" target="_blank" aria-label="Open Scopus in new tab">Scopus (348)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12892714/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1535-6108%2803%2900162-4&amp;pmid=12892714" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Together, these results demonstrate a functional role of tumor cell MEK1 and ROCK2-Myosin II signaling in enhanced tumor cell survival and tumor cell growth after exposure to β3-null pericytes.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0115" role="paragraph">Our data establish that mural cells, by losing β3-integrin expression and thus enhancing signaling via the FAK-HGFR-Akt-NF-κB pathway and increasing CCL2-mediated paracrine signals, can increase tumor burden via tumor cell enrichment of MEK1 and ROCK2 signaling pathways in the absence of affecting tumor blood vessel numbers or functionality. These results are not expected and call for further consideration of the role of tumor PCs in direct control of tumor growth and progression.</div><div id="p0120" role="paragraph">Previous work has established that PCs play critical roles in blood-brain barrier function, vascular development, control of vessel contraction, blood flow, and hemostasis (<span class="dropBlock reference-citations"><a id="body-ref-sref50-2" href="#" role="doc-biblioref" data-xml-rid="bib2 bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-2" aria-controls="sref50-2">Armulik et&nbsp;al., 2011; Raza et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref50-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Armulik, A. ∙ Genové, G. ∙ Betsholtz, C.</div><div><strong>Pericytes: developmental, physiological, and pathological perspectives, problems, and promises</strong></div><div><em>Dev. Cell.</em> 2011; <strong>21</strong>:193-215</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.devcel.2011.07.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.devcel.2011.07.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79961230399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1996)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21839917/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2011.07.001&amp;pmid=21839917" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Raza, A. ∙ Franklin, M.J. ∙ Dudek, A.Z.</div><div><strong>Pericytes and vessel maturation during tumor angiogenesis and metastasis</strong></div><div><em>Am. J. Hematol.</em> 2010; <strong>85</strong>:593-598</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ajh.21745" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77955496673" target="_blank" aria-label="Open Scopus in new tab">Scopus (307)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20540157/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fajh.21745&amp;pmid=20540157" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Based on these accepted functions as essential blood vessel-supporting cells, elimination of PCs is considered a logical anti-angiogenic strategy to control cancer. Indeed, antagonists of platelet-derived growth factor signaling have ben shown to eliminate tumor PCs, resulting in vascular disruption and effective tumor regression (<span class="dropBlock reference-citations"><a id="body-ref-sref31-2" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-2" aria-controls="sref31-2">Heldin, 2013</a><div class="dropBlock__holder" data-db-target-of="sref31-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Heldin, C.H.</div><div><strong>Targeting the PDGF signaling pathway in tumor treatment</strong></div><div><em>Cell Commun. Signal.</em> 2013; <strong>11</strong>:97</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1478-811X-11-97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84890467312" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24359404/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1478-811X-11-97&amp;pmid=24359404" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, similar strategies also result in enhancing vessel leakage and hypoxia, elevating metastasis (<span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib14 bib33 bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">Cooke et&nbsp;al., 2012; Keskin et&nbsp;al., 2015; Xian et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cooke, V.G. ∙ LeBleu, V.S. ∙ Keskin, D. ...</div><div><strong>Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:66-81</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84855912001" target="_blank" aria-label="Open Scopus in new tab">Scopus (440)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22264789/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2011.11.024&amp;pmid=22264789" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Keskin, D. ∙ Kim, J. ∙ Cooke, V.G. ...</div><div><strong>Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2</strong></div><div><em>Cell Rep.</em> 2015; <strong>10</strong>:1066-1081</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.celrep.2015.01.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.celrep.2015.01.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84929142111" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25704811/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2015.01.035&amp;pmid=25704811" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Xian, X. ∙ Håkansson, J. ∙ Ståhlberg, A. ...</div><div><strong>Pericytes limit tumor cell metastasis</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2006; <strong>116</strong>:642-651</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI25705" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-33644643376" target="_blank" aria-label="Open Scopus in new tab">Scopus (300)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16470244/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI25705&amp;pmid=16470244" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Thus, targeting PCs and inducing vascular disruption is unlikely to be a long-term effective method of cancer control. Indeed, more recent reports have suggested that cancer progression can be associated with either increased or reduced PC association with tumor blood vessels (<span class="dropBlock reference-citations"><a id="body-ref-sref78" href="#" role="doc-biblioref" data-xml-rid="bib14 bib20 bib42 bib57 bib58 bib77 bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78" aria-controls="sref78">Cooke et&nbsp;al., 2012; Furuhashi et&nbsp;al., 2004; O’Keeffe et&nbsp;al., 2008; Sennino et&nbsp;al., 2007; Sinha et&nbsp;al., 2016; Xing et&nbsp;al., 2015; Yonenaga et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref78"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cooke, V.G. ∙ LeBleu, V.S. ∙ Keskin, D. ...</div><div><strong>Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:66-81</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84855912001" target="_blank" aria-label="Open Scopus in new tab">Scopus (440)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22264789/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2011.11.024&amp;pmid=22264789" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Furuhashi, M. ∙ Sjöblom, T. ∙ Abramsson, A. ...</div><div><strong>Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate</strong></div><div><em>Cancer Res.</em> 2004; <strong>64</strong>:2725-2733</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-03-1489" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-16544382996" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15087386/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-03-1489&amp;pmid=15087386" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>O’Keeffe, M.B. ∙ Devlin, A.H. ∙ Burns, A.J. ...</div><div><strong>Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes</strong></div><div><em>Oncol. Res.</em> 2008; <strong>17</strong>:93-101</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3727/096504008785055530" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-47549086341" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18669161/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3727%2F096504008785055530&amp;pmid=18669161" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Sennino, B. ∙ Falcón, B.L. ∙ McCauley, D. ...</div><div><strong>Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:7358-7367</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-07-0293" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-34547637867" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17671206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-07-0293&amp;pmid=17671206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Sinha, D. ∙ Chong, L. ∙ George, J. ...</div><div><strong>Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:1813-1824</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-15-1931" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84964329283" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26589433/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-15-1931&amp;pmid=26589433" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Xing, Y. ∙ Zhao, S. ∙ Zhou, B.P. ...</div><div><strong>Metabolic reprogramming of the tumour microenvironment</strong></div><div><em>FEBS J.</em> 2015; <strong>282</strong>:3892-3898</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/febs.13402" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84944273587" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26255648/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Ffebs.13402&amp;pmid=26255648" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Yonenaga, Y. ∙ Mori, A. ∙ Onodera, H. ...</div><div><strong>Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients</strong></div><div><em>Oncology.</em> 2005; <strong>69</strong>:159-166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1159/000087840" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-25444491756" target="_blank" aria-label="Open Scopus in new tab">Scopus (158)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16127287/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1159%2F000087840&amp;pmid=16127287" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Together, these apparently conflicting data suggest that vascular disruption, or even enhanced blood vessel leakage via loss of PCs, may not be an effective method to control cancer. Indeed, they suggest that PCs might control tumor growth through other mechanisms that have not been carefully investigated until now.</div><div id="p0125" role="paragraph">Loss of PC adhesion properties is likely to affect their association and recruitment to endothelial cells of the blood vessel wall. Integrins are a family of cell adhesion molecules that control cell-extracellular matrix interactions. PCs are known to express a variety of integrins, including β1- and β3-integrin heterodimers, and reduced pericyte β1-integrin activity and α4- or α6-integrin levels have been shown to affect blood vessel maturation processes (<span class="dropBlock reference-citations"><a id="body-ref-sref79" href="#" role="doc-biblioref" data-xml-rid="bib21 bib54 bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79" aria-controls="sref79">Garmy-Susini et&nbsp;al., 2005; Reynolds et&nbsp;al., 2017; You et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref79"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Garmy-Susini, B. ∙ Jin, H. ∙ Zhu, Y. ...</div><div><strong>Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2005; <strong>115</strong>:1542-1551</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI23445" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-20444483652" target="_blank" aria-label="Open Scopus in new tab">Scopus (170)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15902308/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI23445&amp;pmid=15902308" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Reynolds, L.E. ∙ D’Amico, G. ∙ Lechertier, T. ...</div><div><strong>Dual role of pericyte α6β1-integrin in tumour blood vessels</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2017; <strong>130</strong>:1583-1595</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.197848" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85018256546" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28289267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.197848&amp;pmid=28289267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>You, W.K. ∙ Yotsumoto, F. ∙ Sakimura, K. ...</div><div><strong>NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function</strong></div><div><em>Angiogenesis.</em> 2014; <strong>17</strong>:61-76</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10456-013-9378-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84892816761" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23925489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10456-013-9378-1&amp;pmid=23925489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); however, the role of β3-integrin in pericyte function was unknown.</div><div id="p0130" role="paragraph">Our data demonstrate that loss of PC-β3-integrin is sufficient to enhance tumor growth in the absence of changes in blood vessel density, number of PC negative vessels, vessel perfusion, or tumor hypoxia. Previous work has demonstrated that global deletion of β3-integrin is sufficient to enhance tumor angiogenesis and tumor growth (<span class="dropBlock reference-citations"><a id="body-ref-sref51-2" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-2" aria-controls="sref51-2">Reynolds et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref51-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Reynolds, L.E. ∙ Wyder, L. ∙ Lively, J.C. ...</div><div><strong>Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins</strong></div><div><em>Nat. Med.</em> 2002; <strong>8</strong>:27-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm0102-27" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0036152857" target="_blank" aria-label="Open Scopus in new tab">Scopus (566)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11786903/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm0102-27&amp;pmid=11786903" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and that deletion of endothelial cell β3-integrin only transiently inhibits tumor angiogenesis in established tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Steri et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Steri, V. ∙ Ellison, T.S. ∙ Gontarczyk, A.M. ...</div><div><strong>Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice</strong></div><div><em>Circ. Res.</em> 2014; <strong>114</strong>:79-91</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/CIRCRESAHA.114.301591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84892931092" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24103390/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FCIRCRESAHA.114.301591&amp;pmid=24103390" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This enhanced angiogenesis has been proposed to be due to elevated vascular endothelial growth factor (VEGF)-induced responses of β3-null endothelial cells because of the upregulated VEGF-receptor 2 expression on these cells (<span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib51 bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Reynolds et&nbsp;al., 2002, 2004</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Reynolds, L.E. ∙ Wyder, L. ∙ Lively, J.C. ...</div><div><strong>Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins</strong></div><div><em>Nat. Med.</em> 2002; <strong>8</strong>:27-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm0102-27" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0036152857" target="_blank" aria-label="Open Scopus in new tab">Scopus (566)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11786903/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm0102-27&amp;pmid=11786903" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Reynolds, A.R. ∙ Reynolds, L.E. ∙ Nagel, T.E. ...</div><div><strong>Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice</strong></div><div><em>Cancer Res.</em> 2004; <strong>64</strong>:8643-8650</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-04-2760" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-9244231286" target="_blank" aria-label="Open Scopus in new tab">Scopus (142)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15574772/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-04-2760&amp;pmid=15574772" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our current study suggests that the mechanisms that control tumor growth in PC-specific-β3-integrin knockout mice are distinct from those in global or endothelial cell-specific knockouts because the enhanced tumor growth is not associated with elevated angiogenesis. Thus, explaining how PC-β3-integrin controls tumor growth was explored.</div><div id="p0135" role="paragraph">Our data point toward a possible role for mural cells in directly affecting tumor growth and that this is controlled by β3-integrin expression. This conclusion is supported by clinical evidence showing that a high percentage of blood vessels that are mural-β3-intgerin negative is significantly associated with increased tumor size in four different human cancers—cutaneous melanoma, mesothelioma, lymphoma, and breast cancer—without affecting blood vessel density.</div><div id="p0140" role="paragraph">Previous studies from other laboratories and our own have demonstrated that vascular endothelial cells can control tumor progression and chemosensitivity without affecting tumor angiogenesis per se via paracrine signals (namely, angiocrine signals) that include cytokines and chemokines (<span class="dropBlock reference-citations"><a id="body-ref-sref64-4" href="#" role="doc-biblioref" data-xml-rid="bib1 bib25 bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-4" aria-controls="sref64-4">Acharyya et&nbsp;al., 2012; Gilbert and Hemann, 2010; Tavora et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Acharyya, S. ∙ Oskarsson, T. ∙ Vanharanta, S. ...</div><div><strong>A CXCL1 paracrine network links cancer chemoresistance and metastasis</strong></div><div><em>Cell.</em> 2012; <strong>150</strong>:165-178</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84863625224" target="_blank" aria-label="Open Scopus in new tab">Scopus (880)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22770218/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2012.04.042&amp;pmid=22770218" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Gilbert, L.A. ∙ Hemann, M.T.</div><div><strong>DNA damage-mediated induction of a chemoresistant niche</strong></div><div><em>Cell.</em> 2010; <strong>143</strong>:355-366</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77958501473" target="_blank" aria-label="Open Scopus in new tab">Scopus (362)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21029859/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2010.09.043&amp;pmid=21029859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These findings indicate that vascular cells can regulate tumor growth in a way beyond their roles in vessel development and maintenance. Our mouse models show that loss of PC-β3-integrin is sufficient to enhance tumor growth via paracrine signals independent of tumor blood vessel function or numbers. Indeed, loss or inhibition of PC-β3-integrin expression significantly enhanced the FAK-p-HGFR-p-Akt-p-p65-CCL2 pathway. Interestingly, FAK and Akt are known regulators of cytokine production and angiocrine signaling (<span class="dropBlock reference-citations"><a id="body-ref-sref64-5" href="#" role="doc-biblioref" data-xml-rid="bib34 bib45 bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-5" aria-controls="sref64-5">LaBarbera et&nbsp;al., 2015; Perkins, 2012; Tavora et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>LaBarbera, K.E. ∙ Hyldahl, R.D. ∙ O’Fallon, K.S. ...</div><div><strong>Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in&nbsp;vitro</strong></div><div><em>Physiol. Rep.</em> 2015; <strong>3</strong></div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.14814/phy2.12309" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85003571538" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25911453/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.14814%2Fphy2.12309&amp;pmid=25911453" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Perkins, N.D.</div><div><strong>The diverse and complex roles of NF-κB subunits in cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2012; <strong>12</strong>:121-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc3204" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84856213846" target="_blank" aria-label="Open Scopus in new tab">Scopus (747)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22257950/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc3204&amp;pmid=22257950" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Importantly, the clinical relevance of these findings was supported by elevated mural cell Akt and p65 phosphorylation in human melanoma, lymphoma, and breast cancer patients who had a high proportion of mural-β3-integrin-negative blood vessels. Furthermore, expression of CXCL1, CCL2, and TIMP-1 was confirmed to be regulated by NF-κB activation, suggesting that these paracrine factors, controlled by NF-κB, could at least be part of the explanation of how β3-null PCs regulate tumor growth. Within tumor cells, inactivation of ROCK2 in B16F0 tumor cells rescued the paracrine effects of β3-null PCs on tumor growth both <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i>, suggesting that inhibition of ROCK2 in cancers with low PC-β3-integrin expression could be a way to control cancer growth and possibly progression. That this increase in tumor cell survival was evident even in the absence of other cell types suggests that the mural cell-derived factors can control tumor cell survival independent of blood flow or other cell types.</div><div id="p0145" role="paragraph">Overall, our study indicates that mural cells are not simply vessel-supporting cells but that, via β3-integrin, they can regulate tumor growth via mural cell-derived paracrine signals. Our data provide proof of principle for a role of mural cell-β3-integrin and shed light on a mechanism of tumor growth control.</div></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key Resources Table</h3><div id="p0155" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Mouse monoclonal anti-HGFR (Met)</td><td>Santa Cruz Biotechnology</td><td>CAT#sc-8057; RRID: <a id="intref0010" href="https://antibodyregistry.org/AB_673755" target="_blank">AB_673755</a></td></tr><tr><td>Rabbit monoclonal anti-phospho-HGFR (Met)</td><td>Cell Signaling Technology</td><td>CAT#3077; RRID: <a id="intref0015" href="https://antibodyregistry.org/AB_2143884" target="_blank">AB_2143884</a></td></tr><tr><td>Rat monoclonal anti-endomucin</td><td>Santa Cruz Biotechnology</td><td>CAT#sc-65495; RRID: <a id="intref0020" href="https://antibodyregistry.org/AB_2100037" target="_blank">AB_2100037</a></td></tr><tr><td>Rabbit monoclonal anti-β3-integrin</td><td>Cell Signaling Technology</td><td>CAT#4702; RRID: <a id="intref0025" href="https://antibodyregistry.org/AB_2296320" target="_blank">AB_2296320</a></td></tr><tr><td>Rabbit monoclonal anti-β5-integrin</td><td>Cell Signaling Technology</td><td>CAT#3629; RRID: <a id="intref0030" href="https://antibodyregistry.org/AB_2249358" target="_blank">AB_2249358</a></td></tr><tr><td>Rabbit monoclonal anti-β1-integrin</td><td>Cell Signaling Technology</td><td>CAT#4706; RRID: <a id="intref0035" href="https://antibodyregistry.org/AB_823544" target="_blank">AB_823544</a></td></tr><tr><td>Rabbit monoclonal anti-PDGFRβ</td><td>Cell Signaling Technology</td><td>CAT#3169; RRID: AB_AB_2162497</td></tr><tr><td>Rabbit polyclonal anti-NG2</td><td>Merck-Millipore</td><td>CAT#AB5320; RRID: <a id="intref0040" href="https://antibodyregistry.org/AB_11213678" target="_blank">AB_11213678</a></td></tr><tr><td>Rabbit monoclonal anti-NF-κB p65</td><td>Cell Signaling Technology</td><td>CAT#8242; RRID: 10859369</td></tr><tr><td>Rabbit monoclonal anti-phospho-NF- κB p65</td><td>Cell Signaling Technology</td><td>CAT#3033; RRID: <a id="intref0045" href="https://antibodyregistry.org/AB_331285" target="_blank">AB_331285</a></td></tr><tr><td>Rabbit monoclonal anti-Akt</td><td>Cell Signaling Technology</td><td>CAT#4691; RRID: <a id="intref0050" href="https://antibodyregistry.org/AB_915783" target="_blank">AB_915783</a></td></tr><tr><td>Rabbit monoclonal anti-phospho-Akt</td><td>Cell Signaling Technology</td><td>CAT#4060; RRID: <a id="intref0055" href="https://antibodyregistry.org/AB_2315049" target="_blank">AB_2315049</a></td></tr><tr><td>Mouse monoclonal anti-Hsc70</td><td>Santa Cruz Biotechnology</td><td>CAT#sc7298; RRID: <a id="intref0060" href="https://antibodyregistry.org/AB_627761" target="_blank">AB_627761</a></td></tr><tr><td>Goat polyclonal anti-MCP-1 (CCL2)</td><td>ThermoFisher Scientific</td><td>CAT#PA5-46954; RRID: <a id="intref0065" href="https://antibodyregistry.org/AB_2609536" target="_blank">AB_2609536</a></td></tr><tr><td>Rat monoclonal anti-CXCL1</td><td>ThermoFisher Scientific</td><td>CAT#MA5-23811; RRID: <a id="intref0070" href="https://antibodyregistry.org/AB_2609587" target="_blank">AB_2609587</a></td></tr><tr><td>Mouse monoclonal anti-TIMP-1</td><td>ThermoFisher Scientific</td><td>CAT#MA5-13688; RRID: <a id="intref0075" href="https://antibodyregistry.org/AB_11004132" target="_blank">AB_11004132</a></td></tr><tr><td>Rabbit monoclonal anti-Myosin Light Chain 2 (MLC2)</td><td>Cell Signaling Technology</td><td>CAT#3672; RRID: <a id="intref0080" href="https://antibodyregistry.org/AB_10692513" target="_blank">AB_10692513</a></td></tr><tr><td>Rabbit monoclonal anti-phospho-Myosin Light Chain 2</td><td>Cell Signaling Technology</td><td>CAT#3674; RRID: <a id="intref0085" href="https://antibodyregistry.org/AB_2147464" target="_blank">AB_2147464</a></td></tr><tr><td>Rabbit monoclonal anti-phospho-Myosin Light Chain 2</td><td>Cell Signaling Technology</td><td>CAT#3671; RRID: <a id="intref0090" href="https://antibodyregistry.org/AB_330248" target="_blank">AB_330248</a></td></tr><tr><td>Rabbit polyclonal anti-phospho-FAK (Tyr397)</td><td>Cell Signaling Technology</td><td>CAT#3283; RRID: <a id="intref0095" href="https://antibodyregistry.org/AB_2173659" target="_blank">AB_2173659</a></td></tr><tr><td>Mouse monoclonal anti-Akt1</td><td>Cell Signaling Technology</td><td>CAT#2967; RRID: <a id="intref0100" href="https://antibodyregistry.org/AB_331160" target="_blank">AB_331160</a></td></tr><tr><td>Rabbit polyclonal anti-phospho-MEK1/2</td><td>Cell Signaling Technology</td><td>CAT#9121; RRID: <a id="intref0105" href="https://antibodyregistry.org/AB_331648" target="_blank">AB_331648</a></td></tr><tr><td>Mouse monoclonal anti-ROCK II</td><td>Biosciences</td><td>CAT#610624; RRID: <a id="intref0110" href="https://antibodyregistry.org/AB_397956" target="_blank">AB_397956</a></td></tr><tr><td>Rabbit polyclonal anti-NG2, Alex Fluor®488 conjugated</td><td>Merck-Millipore</td><td>CAT#AB5320A4; RRID: <a id="intref0115" href="https://antibodyregistry.org/AB_11203143" target="_blank">AB_11203143</a></td></tr><tr><td>Rat monoclonal PE anti-mouse CD31</td><td>BioLegend</td><td>CAT#102408; RRID: <a id="intref0120" href="https://antibodyregistry.org/AB_312903" target="_blank">AB_312903</a></td></tr><tr><td>Rat monoclonal PE anti-mouse/human CD11b (Mac1)</td><td>BioLegend</td><td>CAT#101208; RRID: <a id="intref0125" href="https://antibodyregistry.org/AB_312791" target="_blank">AB_312791</a></td></tr><tr><td>Rat monoclonal APC-anti-mouse CD140b (PDGFRβ)</td><td>BioLegend</td><td>CAT#136008; RRID: <a id="intref0130" href="https://antibodyregistry.org/AB_2268091" target="_blank">AB_2268091</a></td></tr><tr><td>Rat monoclonal APC-anti-mouse CD140a (PDGFRα)</td><td>BioLegend</td><td>CAT#135908; RRID: <a id="intref0135" href="https://antibodyregistry.org/AB_2043970" target="_blank">AB_2043970</a></td></tr><tr><td>Rat monoclonal PE/Cy7-anti-mouse CD146</td><td>BioLegend</td><td>CAT#134714; RRID: <a id="intref0140" href="https://antibodyregistry.org/AB_2563109" target="_blank">AB_2563109</a></td></tr><tr><td>Rabbit polyclonal anti-collagen IV</td><td>Abcam</td><td>CAT#ab6586; RRID: <a id="intref0145" href="https://antibodyregistry.org/AB_305584" target="_blank">AB_305584</a></td></tr><tr><td>Rabbit polyclonal anti-CD61 (β3-integrin)</td><td>ThermoFisher Scientific</td><td>CAT#PA5-32890; RRID: <a id="intref0150" href="https://antibodyregistry.org/AB_2550351" target="_blank">AB_2550351</a></td></tr><tr><td>Rabbit monoclonal anti-β3-integrin</td><td>Abcam</td><td>CAT#ab75872; RRID: <a id="intref0155" href="https://antibodyregistry.org/AB_2249317" target="_blank">AB_2249317</a></td></tr><tr><td>Mouse monoclonal anti-alpha-smooth muscle actin Cy3 conjugated</td><td>Sigma-Aldrich</td><td>CAT#C6198; RRID: <a id="intref0160" href="https://antibodyregistry.org/AB_476856" target="_blank">AB_476856</a></td></tr><tr><td>Rat monoclonal anti-mouse FCγ sort-RII/III</td><td>BD Biosciences</td><td>CAT#553141; RRID: <a id="intref0165" href="https://antibodyregistry.org/AB_394656" target="_blank">AB_394656</a></td></tr><tr><td>Rat monoclonal anti-mouse ICAM-2</td><td>BD Biosciences</td><td>CAT#553326; RRID: 394784</td></tr><tr><td>Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor® 546 Conjugated</td><td>ThermoFisher Scientific</td><td>CAT#A-11035; RRID: <a id="intref0170" href="https://antibodyregistry.org/AB_143051" target="_blank">AB_143051</a></td></tr><tr><td>Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor® 488 Conjugated</td><td>ThermoFisher Scientific</td><td>CAT#A-11034; RRID: <a id="intref0175" href="https://antibodyregistry.org/AB_2576217" target="_blank">AB_2576217</a></td></tr><tr><td>Donkey anti-Rat IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor® 488 Conjugated</td><td>ThermoFisher Scientific</td><td>CAT#A-21208; RRID: <a id="intref0180" href="https://antibodyregistry.org/AB_141709" target="_blank">AB_141709</a></td></tr><tr class="rowsep"><td>Biotinylated goat anti-rabbit secondary antibody</td><td>Vector Laboratories</td><td>CAT#BA-1000; RRID: <a id="intref0185" href="https://antibodyregistry.org/AB_2313606" target="_blank">AB_2313606</a></td></tr><tr class="rowsep"><td colspan="3"><b>Biological Samples</b></td></tr><tr><td>Human ER+ breast cancer samples</td><td>Barts Cancer Institute Breast Cancer Now tissue Bank</td><td><a id="intref0190" href="https://www.breastcancertissuebank.org/about-tissue-bank" target="_blank">https://www.breastcancertissuebank.org/about-tissue-bank</a></td></tr><tr class="rowsep"><td>Human melanoma, mesothelioma and diffuse large B cell lymphoma</td><td>Barts Cancer Institute tissue Bank</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, Peptides, and Recombinant Proteins</b></td></tr><tr><td>Prolong™ Gold Anti-Fade Mountant with DAPI</td><td>ThermoFisher Scientific</td><td>CAT#P36931</td></tr><tr><td>Dual Endogenous Enzyme-Blocking Reagent</td><td>Dako</td><td>CAT#S2003</td></tr><tr><td>Citric acid based antigen unmasking solution</td><td>Vector Laboratories</td><td>CAT#H-3300; RRID: <a id="intref0195" href="https://antibodyregistry.org/AB_2336226" target="_blank">AB_2336226</a></td></tr><tr><td>VECTASTAIN ABC HRP Elite kit</td><td>Vector Laboratories</td><td>CAT#PK-6100; RRID: <a id="intref0200" href="https://antibodyregistry.org/AB_2336819" target="_blank">AB_2336819</a></td></tr><tr><td>Vector® VIP Peroxidase (HRP) Substrate Kit</td><td>Vector Laboratories</td><td>CAT#SK-4600; RRID: <a id="intref0205" href="https://antibodyregistry.org/AB_2336848" target="_blank">AB_2336848</a></td></tr><tr><td>OCT</td><td>Killik, Bio-Optica, IT</td><td>CAT#W01030799</td></tr><tr><td>Hoechst dye</td><td>Sigma-Aldrich</td><td>CAT#B2261</td></tr><tr><td>Collagenase type I</td><td>GIBCO</td><td>CAT#17100017</td></tr><tr><td>Gelatin</td><td>Sigma-Aldrich</td><td>CAT#G9136</td></tr><tr><td>Fibronectin</td><td>Merck-Millipore</td><td>CAT#FC010</td></tr><tr><td>DYNAL® sheep anti-rat IgG-conjugated magnetic beads</td><td>ThermoFisher Scientific</td><td>CAT#11035</td></tr><tr><td>CellTracker™ Red CMTPX Dye</td><td>ThermoFisher Scientific</td><td>CAT#C34552</td></tr><tr><td>Lipofectamine 2000</td><td>ThermoFisher Scientific</td><td>CAT#11668019</td></tr><tr><td>MegaMix-Blue</td><td>MicroZone, Client life science</td><td>CAT#2MMB-100</td></tr><tr><td>HGFR inhibitor (PHA-665752)</td><td>Merck</td><td>CAT#PZ0147-25MG</td></tr><tr><td>Akt inhibitor (LY294002)</td><td>Merck</td><td>CAT#L9908</td></tr><tr><td>FAK inhibitor (PF573228)</td><td>TORCIS</td><td>CAT#3239</td></tr><tr><td>ROCK inhibitor (GSK269962A)</td><td>TORCIS</td><td>CAT#4009</td></tr><tr><td>MEK inhibitor (U0126)</td><td>TORCIS</td><td>CAT#1144</td></tr><tr class="rowsep"><td>CCR2 inhibitor (CCR2<i>i</i>)</td><td>ChemoCentryx</td><td>Patent Application Numbers: WO 2014089495 and WO 2016187393</td></tr><tr class="rowsep"><td colspan="3"><b>Critical Commercial Assays</b></td></tr><tr><td>Hypoxyprobe™-1 Kit</td><td>Hypoxyprobe, Inc</td><td>CAT#HP1-1000Kit</td></tr><tr><td>Tyramide SuperBoost Kit</td><td>ThermoFisher Scientific</td><td>CAT#B40953</td></tr><tr><td>Vevo Micromarker™ Contrast Agent Kit</td><td>Visualsonics</td><td>N/A</td></tr><tr><td>CellTiter 96® Aqueous One Solution Reagent</td><td>Promega</td><td>CAT#G3582</td></tr><tr><td>Proteome-Profiler Mouse Cytokine Array Kit</td><td>R&amp;D systems</td><td>CAT#ARY006</td></tr><tr><td>Proteome Profiler Phospho-Receptor Tyrosine Kinase Array Kit</td><td>R&amp;D systems</td><td>CAT#ARY001B</td></tr><tr class="rowsep"><td>Proteome Profiler Tyrosine Kinase Array Kit</td><td>R&amp;D systems</td><td>CAT#ARY003B</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited Data</b></td></tr><tr class="rowsep"><td>Mass spectrometry proteomics data</td><td>the ProteomeXchange Consortium</td><td>PXD014513</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Cell Lines</b></td></tr><tr><td>LLC</td><td>ATCC</td><td>CRL-1642</td></tr><tr><td>B16F0</td><td>ATCC</td><td>CRL-6322</td></tr><tr><td>B16F10</td><td>ATCC</td><td>CRL-6475</td></tr><tr class="rowsep"><td>E0771</td><td>CH3 Biosystems</td><td>SKU:940001</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Organisms/Strains</b></td></tr><tr><td>Mouse: <i>pdgfrβcre</i></td><td><span class="dropBlock reference-citations"><a id="body-ref-sref19" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19" aria-controls="sref19">Foo et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Foo, S.S. ∙ Turner, C.J. ∙ Adams, S. ...</div><div><strong>Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly</strong></div><div><em>Cell.</em> 2006; <strong>124</strong>:161-173</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2005.10.034&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2005.10.034&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-30344440869" target="_blank" aria-label="Open Scopus in new tab">Scopus (393)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16413489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2005.10.034&amp;pmid=16413489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: <i>β3</i><sup><i>fl/fl</i></sup></td><td><span class="dropBlock reference-citations"><a id="body-ref-sref41-1" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-1" aria-controls="sref41-1">Morgan et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref41-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Morgan, E.A. ∙ Schneider, J.G. ∙ Baroni, T.E. ...</div><div><strong>Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit</strong></div><div><em>FASEB J.</em> 2010; <strong>24</strong>:1117-1127</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1096/fj.09-138420" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77951625288" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19933310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1096%2Ffj.09-138420&amp;pmid=19933310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup></td><td>This paper</td><td>N/A</td></tr><tr><td>Mouse: <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup></td><td>This paper</td><td>N/A</td></tr><tr><td>Mouse: mTmG</td><td>Cancer Research UK</td><td>N/A</td></tr><tr><td>Mouse: <i>pdgfrβcre-;mTmG</i></td><td>This paper</td><td>N/A</td></tr><tr><td>Mouse: <i>pdgfrβcre+;mTmG</i></td><td>This paper</td><td>N/A</td></tr><tr><td>Mouse: <i>RIPtag-2</i></td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Hanahan, 1985</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Hanahan, D.</div><div><strong>Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes</strong></div><div><em>Nature.</em> 1985; <strong>315</strong>:115-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/315115a0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0021888904" target="_blank" aria-label="Open Scopus in new tab">Scopus (1095)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2986015/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F315115a0&amp;pmid=2986015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse: <i>RIPtag-2;pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup></td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Mouse: <i>RIPtag-2;pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup></td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>PCR primers, see method</td><td>This paper</td><td>N/A</td></tr><tr><td>shRNA sequences for ROCK2 and non-targeting shControl, see <a id="crosref0775" href="#sec-4-4">Method Details</a></td><td>This paper</td><td>GenScript USA Inc.</td></tr><tr class="rowsep"><td>sgRNAs sequences for TIMP-1, CXCL1, CCL2, Akt1 and HGFR, see <a id="crosref0780" href="#mmc1">Table S1</a></td><td>This paper</td><td>Invitrogen</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>Lenti-CRISPR–EGFP plasmid</td><td>Addgene;<br><span class="dropBlock reference-citations"><a id="body-ref-sref39" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39" aria-controls="sref39">McComb et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>McComb, S. ∙ Aguadé-Gorgorió, J. ∙ Harder, L. ...</div><div><strong>Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:339ra70</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad2986" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84969626016" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27194728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad2986&amp;pmid=27194728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>CAT#75159</td></tr><tr><td>pLKO-neo lentiviral shRNA construct</td><td>Addgene;<br><span class="dropBlock reference-citations"><a id="body-ref-sref72" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72" aria-controls="sref72">Wiederschain et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref72"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Wiederschain, D. ∙ Wee, S. ∙ Chen, L. ...</div><div><strong>Single-vector inducible lentiviral RNAi system for oncology target validation</strong></div><div><em>Cell Cycle.</em> 2009; <strong>8</strong>:498-504</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4161/cc.8.3.7701" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-59449092185" target="_blank" aria-label="Open Scopus in new tab">Scopus (321)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19177017/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4161%2Fcc.8.3.7701&amp;pmid=19177017" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>CAT#21916</td></tr><tr><td>pMDLg/pRRE</td><td>Addgene;<br><span class="dropBlock reference-citations"><a id="body-ref-sref17-1" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-1" aria-controls="sref17-1">Dull et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref17-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Dull, T. ∙ Zufferey, R. ∙ Kelly, M. ...</div><div><strong>A third-generation lentivirus vector with a conditional packaging system</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:8463-8471</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.11.8463-8471.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9765382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.11.8463-8471.1998&amp;pmid=9765382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>CAT#12251</td></tr><tr><td>pRSV-Rev</td><td>Addgene;<br><span class="dropBlock reference-citations"><a id="body-ref-sref17-2" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-2" aria-controls="sref17-2">Dull et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref17-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Dull, T. ∙ Zufferey, R. ∙ Kelly, M. ...</div><div><strong>A third-generation lentivirus vector with a conditional packaging system</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:8463-8471</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.11.8463-8471.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9765382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.11.8463-8471.1998&amp;pmid=9765382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>CAT#12253</td></tr><tr class="rowsep"><td>pMD2.G</td><td>Addgene,<br>Trono Lab Packaging and Envelope Plasmid (unpublished): <a id="intref0210" href="https://www.epfl.ch/labs/tronolab/" target="_blank">https://www.epfl.ch/labs/tronolab/</a></td><td>CAT#12259</td></tr><tr class="rowsep"><td colspan="3"><b>Software and Algorithms</b></td></tr><tr><td>ImageJ</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref56" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56" aria-controls="sref56">Schneider et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref56"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Schneider, C.A. ∙ Rasband, W.S. ∙ Eliceiri, K.W.</div><div><strong>NIH Image to ImageJ: 25 years of image analysis</strong></div><div><em>Nat. Methods.</em> 2012; <strong>9</strong>:671-675</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2089" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84863205849" target="_blank" aria-label="Open Scopus in new tab">Scopus (43944)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22930834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2089&amp;pmid=22930834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0215" href="https://imagej.nih.gov/ij/" target="_blank">https://imagej.nih.gov/ij/</a></td></tr><tr><td>Graphpad Prism (Version 6 and 8)</td><td>Graphpad</td><td><a id="intref0220" href="https://graphpad.com/" target="_blank">https://graphpad.com/</a></td></tr><tr><td>Flowjo</td><td>N/A</td><td><a id="intref0225" href="https://www.flowjo.com" target="_blank">https://www.flowjo.com</a></td></tr><tr><td>QuPath v0.1.2</td><td>Quantitative Pathology &amp; Bioimage analysis</td><td><a id="intref0230" href="https://qupath.github.io/" target="_blank">https://qupath.github.io/</a></td></tr><tr><td>The RNAi Consortium collection</td><td>Sigma-Aldrich</td><td><a id="intref0235" href="https://www.sigmaaldrich.com/life-science/functional-genomics-and-rnai/shrna/library-information.html" target="_blank">https://www.sigmaaldrich.com/life-science/functional-genomics-and-rnai/shrna/library-information.html</a></td></tr><tr><td>CRISPOR algorithm</td><td>Cripsor</td><td><a id="intref0240" href="http://crispor.tefor.net" target="_blank">http://crispor.tefor.net</a></td></tr><tr><td>Pescal software</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref74-1" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-1" aria-controls="sref74-1">Wilkes et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref74-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Wilkes, E.H. ∙ Casado, P. ∙ Rajeeve, V. ...</div><div><strong>Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability</strong></div><div><em>Mol. Cell. Proteomics.</em> 2017; <strong>16</strong>:1694-1704</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1074%2Fmcp.O116.064360&amp;cf=fulltext&amp;site=mcpro-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1074%2Fmcp.O116.064360&amp;cf=pdf&amp;site=mcpro-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85029166644" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28674151/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.O116.064360&amp;pmid=28674151" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mascot Daemon 2.5.0</td><td>Mascot</td><td>N/A</td></tr><tr class="rowsep"><td>VevoCQ™ contrast quantification software</td><td>Visualsonics</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Other</b></td></tr><tr><td>Nucleofector® electroporation system</td><td>Lonza</td><td>Nucleofactor® II</td></tr><tr><td>Neon Transfection system</td><td>ThermoFisher Scientific</td><td>MPK5000</td></tr><tr><td>NanoZoomer S210 slide scanner</td><td>Hamamatsu, Japan</td><td>S210</td></tr><tr><td>FACSAria™ III flow cytometer</td><td>BD Biosciences</td><td>FACSAria™ III</td></tr><tr><td>Nano SPECT/CT® <i>In&nbsp;vivo</i> preclinical imager</td><td>BioScan</td><td>Nano SPECT/CT®</td></tr><tr><td>Ultrasound imaging system</td><td>Visualsonics</td><td>Vevo® 2100 system</td></tr><tr><td>Decloaking Chamber™ NxGen</td><td>Biocare Medical</td><td>NxGen</td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2820%2930147-1" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Lead Contact and Materials Availability</h3><div id="p0160" role="paragraph">Further information requests and reagents should be directed to and will be fulfilled by the Lead Contact, Kairbaan Hodivala-Dilke (<a id="intref0245" href="mailto:k.hodivala-dilke@qmul.ac.uk">k.hodivala-dilke@qmul.ac.uk</a>).</div><div id="p0165" role="paragraph">All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement where required.</div></section><section id="sec-4-3"><h3>Experimental Model and Subject Details</h3><section id="sec-4-3-1"><h4>Human samples collection and patient information</h4><div id="p0170" role="paragraph">Human ER+ breast cancer samples were obtained from the Barts Cancer Institute Breast Cancer Now tissue Bank and were covered by Research Tissue Bank Ethics Approval (Ethnic code 15/EE/0192). Human melanoma, mesothelioma and diffuse large B cell lymphoma samples were obtained with signed informed consent from patients and ethical committee approval. Large B cell lymphoma (Ethnic code 05/Q0605/140). Melanoma samples were covered by East London and City Health Authority Ethical Approval (07/Q0604/23 MM: East London and City Health Authority: ‘Molecular mechanisms in the pathogenesis of malignant melanoma’, with a minor amendment in March 2018: ReDa 005044Q1.</div><div id="p0175" role="paragraph">Mesothelioma samples were analyzed with approval from Leeds East (Yorkshire and The Humber) ethical review board (14/YH/0090); all patients provided written informed consent.</div><div id="p0180" role="paragraph">For human clinical samples, the results have been stratified according to the mean of the population. We used the following number of samples (n): 52 for human cutaneous melanoma, 54 for human diffuse large B cell lymphoma, 80 for breast cancer and 22 for mesothelioma.</div></section><section id="sec-4-3-2"><h4>Animal Models</h4><div id="p0185" role="paragraph"><i>pdgfrβcre</i> mice were obtained from Professor Ralf Adams (Max Planck Institute for Molecular Biomedicine, Münster, Germany). <i>β3</i><sup><i>fl/fl</i></sup> mice were generated by Professor Katherine Weilbaecher (<span class="dropBlock reference-citations"><a id="body-ref-sref41-2" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-2" aria-controls="sref41-2">Morgan et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref41-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Morgan, E.A. ∙ Schneider, J.G. ∙ Baroni, T.E. ...</div><div><strong>Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit</strong></div><div><em>FASEB J.</em> 2010; <strong>24</strong>:1117-1127</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1096/fj.09-138420" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77951625288" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19933310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1096%2Ffj.09-138420&amp;pmid=19933310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were maintained on a pure C57 background for experiments. <i>β3</i><sup><i>fl/fl</i></sup> mice were bred with <i>RIPtag-2</i> mice provided by Professor Douglas Hanahan, generating both male and female mice were used. mTmG mice were obtained from Cancer Research UK. mTmG mice were crossed with <i>pdgfrβcre+</i> mice to generate <i>pdgfrβcre-;mTmG</i> and <i>pdgfrβcre+;mTmG</i> mice for Cre-specificity analysis. Unchallenged adult skin from <i>TdTom;pdgfrβcre+ and TdTom;pdgfrβcre- control mice</i>, fixed in 4% formalin, sucrose infiltrated, and snap frozen in OCT were used to assess pdgfrβ-driven cre activity in skin mural cells.</div><div id="p0190" role="paragraph">Experimental procedures with <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were taken with 12-14&nbsp;weeks-old mice. LLC, B16F0 and B16F0 experiments were performed in males and females. E0771 injection were performed in females. <i>RIPtag-2;pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup>; and <i>RIPtag-2;pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> (males and females) were culled at 13&nbsp;weeks of age. Co-injection experiments were performed in C57BL/6 females (Charles River) 8-12&nbsp;weeks old.</div><div id="p0195" role="paragraph"><i>In&nbsp;vivo</i> experiments have been done in replicate to confirm observations. For all the animal experiments, mice have been randomized in order that every experimental condition is represented with different gender, age or weight as above. For animals bred in-house –health screens (quarterly) were conducted in accordance with FELASA guidelines for health monitoring of rodent colonies, to confirm their free status of known pathogens in accordance with the FELASA screens. No clinical signs were detected. Animals were housed in groups of 4–6 per individually ventilated cage in a 12&nbsp;h light dark cycle (06:30–18:30 light; 18:30–06:30 dark), with controlled room temperature (21 ± 1°C) and relative humidity (40%–60%). The cages contained 1–1.5&nbsp;cm layer of animal bedding, and with environmental enrichment including cardboard Bio-tunnel and crinkled paper nesting material. Animals had access to food and water <i>ad libitum</i>.</div><div id="p0200" role="paragraph">All animal procedures were approved by our local animal ethics committee, Queen Mary University of London and were executed in accordance with United Kingdom Home Office regulations.</div></section><section id="sec-4-3-3"><h4>Cell lines</h4><div id="p0205" role="paragraph">Lewis lung carcinoma (LLC), B16F0 (melanoma, derived from C57BL/6), B16F10 (melanoma, derived from C57BL/6), E0771 (breast cancer, derived from C57BL/6) (all from ATCC). LLC, B16F0 and B16F10 were cultured in DMEM supplemented with 10% fetal bovine serum (GIBCO 10500 (batch 07Q8041K) Pencillin and Streptomcyin. E0771 cells were grown in RPMI supplemented with 10% fetal bovine serum (GIBCO 10500 (batch 07Q8041K) Pencillin and Streptomcyin. Cell lines were maintained in a 5% CO<sub>2</sub> incubator at 37°C.</div></section><section id="sec-4-3-4"><h4>Primary cell cultures</h4><div id="p0210" role="paragraph">Pericytes (WT, β3 null, WT; Cas9, β3 null;Cas9, β3 null;CCL2<sup>KO</sup>, β3 null;CXCL1<sup>KO</sup>, β3 null;TIMP1<sup>KO</sup>) were cultured in pericyte medium including supplied pericyte growth supplement, FBS and penicillim/streptomycin (ScienCell-#0010).</div><div id="p0215" role="paragraph">Primary mouse endothelial cells (MLEC) were isolated from mouse brains and maintained in MLEC medium (Ham’s F-12, DMEM (low glucose) 10% FCS, heparin and endothelial mitogen (Generon),</div><div id="p0220" role="paragraph">Primary fibroblasts were also isolated from brains and cultured in DMEM&nbsp;+ 10% FCS.</div></section></section><section id="sec-4-4"><h3>Method Details</h3><section id="sec-4-4-1"><h4>Human tissue sections</h4><div id="p0225" role="paragraph">Formalin fixed paraffin embedded tissue samples from human melanoma, diffuse large B cell lymphoma, breast cancer and mesothelioma were sectioned, dewaxed, and antigen retrieval carried out in boiling 10&nbsp;mM citrate buffer pH 6.0, 4&nbsp;μm sections were washed three times in PBS, blocked in 1% normal goat serum (NSG) 0.1% Triton X-100 (TX-100) for 1 h. Sections were double or triple immunostained for mouse monoclonal anti-alpha-smooth muscle actin Cy3-conjugated (Sigma-Aldrich-#C6198) and for either rabbit monoclonal anti-CD31 (Abcam-#ab76533), rabbit monoclonal anti-phospho-Akt (ser 473) (Cell Signaling Technology-#3787), rabbit monoclonal anti-NF-κB p65 (Cell Signaling Technology-#8242), rabbit monoclonal anti-β3-integrin (Abcam-#ab75872) or rabbit polyclonal anti-CD61 (ThermoFisher Scientific-#PA5-32890). Sections were then washed three times with PBS, incubated with Alexa® 488-/546-conjugated anti-rabbit diluted 1:200 in 1% NGS 0.1% TX-100, washed three times and mounted with Prolong Gold Anti-Fade Mountant with DAPI (ThermoFisher Scientific-#P36931). For triple immunostaining, the tissue sections were further processed by using Tyramide SuperBoost Kit (Invitrogen-#B4093) combined with IHC (TSA-IHC). Different primary antibodies were sequentially applied, followed by horseradish peroxidase-conjugated secondary antibody incubation and tyramide signal amplification. The slides were microwave heat-treated after each TSA operation.</div><div id="p0230" role="paragraph">For data analysis, the percentage of β3-integrin or p-Akt or p65 and α-SMA-double-positive blood vessels was calculated as the number of β3-integrin or p-Akt or p65 and α-SMA-double-positive blood vessels over the total number of α-SMA-positive blood vessels. Patient data are expressed as those with either less, or more, than the mean percentage of blood vessels that are mural β3-integrin negative.</div></section><section id="sec-4-4-2"><h4>PCR genotyping</h4><div id="p0235" role="paragraph">The primers for the Cre PCR: forward primer: 5′-GCTGTAGACGTAGTAAGTATCG-3′; reverse primer: 5′-GCTGGAGTTTCAATACCGGAG-3′. The reaction generates a fragment of approximately 669&nbsp;bp. The primers for the <i>β3-floxed</i> PCR: forward primer: 5′-TTGTTGGAGGTGAGCGAGTC-3′ and reverse primer: 5′-GCCCAGCGGATCTCCATCT-3′. The PCR reaction generates a 272&nbsp;bp fragment for the <i>β3-floxed</i> allele and a 182&nbsp;bp fragment for the <i>wild-type</i> allele. All the primers were purchased from ThermoFisher Scientific. For PCR reactions, the 25&nbsp;μL reactions contain 21&nbsp;μL MegaMix-Blue (MicroZone, Client life science), 100&nbsp;ng DNA, 1&nbsp;μL of 10&nbsp;nM forward and reverse primers respectively. For Cre PCR, the PCR program was run as a simplified hot start PCR with initial denaturation at 95°C for 5&nbsp;min, 35 cycles of 30&nbsp;s at 95°C, 1.5&nbsp;min at 60°C and 1&nbsp;min at 72°C, followed by a final extension for 5&nbsp;min at 72°C. For <i>β3-floxed</i> PCR, the PCR program was run with initial denaturation at 95°C for 2&nbsp;min, 35 cycles of 30&nbsp;s at 95°C, 30&nbsp;s at 56°C and 30&nbsp;s at 70°C, followed by a final extension for 8&nbsp;min at 72°C. The thermocycler used were GeneAmp PCR systems 9700 (Applied Biosystems). 20&nbsp;μL of the PCR products were separated by electrophoresis on a 1.8% agarose gel, stained with ethidium bromide (0.25&nbsp;μg/ml) and viewed by a gel image system (BioRad, Germany).</div></section><section id="sec-4-4-3"><h4>Mouse tumor models</h4><div id="p0240" role="paragraph">All <i>in&nbsp;vivo</i> experiments have been performed according to Arrive Guidelines. 12-14&nbsp;week old <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were given a subcutaneous injection of either 1&nbsp;× 10<sup>5</sup> Lewis lung carcinoma (LLC) or B16F0 (melanoma, derived from C57BL/6) into the flank for subcutaneous tumor growth. Tumor growth was measured by using callipers every two days. Tumor volume (V) was calculated: V&nbsp;= (Length x width<sup>2</sup>) x 0.52. After 20-26&nbsp;days, animals were culled, tumors excised and either fixed in 4% formaldehyde in PBS overnight, or snap frozen in liquid nitrogen for subsequent immunohistochemical analysis. For experimental metastasis assays, 5&nbsp;× 10<sup>5</sup> LLC or B16F10 melanoma cells were injected via the tail vein of <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. Lung tumor burden was measured by a Nano SPECT/CT® <i>In&nbsp;vivo</i> preclinical imager (Bioscan) 3-4 times over 16&nbsp;days according to the manufacturer’s instruction (<span class="dropBlock reference-citations"><a id="body-ref-sref75" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75" aria-controls="sref75">Wong et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref75"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Wong, P.P. ∙ Demircioglu, F. ∙ Ghazaly, E. ...</div><div><strong>Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread</strong></div><div><em>Cancer Cell.</em> 2015; <strong>27</strong>:123-137</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2014.10.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2014.10.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84922180322" target="_blank" aria-label="Open Scopus in new tab">Scopus (168)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25584895/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2014.10.015&amp;pmid=25584895" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For breast cancer orthotopic model, 1&nbsp;× 10<sup>5</sup> E0771 cells were orthotopically injected into mammary fat pad of <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. <i>RIPtag-2;pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup>; and <i>RIPtag-2;pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup>; were culled at 13&nbsp;weeks of age. At necropsy, pancreas with peri-pancreatic lymph nodes, were fixed in 4% formaldehyde in PBS or snap frozen for subsequent immunohistochemical analysis.</div><div id="p0245" role="paragraph">For co-injection tumor growth assays, wild-type C57BL/6 mice (Charles River) were intravenously co-injected with 1&nbsp;× 10<sup>5</sup> B16F10 cells and either 4&nbsp;× 10<sup>5</sup> WT or β3 null pericytes, or with 1&nbsp;× 10<sup>5</sup> B16F10 cells and either 8&nbsp;× 10<sup>5</sup> WT or β3 null pericytes. Three weeks post injection, the mice were sacrificed and the number of metastases in their lungs was counted. For breast cancer orthotopic model, 1&nbsp;× 10<sup>5</sup> E0771 cells were co-injected with either 4&nbsp;× 10<sup>5</sup> WT or β3 null pericytes into the mammary fat pad of wild-type C57BL/6 mice. To perform metastasis analysis, the tumor bearing mice were harvested when their primary tumor sizes reached 600&nbsp;mm<sup>3</sup>, and their lungs were fixed for further metastasis analysis.</div><div id="p0250" role="paragraph">For <i>in&nbsp;vivo</i> rescue experiment, β3 null pericytes were transfected using the Nucleofector® electroporation system (Lonza) with either the empty vector (mock control) or Iκ-BαSR (kindly provided by Professor Neil Perkins) for 48 h. Wild-type C57BL/6 mice were intravenously coinjected with 1&nbsp;× 10<sup>5</sup> B16F10 cells and either 4&nbsp;× 10<sup>5</sup> mock transfected- or Iκ-BαSR transfected-β3 null pericytes. Three weeks post injection, mice were sacrificed and the number of metastases in their lungs was quantified by counting the average of the number of metastases across entire lung H&amp;E stained section area from three different levels of the lungs, with 10&nbsp;μm separation between each level. H&amp;E stained sections from E0771 metastases and RIPTag-2 metastases were used to assess metastatic burden.</div></section><section id="sec-4-4-4"><h4><i>In&nbsp;vivo</i> cell tracking</h4><div id="p0255" role="paragraph">B16F10 melanoma, WT or β3 null pericytes, previously labeled with CellTracker™ Red CMTPX Dye (Molecular probes, Invitrogen, Life Science), were resuspended at 0.5&nbsp;× 10<sup>6</sup> cells per 100 ul of PBS and injected via the tail vein into mice. At 2 or 48&nbsp;h post inoculation, mice were sacrificed and lungs were fixed in 4% paraformaldehyde, dissected and images were captured using a Leica MZ16F stereomicroscope. Then lungs were snap-frozen (<span class="dropBlock reference-citations"><a id="body-ref-sref4" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4" aria-controls="sref4">Batista et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Batista, S. ∙ Maniati, E. ∙ Reynolds, L.E. ...</div><div><strong>Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis</strong></div><div><em>Nat. Commun.</em> 2014; <strong>5</strong>:5054</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms6054" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84923363475" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25270220/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms6054&amp;pmid=25270220" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Lungs were dissected, photographed using a Leica M16F fluorescence stereomicropscope, snap-frozen in OCT (Killik, Bio-Optica, IT) and 4&nbsp;μm cryosections were prepared for analysis. Total number of CMTPX positive tumor cells or pericytes were quantified by counting the average of the number of CMTPX positive cells across entire lung section area from three different levels of the lungs (with 10&nbsp;μm separation between each level), using a Zeiss Axioplan microscope (Zeiss).</div></section><section id="sec-4-4-5"><h4>Immunofluorescence</h4><div id="p0260" role="paragraph">Mouse tissues were fixed in formalin for 24&nbsp;hr and transferred to 70% ethanol. The tissues were then paraffin embedded, sectioned, dewaxed, and unmasked in boiling 10&nbsp;mM citrate buffer pH 6.0. 5&nbsp;μm sections were washed three times in PBS, blocked in 1% normal goat serum (NSG) 0.1% Triton X-100 (TX-100) for 1&nbsp;hr. Sections were double immunostained for mouse monoclonal anti-alpha-smooth muscle actin Cy3-conjugated (Sigma-Aldrich-C6198) and for either rat monoclonal anti-endomucin (Santa Cruz Biotechnology-#sc-65495) or rabbit monoclonal anti-β3-integrin (Abcam-#ab75872). Sections were washed three times with PBS, incubated with Alexa® 488-/546-conjugated anti-rabbit or Alexa® 488-conjugated anti-rat secondary antibody (Invitrogen) diluted 1:200 in 1% NGS 0.1% TX-100, washed three times and mounted with Prolong Gold anti-Fade Mountant with DAPI. The percentage of α-SMA-positive blood vessels with β3-integrin expression was calculated as described previously. For collagen IV (rabbit polyclonal anti-collagen IV (Abcam-#ab6586))/endomucin (rat monoclonal anti-endomucin (Santa Cruz Biotechnology-#sc-65495)) and β3-integrin (rabbit polyclonal anti-CD61 (ThermoFisher Scientific-#PA5-32890))/PDGFRβ (rabbit monoclonal anti-PDGFRβ (Cell Signaling Technology-#3169) double immunostaining experiments, mouse tumors were snap-frozen, sectioned and fixed in ice-cold acetone for 10&nbsp;min. 4&nbsp;μm sections were blocked for 45&nbsp;min with 1.0% bovine serum albumin (BSA) and 0.1% Tween 20 in PBS. Primary antibodies were incubated overnight at 4°C followed by incubation with Alexa 546-conjugated secondary antibody for 1&nbsp;h at RT (Invitrogen) diluted 1:200 in 1.0% bovine serum albumin (BSA) and 0.1% Tween 20 in PBS, washed three times and mounted with Prolong Gold anti-Fade Mountant with DAPI (ThermoFisher Scientific). <i>TdTom;pdgfrβcre-</i> and <i>TdTom;pdgfrβcre+</i> mouse unchallenged skin tissues were obtained from Neil Henderson lab (University of Edinburgh).</div><div id="p0265" role="paragraph"><i>In&nbsp;vitro</i>, cells were fixed with 4% formaldehyde in PBS for 10&nbsp;min at RT. Rabbit monoclonal anti-phospho-NF-κB p65 (Ser 536) (Cell Signaling Technology-#3033) antibody was incubated overnight at 4°C and washed three times with PBS followed by incubation with Alexa® 546-conjugated secondary antibody (Invitrogen) for 1&nbsp;h at RT diluted 1:200 in 1.0% bovine serum albumin (BSA) and 0.1% Tween 20 in PBS, washed three times and mounted with Prolong Gold anti-Fade Mountant with DAPI (ThermoFisher Scientific).</div></section><section id="sec-4-4-6"><h4>Blood vessel density and pericyte coverage</h4><div id="p0270" role="paragraph">The number of endomucin-positive blood vessels present across the entire area of each mid-line tumor section from size and age-matched tumors or unchallenged skins was counted and divided by the area of the section to determine tumor blood vessel density.</div><div id="p0275" role="paragraph">For pericyte coverage, the percentage of α-SMA-positive, endomucin-positive blood vessels were counted.</div></section><section id="sec-4-4-7"><h4>Vascular perfusion</h4><div id="p0280" role="paragraph">Vascular perfusion was visualized by injecting mice via the tail vein with PE-conjugated 20&nbsp;μg of rat monoclonal anti-PE-PECAM (BioLegend-#102408) 10&nbsp;min prior to culling. Tumors were snap frozen, sectioned and stained for endomucin. The ratio (%) of double-positive blood vessels over endomucin-positive vessels provided an indication of blood vessel perfusion.</div></section><section id="sec-4-4-8"><h4>Hypoxia quantification (Pimonidazole) and vessel leakage (Hoechst diffusion)</h4><div id="p0285" role="paragraph">Hypoxia and extravascular diffusion (vessel leakage) were tested by injecting mice with pimonidazole (Hypoxyprobe-1 Kit) intraperitoneally 1&nbsp;h prior to culling, and followed by intravenous injection of Hoechst dye (0.4&nbsp;mg, Sigma-Aldrich) 1&nbsp;min prior to culling and anti-PE-PECAM as above. Tumors were snap frozen, sectioned and fixed in ice-cold acetone for 10&nbsp;min. 100&nbsp;μm thick frozen tumor sections were incubated overnight at 4°C with a FITC-conjugated mouse monoclonal anti-pimonidazole (Hydroxyprobe HPI Burlington-#MA01803), and then washed and mounted. Sections were analyzed using confocal microscopy (LSM710, Carl Zeiss). Confocal stacks of 100&nbsp;μm were taken at 0.5&nbsp;μm intervals (20x) on multiple fields using 488&nbsp;nm laser to excite anti-pimonidazole, 543&nbsp;nm laser to excite anti-PE-PECAM, and 740&nbsp;nm Mai-Tai fentosecond pulsing laser to excite Hoechst. For Hoechst diffusion quantification, the mean areas for PE-PECAM and Hoechst staining for each 100&nbsp;μm stack was calculated using ImageJ software. The Hoechst dye diffusion leakage area was calculated relative to PE-PECAM stained vessel area. For hypoxia quantification, the hypoxia index was calculated as the area of pimonidazole staining intensity across the area of tumor section.</div></section><section id="sec-4-4-9"><h4>Blood vessel collagen IV assessment</h4><div id="p0290" role="paragraph">The percentage of endomucin-positive vessels with collagen IV expression was calculated as the number of collagen IV and endomucin-double positive blood vessels over the total number of endomucin-positive blood vessels.</div></section><section id="sec-4-4-10"><h4>Phospho-MLC2 staining and digital analysis</h4><div id="p0295" role="paragraph">Tumors were formalin-fixed and paraffin-embedded using standard protocols. 4&nbsp;μm thick sections were incubated at 60 C° for 20&nbsp;min and then subjected to antigen retrieval using citric acid based antigen unmasking solution (1:100; Vector Laboratories-#H-3300) at 110 C° for 6&nbsp;min in a Decloaking Chamber™ NxGen (Biocare Medical). Samples were blocked with Dual Endogenous Enzyme-Blocking Reagent (Dako-#S2003) for 10&nbsp;min and then were incubated with rabbit polyclonal anti-phospho-MLC2 (1:50; Cell Signaling Technology-#3671) for 40&nbsp;min at RT, washed and then incubated with biotinylated goat anti-rabbit secondary antibody (1:200; Vector Laboratories-#BA-1000) for 30&nbsp;min at RT. Signal was then amplified using VECTASTAIN ABC HRP Elite kit (Vector Laboratories-#PK-6100;) for 20&nbsp;min at RT and the reaction was developed using Vector® VIP Peroxidase (HRP) Substrate Kit (Vector Laboratories-#SK-4600) for 10&nbsp;min at RT. Staining was counterstained with Hematoxylin.</div><div id="p0300" role="paragraph">Sections from tumor xenograft experiments were imaged using NanoZoomer S210 slide scanner (Hamamatsu, Japan). Staining quantification was performed using QuPath v0.1.2. The entire whole-section images (WSI) were analyzed performing positive cell detection, and three different thresholds were applied according to the intensity scores (0, 1, 2 and 3). Next, the software was trained by creating random trees classification algorithm combined with the intensity information, in order to differentiate tumor from stroma, necrosis and immune cells. Values used in the analysis correspond to the quantification of p-MLC2 in the tumor margins.</div></section><section id="sec-4-4-11"><h4>Ultrasound analysis of blood flow, volume and perfusion</h4><div id="p0305" role="paragraph">High-resolution ultrasound imaging of B16F0 tumors using the Vevo® 2100 system with a MS250 transducer was performed according to manufacturer instruction (Visualsonics). For blood flow, volume and perfusion measurement, contrast-enhanced ultrasound imaging was performed according to manufacturer instructions (Vevo® 2100 system). Briefly, B16F0 tumor bearing <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice were administered with 100&nbsp;μL of bolus Vevo Micromarker suspension (VisualSonics) via tail vein using tail vein Micromarker™ catheter. The ultrasound images were processed and analyzed by using VevoCQ™ contrast quantification software.</div></section><section id="sec-4-4-12"><h4>Primary pericyte, endothelial cell and fibroblast isolation and culture</h4><div id="p0310" role="paragraph">Primary mouse endothelial cells, fibroblasts and pericytes were isolated from mouse brains and maintained as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref54-3" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-3" aria-controls="sref54-3">Reynolds et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref54-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Reynolds, L.E. ∙ D’Amico, G. ∙ Lechertier, T. ...</div><div><strong>Dual role of pericyte α6β1-integrin in tumour blood vessels</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2017; <strong>130</strong>:1583-1595</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.197848" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85018256546" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28289267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.197848&amp;pmid=28289267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, <i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mouse brains were minced, collagenase type I digested (GIBCO-#17100017), strained through a 70&nbsp;μm cell strainer (BD Falcon) and the resulting cell suspension plated on flasks coated with a mixture of 0.1% gelatin (Sigma-Aldrich-#G9136), 10&nbsp;μg/ml fibronectin (Merck-Millipore-#FC010) and 30&nbsp;μg/ml rat tail collagen (Sigma-Aldrich). Endothelial cells were purified by a single negative (Rat monoclonal anti-mouse FCγ sort-RII/III; BD Biosciences-#553141) and two positive cell sorts (Rat monoclonal anti-mouse ICAM-2; BD Biosciences-#553326), using DYNAL® sheep anti-rat IgG-conjugated magnetic beads (ThermoFisher Scientific-#11035). During preparation of primary endothelial cells, fibroblasts were isolated from the non-endothelial cell population that was generated during the first positive sorting. For all cell types, passaging occurred when cells reached 70% confluency. Cells were trypsinized, centrifuged, washed with PBS and re-plated on pre-coated flasks for endothelial cells and pericytes and non-coated flasks for fibroblasts. For culture conditions, fibroblasts were cultured in DMEM&nbsp;+ 10% FCS to passage 4, endothelial cells in MLEC medium (Ham’s F-12, DMEM (low glucose), 10% FCS, heparin and endothelial mitogen (Generon)) to passage 4-5. Pericytes were cultured in pericyte medium including supplied pericyte growth supplement, FBS and pen/strep (ScienCell-#0010) to passage 10.</div></section><section id="sec-4-4-13"><h4>Generation of CRISPR/Cas9-KO cells</h4><div id="p0315" role="paragraph">SgRNAs were designed using the CRISPOR algorithm (<a id="intref0250" href="http://crispor.tefor.net" target="_blank">http://crispor.tefor.net</a>). sgRNA sequences targeting TIMP-1 (Gene ID: 21857), CXCL1 (Gene ID: 14825), CCL2 (Gene ID: 20296), Akt1 (Gene ID: 11651), and HGFR (Met) (Gene ID: 17295) (see <a id="crosref0835" href="#mmc1">Table S1</a>) were cloned into the pLenti-CRISPR–EGFP plasmid (Addgene-#75159) using BsmBI enzyme site. 5.0&nbsp;× 10<sup>5</sup> cells were centrifuged at 300&nbsp;g for 5&nbsp;min and re-suspended in 100&nbsp;μL of R1 buffer (Invitrogen). CRISPR/Cas9-EGFP plasmid DNA (10&nbsp;μg) were added into the WT and β3 null pericytes and loaded into a 100&nbsp;μL Neon electroporation tip (Invitrogen). Electroporation was performed using 1350&nbsp;mV for 20&nbsp;ms with 2 pulse program on the Neon Electroporator (ThermoFisher Scientific). After electroporation, cells were rescued in pre-warmed supplemented media in the 0.1% gelatin with collagen and fibronectin-coated plates. 48&nbsp;h post transfection, cells were washed with phosphate-buffered saline (PBS) and harvested with 500&nbsp;μL of FACS buffer (1% BSA and 0.5&nbsp;mM EDTA in PBS). A 488-nm diode laser was used for the detection of EGFP. In each sample, viable singlet cells were gated via forward-scatter (FSC) laser and side-scatter (SSC) and EGFP positive cells, regardless of expression levels, were sorted using a FACSAria™ III flow cytometer (BD Biosciences) at the Chelsea Flow Cytometry and Light Microscopy Facility.</div></section><section id="sec-4-4-14"><h4>Generation of B16F0;ROCK2<sup>KO</sup> cell lines</h4><div id="p0320" role="paragraph">ROCK2 knockdown in B16F0 melanoma cells was achieved using doxycycline inducible Tet-pLKO-neo lentiviral shRNA constructs (Addgene-#21916). shRNA sequences for ROCK2 (5′-GCATCTCTTGAAGAAACAAAT-3′) and non-targeting shControl (5′-GCGCGATAGCGCTAATAATTT-3′) were designed using The RNAi Consortium collection (MISSION® shRNA, Sigma-Aldrich) and plasmids were generated by GenScript USA Inc. For lentivirus generation, 2&nbsp;× 10<sup>6</sup> HEK293T cells on p100 dishes were transfected with lentiviral vector (5&nbsp;μg) along with packaging vectors (pMDLg/pRRE (2.5&nbsp;μg), pRSV-Rev (2.5&nbsp;μg) and pMD2.G (2&nbsp;μg) (Addgene)) using Optimem-I and Lipofectamine 2000 (ThermoFisher Scientific). Supernatants with lentiviruses were collected 48&nbsp;h after transfection, spun down and filtered (0.45&nbsp;μm). For lentiviral transduction, 2.5&nbsp;× 10<sup>5</sup> melanoma cells were seeded in T25 flasks and infected with lentiviruses. Stable cells were selected with 500&nbsp;μg/ml G418 (Sigma-Aldrich). Gene knock-down was induced by the presence of doxycycline in the culture media (2&nbsp;μg/ml) for <i>in&nbsp;vitro</i> experiments.</div></section><section id="sec-4-4-15"><h4>FACS analysis</h4><div id="p0325" role="paragraph">For characterization of primary mouse brain pericytes, pericytes were washed with PBS and trypsinized at 37°C. The cell suspensions were washed in medium containing serum and centrifuged at 1, 200&nbsp;rpm for 3&nbsp;min. Cells were washed with cold FACS buffer (1% BSA/PBS) and fixed with 4% formaldehyde for 10&nbsp;min at room temperature. Cells were washed with FACS buffer and the cell suspensions were incubated with the following primary antibodies: Rabbit polyclonal anti-NG2, Alexa Flour®488 conjugated (Merck Millipore-#AB5320A4), Rat monoclonal PE-anti-CD31 (BioLegend-#102508), rat monoclonal PE-anti-CD11b (Mac1) (BioLegend-#101208), rat monoclonal APC-anti-PDGFRβ (BioLegend-#136008), rat monoclonal APC-anti-PDGFRα (BioLegend-#135908), rat monoclonal PE/Cy7-anti-CD146 (BioLegend-#134714) for 30&nbsp;min. Cells were then washed three times in sample buffer and re-suspended in a final volume of 400&nbsp;ml. As a control, unstained cells were FACS sorted.</div></section><section id="sec-4-4-16"><h4>Proteome profiler phospho-receptor tyrosine kinase and tyrosine kinase arrays</h4><div id="p0330" role="paragraph">WT and β3 null pericytes were grown in normal pericyte media and the whole-cell lysates were extracted after 72&nbsp;h incubation. Phospho-receptor tyrosine kinase and tyrosine kinase arrays (<i>Proteome-Profilers</i> ARY001B &amp; ARY003B, R&amp;D systems) were processed according to the manufacturer’s instruction using 300&nbsp;μg of lysates per membrane. Pixel analysis was used for quantification with ImageJ software.</div></section><section id="sec-4-4-17"><h4>Western blotting</h4><div id="p0335" role="paragraph">Pericytes, endothelial cells or fibroblasts were harvested and lysed with NP40 lysis buffer (Invitrogen). Protein concentration was determined using the Bio-Rad Dc Protein Assay Kit (Bio-Rad Laboratories). 15-30&nbsp;μg of protein from each sample was loaded onto 8%–12% polyacrylamide gels. The protein was transferred to a nitrocellulose membrane and incubated for 1&nbsp;h in 5% milk phosphate buffered saline with 0.1% Tween-20 (PBS-T), followed by an overnight incubation of primary antibody diluted 1:1000 in 2% milk PBS-T at 4°C. The blots were then washed three times with PBS-T and incubated with the relevant horseradish peroxidase (HRP)-conjugated antibody diluted 1:1000 in 2% milk in PBS-T, for 1h at RT. Chemiluminescence was detected by exposing the membrane to high performance Super XR film (Fujifilm, PYSER-SGI limited). Densitometry readings were calculated with ImageJ software. Hsc70 was used as loading control. The following antibodies were used: rat monoclonal anti-endomucin (Santa Cruz Biotechnology-sc-65495), rabbit monoclonal anti-β3-integrin (Cell Signaling Technology-#4702), rabbit monoclonal anti-β5-integrin (Cell Signaling-#3629), rabbit monoclonal anti-β1-integrin (Cell Signaling Technology-#4706), rabbit monoclonal anti-PDGFRβ (Cell Signaling Technology-#3169), rabbit polyclonal anti-NG2 (Merck Millpore-AB5320), rabbit monoclonal anti-NF-κB p65 (Cell Signaling Technology-#8242), rabbit monoclonal anti-phospho-NF- κB p65 (Ser 536) (Cell Signaling Technology-#3033), rabbit monoclonal anti-Akt (Cell Signaling Technology-#4691), rabbit monoclonal anti-phospho-Akt (Ser 473) (Cell Signaling Technology-#4060), mouse monoclonal anti-Hsc70 (Santa Cruz Biotechnology-#sc7298), goat polyclonal anti-MCP-1 (CCL2) (ThermoFisher Scientific-#PA5-46954), rat monoclonal anti-CXCL1 (ThermoFisher Scientific-#MA5-23811), mouse monoclonal anti-TIMP-1 (ThermoFisher Scientific-#MA5-13688), rabbit monoclonal anti-Myosin Light Chain 2 (Cell Signaling Technology-#3672), rabbit anti-phospho-FAK (Tyr397) (Cell Signaling Technology-#3283), mouse monoclonal anti-Met (HGFR) (Santa Cruz Biotechnology-#sc-8057), rabbit monoclonal anti-phospho-Met (HGFR) (Tyr1234/1235) (Cell Signaling Technology-#3077), mouse monoclonal anti-Akt1 (Cell Signaling Technology-#2967), rabbit polyclonal anti-phospho-MEK1/2 (Ser217/221) (Cell Signaling Technology-#9121), mouse monoclonal anti-Rock II (Biosciences-#610624).</div></section><section id="sec-4-4-18"><h4>Mass spectrometry-based phosphoproteomics</h4><div id="p0340" role="paragraph">WT and β3 null pericytes were seeded in 100&nbsp;cm<sup>2</sup> Petri dishes at (1&nbsp;× 10<sup>6</sup> cells/ml). concentration. B16f0 cells were treated with CM from WT and β3 null pericytes for 30&nbsp;min and 24&nbsp;h in 100&nbsp;cm<sup>2</sup> Petri dishes (1&nbsp;× 10<sup>6</sup> cells/ml). Cells were washed twice with cold PBS supplemented with 1&nbsp;mM Na<sub>3</sub>VO<sub>4</sub> and 1&nbsp;mM NaF and lysed in 500 ul urea buffer (8&nbsp;M urea in 20&nbsp;mM in HEPES pH 8.0 supplemented with 1&nbsp;mM Na<sub>3</sub>VO<sub>4</sub>, 1&nbsp;mM NaF, 1&nbsp;mM Na<sub>4</sub>P<sub>2</sub>O<sub>7</sub> and 1&nbsp;mM sodium β-glycerophosphate). Cell lysates were homogenized by sonication for 15 cycles of 30&nbsp;s on 35&nbsp;s off (Diagenode Bioruptor® Plus, Liege, Belgium). Insoluble material was removed by centrifugation at 16,000 x <i>g</i> for 15&nbsp;min at 4°C and protein in the cell extracts was quantified by bicinchoninic acid (BCA) analysis (ThermoFisher Scientific-#23225).</div><div id="p0345" role="paragraph">For phosphoproteome analyses, we used published methods (<span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib26 bib35 bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Gruhler et&nbsp;al., 2005; Larsen et&nbsp;al., 2005; Montoya et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Gruhler, A. ∙ Olsen, J.V. ∙ Mohammed, S. ...</div><div><strong>Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway</strong></div><div><em>Mol. Cell. Proteomics.</em> 2005; <strong>4</strong>:310-327</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/mcp.M400219-MCP200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-15944377809" target="_blank" aria-label="Open Scopus in new tab">Scopus (709)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15665377/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.M400219-MCP200&amp;pmid=15665377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Larsen, M.R. ∙ Thingholm, T.E. ∙ Jensen, O.N. ...</div><div><strong>Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns</strong></div><div><em>Mol. Cell. Proteomics.</em> 2005; <strong>4</strong>:873-886</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/mcp.T500007-MCP200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-24944519450" target="_blank" aria-label="Open Scopus in new tab">Scopus (1361)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15858219/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.T500007-MCP200&amp;pmid=15858219" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Montoya, A. ∙ Beltran, L. ∙ Casado, P. ...</div><div><strong>Characterization of a TiO<sub>2</sub> enrichment method for label-free quantitative phosphoproteomics</strong></div><div><em>Methods.</em> 2011; <strong>54</strong>:370-378</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.ymeth.2011.02.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79961193839" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21316455/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ymeth.2011.02.004&amp;pmid=21316455" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As they were eluted from the nano-LC system, peptides were infused into the online connected Q-Exactive Plus system operating with a 2.1&nbsp;s duty cycle. Acquisition of full scan survey spectra (m/z 375-1,500) with a 70,000 FWHM resolution was followed by, data-dependent acquisition in which the 15 most intense ions were selected for HCD (higher energy collisional dissociation) and MS/MS scanning (200-2,000 m/z) with a resolution of 17,500 FWHM. A 30&nbsp;s dynamic exclusion period was enabled with an exclusion list with 10 ppm mass window. Overall duty cycle generated chromatographic peaks of approximately 30&nbsp;s at the base, which allowed the construction of extracted ion chromatograms (XICs) with at least 10 data points. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (<span class="dropBlock reference-citations"><a id="body-ref-sref69-1" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-1" aria-controls="sref69-1">Vizcaíno et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref69-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Vizcaíno, J.A. ∙ Csordas, A. ∙ del-Toro, N. ...</div><div><strong>2016 update of the PRIDE database and its related tools</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:D447-D456</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv1145" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84976871411" target="_blank" aria-label="Open Scopus in new tab">Scopus (2916)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26527722/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv1145&amp;pmid=26527722" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Partner repository with the dataset identifier PXD014513 (project DOI 10.6019/ PXD014513)</div><div id="p0350" role="paragraph">Mascot Daemon 2.5.0 was used to automate peptide identification from MS data. Peak list files (MGFs) from RAW data were generated with Mascot Distiller v2.6.1.0 and loaded into the Mascot search engine (v2.5) in order to match MS/MS data to peptides (<span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Perkins et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Perkins, D.N. ∙ Pappin, D.J. ∙ Creasy, D.M. ...</div><div><strong>Probability-based protein identification by searching sequence databases using mass spectrometry data</strong></div><div><em>Electrophoresis.</em> 1999; <strong>20</strong>:3551-3567</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/(SICI)1522-2683(19991201)20:18%3C3551::AID-ELPS3551%3E3.0.CO;2-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0033434080" target="_blank" aria-label="Open Scopus in new tab">Scopus (7034)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10612281/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2F%28SICI%291522-2683%2819991201%2920%3A18%253C3551%3A%3AAID-ELPS3551%253E3.0.CO%3B2-2&amp;pmid=10612281" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The searches were performed against the SwissProt Database (SwissProt_2018_09. fasta) with a FDR of ∼1% and the following parameters: 2 trypsin missed cleavages, mass tolerance of ± 10 ppm for the MS scans and ± 25&nbsp;mmu for the MS/MS scans, carbamidomethyl of Cys as a fixed modification, PyroGlu on N-terminal Gln and oxidation of Met and phosphorylation on Ser, Thr, and Tyr as variable modifications. The in-house developed Pescal software was used for label-free peptide quantification (<span class="dropBlock reference-citations"><a id="body-ref-sref74-2" href="#" role="doc-biblioref" data-xml-rid="bib15 bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-2" aria-controls="sref74-2">Cutillas, 2017; Wilkes et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref74-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Cutillas, P.R.</div><div><strong>Targeted In-Depth Quantification of Signaling Using Label-Free Mass Spectrometry</strong></div><div><em>Methods Enzymol.</em> 2017; <strong>585</strong>:245-268</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/bs.mie.2016.09.021" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85008618868" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28109432/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fbs.mie.2016.09.021&amp;pmid=28109432" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Wilkes, E.H. ∙ Casado, P. ∙ Rajeeve, V. ...</div><div><strong>Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability</strong></div><div><em>Mol. Cell. Proteomics.</em> 2017; <strong>16</strong>:1694-1704</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1074%2Fmcp.O116.064360&amp;cf=fulltext&amp;site=mcpro-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1074%2Fmcp.O116.064360&amp;cf=pdf&amp;site=mcpro-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85029166644" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28674151/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.O116.064360&amp;pmid=28674151" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), XICs for all the peptides identified across all samples were constructed with ± 7 ppm and ± 2&nbsp;min mass and retention time windows, respectively. Peak areas from all XICs were calculated. Undetectable peptides were given an intensity value of 0. Values of 2 technical replicates per sample were averaged and intensity values for each peptide were normalized to total sample intensity. Unpaired, two-tail Student’s t test was used to assess significance in phosphoproteomics data.</div></section><section id="sec-4-4-19"><h4><i>In&nbsp;vitro</i> inhibitor experiments</h4><div id="p0355" role="paragraph">For αvβ3-integrin inhibitor experiments, β3 null pericytes were treated with either placebo or 20&nbsp;μM Cilengitide (purchased from Bachem) for 24 h. For HGFR inhibitor experiments, β3 null pericytes were treated with either DMSO or 1&nbsp;μM HGFR inhibitor (PHA-665752, provided by Dr. <i>Stéphanie</i> Kermorgant) for 10, 30 and 60&nbsp;min respectively. For Akt inhibitor experiments, β3 null pericytes were treated with either DMSO or 10&nbsp;μM Akt inhibitor (LY294002, Sigma-Aldrich-#L9908) for 10, 30 and 60&nbsp;minutes respectively. For FAK inhibitor experiments, β3 null pericytes were treated with either DMSO or 10&nbsp;μM FAK inhibitor (PF573228, TOCRIS-#3239) for 24 hours respectively.</div><div id="p0360" role="paragraph">For MEK or ROCK inhibitor experiments, B16F0 cells were treated with either the conditioned medium from WT or β3 null pericytes in the presence of either DMSO, MEK inhibitor (U0126, TOCRIS-#1144) or ROCK inhibitor (GSK269962A, TOCRIS-#4009) for 3&nbsp;days in MTS experiments and 3&nbsp;days for <i>in&nbsp;vivo</i> experiments or 1&nbsp;day for western blot analysis.</div></section><section id="sec-4-4-20"><h4><i>In&nbsp;vitro</i> treatment of B16F0 cells with CCR2i</h4><div id="p0365" role="paragraph">CCR2<i>i</i> was discovered through structure-activity relationship modification of screening hits and synthesized by the Medicinal Chemistry Department at ChemoCentryx (Mountain View, CA) according to procedures described (Patent Application Numbers: WO 2014089495 and WO 2016187393). B16F0 cells were treated with conditioned medium form β3 null pericytes in combination or not with CCR2<i>i</i> for 48&nbsp;h for MTS assays.</div></section><section id="sec-4-4-21"><h4>Cytokine arrays</h4><div id="p0370" role="paragraph">WT and β3 null pericytes or transfected WT and β3 null pericytes were grown in normal pericyte media. After 72&nbsp;h of transfection, the whole-cell lysates were extracted. Mouse cytokine arrays (<i>Proteome-Profiler</i> ARY006, R&amp;D systems) were processed according to the manufacturer’s instruction using 300&nbsp;μg of lysates per membrane, incubated overnight and developed using Streptavidin-HRP system (<span class="dropBlock reference-citations"><a id="body-ref-sref64-6" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-6" aria-controls="sref64-6">Tavora et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref64-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Pixel analysis was used for quantification with ImageJ software.</div></section><section id="sec-4-4-22"><h4>Conditioned media production from WT/β3 null pericytes, Cas9, Akt<sup>KO</sup>, HGFR<sup>KO</sup>, CXCL1<sup>KO</sup>, CCL2<sup>KO</sup>, TIMP-1<sup>KO</sup> or mock/Iκ-BαSR transfected pericytes</h4><div id="p0375" role="paragraph">WT and β3 null pericytes were cultured with pericyte medium for 72 h. This medium was then collected and applied to B16F0, B16F10, LLC cells for 3&nbsp;days at 37°C and tumor cell survival was assessed using the MTS assay as described later. For mock/Iκ-BαSR-transfected pericyte medium, the pericytes were transfected using the Nucleofector® electroporation system (Lonza) with either the empty vector or Iκ-BαSR. After 72&nbsp;h incubation, this medium was collected and applied to B16F0, B16F10, LLC cells for 3&nbsp;days.</div></section><section id="sec-4-4-23"><h4><i>In&nbsp;vitro</i> cell viability assays</h4><div id="p0380" role="paragraph">LLC, B16F0 or B16F10 cell survival was assessed using the CellTiter 96® Aqueous One Solution Reagent (Promega-#G3582), according to the manufacturer’s instructions. Plates were read at a wavelength of 490&nbsp;nm, with absorbance measured relative to blank wells containing reagent only.</div></section><section id="sec-4-4-24"><h4>Transwell invasion assays</h4><div id="p0385" role="paragraph">Invasion assays were performed using transwell polycarbonate membranes (Sigma Aldrich). A suspension of 5&nbsp;× 10<sup>4</sup> B16F0 cells in 100&nbsp;μL OptiMEM was seeded in the upper chamber of the transwell, being the 8&nbsp;μm-pore membrane pre-coated with 50&nbsp;μL of collagen (3&nbsp;mg/ml in serum free DMEM). The lower chamber was filled with conditioned medium from WT or β3 null pericytes during 48 h. At the endpoint membranes were fixed with PFA 4% and stained with DAPI. Number of cells per field were quantified using using a Zeiss Axioplan microscope (Zeiss).</div></section><section id="sec-4-4-25"><h4>B16F0;ROCK2<sup>KO</sup><i>in&nbsp;vivo</i> tumor growth assays with doxycycline</h4><div id="p0390" role="paragraph"><i>pdgfrβcre-;β3</i><sup><i>fl/fl</i></sup> and <i>pdgfrβcre+;β3</i><sup><i>fl/f</i></sup> were injected with 1&nbsp;× 10<sup>5</sup> B16F0;ROCK2<sup>KO</sup> cells or and B16F0;ROCK2<sup>WT</sup> cells. Induction of the transgene in the cell lines <i>in&nbsp;vivo</i> was performed by administering doxycycline 2&nbsp;mg/l in drinking water with 5% sucrose. The administration of doxycycline took place once the tumors were palpable (7&nbsp;days after injection).</div></section></section><section id="sec-4-5"><h3>Quantification and Statistical Analysis</h3><div id="p0395" role="paragraph">Student’s t test, Chi-square test and two way ANOVA were performed for the statistical analysis and the details can be found in the figure legends: test used, exact value of n and dispersion measures. Statistical analysis were performed using GraphPad Prism. Outliers have been identified using ROUT test and excluded from the analysis.</div></section><section id="sec-4-6"><h3>Data and Code Availability</h3><div id="p0400" role="paragraph">The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (<a id="intref0255" href="http://www.proteomexchange.org" target="_blank">http://www.proteomexchange.org</a>) via the PRIDE (<span class="dropBlock reference-citations"><a id="body-ref-sref69-2" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-2" aria-controls="sref69-2">Vizcaíno et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref69-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Vizcaíno, J.A. ∙ Csordas, A. ∙ del-Toro, N. ...</div><div><strong>2016 update of the PRIDE database and its related tools</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:D447-D456</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv1145" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84976871411" target="_blank" aria-label="Open Scopus in new tab">Scopus (2916)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26527722/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv1145&amp;pmid=26527722" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Partner repository with the dataset identifier PXD014513 (project <a id="interref0010" href="https://doi.org/10.6019/PXD014513" target="_blank">https://doi.org/10.6019/PXD014513</a>)</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0405" role="paragraph">The authors would like to thank Barts Cancer Institute members Julie Holdsworth and Bruce Williams for technical assistance, Jane Sosabowski for technical advice regarding microCT imaging, Prof. Ralf Adams (Max Planck Institute for Molecular Biomedicine, Münster, Germany) for providing the <i>pdgfrβcre+</i> mice, Prof. Katherine Weilbaecher for generating and providing the <i>β3</i><sup>fl/fl</sup> mice, Dr. Stéphanie Kermorgant for technical advice regarding HGFR inhibitor experiments, and Dr. Ilaria Malanchi and Anna Pedrix for providing shRNA reagents. This work was supported by grants from the Natural Science Foundation of China (81920108028 and 81872142), the Guangzhou Science and Technology Program (201904020008); the Key Training Program for Young Scholars of Sun Yat-Sen University (18ykzd07), the Guangdong Science and Technology Department (2017B030314026), CRUK C8218/A18673, Worldwide Cancer Research (16-0390 and 19-0108), and the British Heart Foundation (FS/14/66/31293). N.C.H. is supported by Wellcome Trust Senior Research Fellowship in Clinical Science 103749. H.K. and P.M. are funded by program grants from Breast Cancer Now as part of program funding to the Breast Cancer Now Toby Robins Research Centre. P.M. acknowledges NIHRfunding to the Royal Marsden Hospital Biomedical Research Centre (BRC). V.S.-M., I.R.-H., and O.M. are supported by CRUK C33043/A24478 and Barts Charity. The authors wish to acknowledge the role of the Breast Cancer Now Tissue Bank in collecting and making available the samples used in the generation of this publication.</div><section id="sec-5"><h3>Author Contributions</h3><div id="p0410" role="paragraph">P.-P.W. and J.M.M.-F. carried out the majority of the experiments, designed and conceived the project, and wrote the paper. P.-P.W. performed the clinical study; the tumor growth study of LLC and B16F0 subcutaneous models, as well as LLC and B16F10 lung nodule experiments; the conditioned medium experiment; the <i>in&nbsp;vivo</i> cell tracking experiment; rescue experiments using IκBαSR; tail vein co-injection of pericyte and tumor cells; protein profiler arrays; cilengitide, Akt, and HGFR inhibitor experiments; and generation and characterization of <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> mice. J.M.M.-F. performed the clinical study; characterization of pericytes by flow cytometry; characterization of <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup>-free tumor tissue and <i>TdTom;pdgfrβcre+</i> unchallenged skin; the tumor growth and metastasis study in E0771 and <i>RIPtag2+</i> mice; ultrasound analysis of B16F0 tumors; subcutaneous and mammary fat pad injection of pericytes; FAK, MEK, ROCK, and CCR2 inhibition experiments; invasion assays; and <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i> rescue experiments with CRISPR-KO pericytes (HGFR<sup>KO</sup>, Akt<sup>KO</sup>, CXCL1<sup>KO</sup>, CCL2<sup>KO</sup>, and TIMP-1<sup>KO</sup>) and B16F0 ROCK2<sup>KO</sup> pericytes. M.H. and P.R.C. performed the mass spectrometry analysis. H.K. and P.M. established the CRISPR-KO pericytes. Y.-M.M. and Q.M. performed triple immunostaining of breast cancer tissues. B.D.L.-D. helped with the cell signaling studies. S.D.R. initiated the <i>pdgfrβcre+;β3</i><sup><i>fl/fl</i></sup> colonies. I.R.-H. established the B16F0 ROCK2<sup>KO</sup> cell lines. O.M. performed and analyzed p-MLC2 staining in tumors. N.B. carried out collagen staining and quantitation. M.S.D. performed the pimonidazole staining. L.E.R. helped with the TdTom and mTmG tissue analysis. G.E. performed histology. K.P.M. and N.C.H. provided <i>TdTom;pdgfrβcre-</i> and <i>TdTom;pdgfrβcre+</i> unchallenged skin tissue. A.C. and J.G.G. provided human lymphoma tissue sections. S.A.D., S.S., and J.L.J. provided human breast cancer tissue. P.W.S. and C.H. provided the human mesothelioma and melanoma sections, respectively. P.Z., T.J.S., Y.W., J.J.C., and R.S. developed and characterized the chemokine receptor inhibitor. J.J.C. and R.S. coordinated collaboration between K.M.H.-D. and Chemocentryx. V.S.-M. helped interpret the ROCK2 data and helped write the paper. K.H.-D. designed and conceived the study, supervised the project, and wrote the paper.</div></section><section id="sec-6"><h3>Declaration of Interests</h3><div id="p0415" role="paragraph">J.J.C., Y.W., R.S., T.J.S., and P.Z. are employees of ChemoChentryx. They developed and provided the CCR2 inhibitor used in this study.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental Information (2)</h2><div id="p0425" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.02.003/attachment/0f9005fd-c2e2-4b4d-a60c-193fc88285c4/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (47.68 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. Construction of CRISPR/Cas9-EGFP Plasmids, Related to Figure&nbsp;6</div><div id="espara0010" role="paragraph">sgRNA sequences targeting TIMP-1 (Gene ID: 21857), CXCL1 (Gene ID: 14825), CCL2 (Gene ID: 20296), Akt1 (Gene ID: 11651), and HGFR (Met) (Gene ID: 17295) (See Table S1) were cloned into the pLenti-CRISPR–EGFP plasmid using BsmBI enzyme site.</div></div></div><div class="core-supplementary-material" data-category="video"><div class="core-link"><div class="cloudflare-stream-container" id="mmc2" data-type="mp4"><span id="video_stream_mmc2_src" class="video-stream-source" style="display:none">eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiIyZmY0NjA5MTA2YmUzYjY0MzljN2I0ZmJkMWMxZTIzZCIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjA4MjgzfQ.SaOwvOQCw7csQnvELbzN0hHCkhULwcDhudnQ1ibM7bQUIUgd-gNnwU_oYVrYdrQw9CTUyWXzs2crxtX26dce3hbJWR1PDI-HVZYxewa3CpCxNPcDPQd4cDOfWdg5UulUFmFFYUFgUavc_iPT4ZKncU938kcyhkwZCuqPJNcRD_TSw_07l0Ui8G5DePitzgIlySY47xM7PwkX7TEVKVZmny--gAwu-BJXdwzFsn8XfqeNxZNyZ7mOgnbdi9Z5sbaSk85S8pFvpc1vt8Msrqz9DtcgyGf7fygX7-eEn5qOhQ1zSXXB1oz3tJ_6ZeMU0Pg2qz6BxNdpSOms2SWHw_B-EA</span><stream src="eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiIyZmY0NjA5MTA2YmUzYjY0MzljN2I0ZmJkMWMxZTIzZCIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjA4MjgzfQ.SaOwvOQCw7csQnvELbzN0hHCkhULwcDhudnQ1ibM7bQUIUgd-gNnwU_oYVrYdrQw9CTUyWXzs2crxtX26dce3hbJWR1PDI-HVZYxewa3CpCxNPcDPQd4cDOfWdg5UulUFmFFYUFgUavc_iPT4ZKncU938kcyhkwZCuqPJNcRD_TSw_07l0Ui8G5DePitzgIlySY47xM7PwkX7TEVKVZmny--gAwu-BJXdwzFsn8XfqeNxZNyZ7mOgnbdi9Z5sbaSk85S8pFvpc1vt8Msrqz9DtcgyGf7fygX7-eEn5qOhQ1zSXXB1oz3tJ_6ZeMU0Pg2qz6BxNdpSOms2SWHw_B-EA" class="cloudflare-stream-player ready tracked" id="video_stream_mmc2" controls="true"><div class="player-share-button" title="Share Video"><div class="share-player-icon"></div></div><div class="player-share-container hidden"><span class="player-close-share"></span><div class="social-links-container"><ul class="social-links-list"><li class="html5-share-facebook-icon" data-share-url="https://www.facebook.com/sharer/sharer.php?u=https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1" target="_blank"></li><li class="html5-share-twitter-icon" data-share-url="https://twitter.com/share?url=https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1" target="_blank"></li><li class="html5-share-mail-icon" data-share-url="mailto:?body=https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1" target="_blank"></li></ul><input type="text" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1" readonly="readonly" class="share-input"></div></div><div style="position: relative; height: 0px; width: 100%; padding-top: 56.25%;"><iframe src="https://embed.cloudflarestream.com/embed/iframe.fla9.823df22.html?videoId=eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiIyZmY0NjA5MTA2YmUzYjY0MzljN2I0ZmJkMWMxZTIzZCIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjA4MjgzfQ.SaOwvOQCw7csQnvELbzN0hHCkhULwcDhudnQ1ibM7bQUIUgd-gNnwU_oYVrYdrQw9CTUyWXzs2crxtX26dce3hbJWR1PDI-HVZYxewa3CpCxNPcDPQd4cDOfWdg5UulUFmFFYUFgUavc_iPT4ZKncU938kcyhkwZCuqPJNcRD_TSw_07l0Ui8G5DePitzgIlySY47xM7PwkX7TEVKVZmny--gAwu-BJXdwzFsn8XfqeNxZNyZ7mOgnbdi9Z5sbaSk85S8pFvpc1vt8Msrqz9DtcgyGf7fygX7-eEn5qOhQ1zSXXB1oz3tJ_6ZeMU0Pg2qz6BxNdpSOms2SWHw_B-EA" allowfullscreen="true" allow="autoplay; picture-in-picture" style="height: 100%; width: 100%; position: absolute; top: 0px; left: 0px; border: none;"></iframe></div></stream></div><a href="/cms/10.1016/j.cell.2020.02.003/attachment/ed7665c9-e891-4ee7-b52c-3bb8d973c39c/mmc2.mp4" download="mmc2.mp4" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Video (234.48 MB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Video S1. 360 Video of How Mural Cell-β3-Integrin Regulates Tumor Growth, Related to Figure 7</div><div id="espara0015" role="paragraph">In-depth discussion of the paper at large.</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">1.</a></div><div>Acharyya, S. ∙ Oskarsson, T. ∙ Vanharanta, S. ...</div><div><strong>A CXCL1 paracrine network links cancer chemoresistance and metastasis</strong></div><div><em>Cell.</em> 2012; <strong>150</strong>:165-178</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2012.04.042&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84863625224" target="_blank" aria-label="Open Scopus in new tab">Scopus (880)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22770218/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2012.04.042&amp;pmid=22770218" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">2.</a></div><div>Armulik, A. ∙ Genové, G. ∙ Betsholtz, C.</div><div><strong>Pericytes: developmental, physiological, and pathological perspectives, problems, and promises</strong></div><div><em>Dev. Cell.</em> 2011; <strong>21</strong>:193-215</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.devcel.2011.07.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.devcel.2011.07.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79961230399" target="_blank" aria-label="Open Scopus in new tab">Scopus (1996)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21839917/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.devcel.2011.07.001&amp;pmid=21839917" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">3.</a></div><div>Arozarena, I. ∙ Sanchez-Laorden, B. ∙ Packer, L. ...</div><div><strong>Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A</strong></div><div><em>Cancer Cell.</em> 2011; <strong>19</strong>:45-57</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2010.10.029&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2010.10.029&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-78651457445" target="_blank" aria-label="Open Scopus in new tab">Scopus (183)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21215707/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2010.10.029&amp;pmid=21215707" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4" title="View in article">4.</a></div><div>Batista, S. ∙ Maniati, E. ∙ Reynolds, L.E. ...</div><div><strong>Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis</strong></div><div><em>Nat. Commun.</em> 2014; <strong>5</strong>:5054</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms6054" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84923363475" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25270220/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms6054&amp;pmid=25270220" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">5.</a></div><div>Brantley-Sieders, D.M. ∙ Dunaway, C.M. ∙ Rao, M. ...</div><div><strong>Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium</strong></div><div><em>Cancer Res.</em> 2011; <strong>71</strong>:976-987</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-10-3396" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79551567742" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21148069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-10-3396&amp;pmid=21148069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">6.</a></div><div>Brooks, P.C. ∙ Clark, R.A. ∙ Cheresh, D.A.</div><div><strong>Requirement of vascular integrin alpha v beta 3 for angiogenesis</strong></div><div><em>Science.</em> 1994; <strong>264</strong>:569-571</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.7512751" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0028362876" target="_blank" aria-label="Open Scopus in new tab">Scopus (2823)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7512751/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.7512751&amp;pmid=7512751" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">7.</a></div><div>Brooks, P.C. ∙ Montgomery, A.M. ∙ Rosenfeld, M. ...</div><div><strong>Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels</strong></div><div><em>Cell.</em> 1994; <strong>79</strong>:1157-1164</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2F0092-8674%2894%2990007-8&amp;cf=abstract&amp;site=cell-site">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2F0092-8674%2894%2990007-8&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0028670833" target="_blank" aria-label="Open Scopus in new tab">Scopus (2216)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7528107/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0092-8674%2894%2990007-8&amp;pmid=7528107" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">8.</a></div><div>Brooks, P.C. ∙ Strömblad, S. ∙ Klemke, R. ...</div><div><strong>Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1995; <strong>96</strong>:1815-1822</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI118227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0028972105" target="_blank" aria-label="Open Scopus in new tab">Scopus (766)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7560073/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI118227&amp;pmid=7560073" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">9.</a></div><div>Cao, Z. ∙ Ding, B.S. ∙ Guo, P. ...</div><div><strong>Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:350-365</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2014.02.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2014.02.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84896098492" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24651014/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.02.005&amp;pmid=24651014" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">10.</a></div><div>Cao, Z. ∙ Scandura, J.M. ∙ Inghirami, G.G. ...</div><div><strong>Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells</strong></div><div><em>Cancer Cell.</em> 2017; <strong>31</strong>:110-126</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2016.11.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2016.11.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85008402585" target="_blank" aria-label="Open Scopus in new tab">Scopus (102)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27989801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.11.010&amp;pmid=27989801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">11.</a></div><div>Caspani, E.M. ∙ Crossley, P.H. ∙ Redondo-Garcia, C. ...</div><div><strong>Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e101402</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0101402" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84904512087" target="_blank" aria-label="Open Scopus in new tab">Scopus (98)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25032689/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0101402&amp;pmid=25032689" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">12.</a></div><div>Cheng, J. ∙ Phong, B. ∙ Wilson, D.C. ...</div><div><strong>Akt fine-tunes NF-κB-dependent gene expression during T&nbsp;cell activation</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2011; <strong>286</strong>:36076-36085</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M111.259549" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-80053909808" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21862580/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M111.259549&amp;pmid=21862580" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Chung, A.S. ∙ Lee, J. ∙ Ferrara, N.</div><div><strong>Targeting the tumour vasculature: insights from physiological angiogenesis</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:505-514</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2868" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77953988924" target="_blank" aria-label="Open Scopus in new tab">Scopus (660)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20574450/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2868&amp;pmid=20574450" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">14.</a></div><div>Cooke, V.G. ∙ LeBleu, V.S. ∙ Keskin, D. ...</div><div><strong>Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:66-81</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2011.11.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84855912001" target="_blank" aria-label="Open Scopus in new tab">Scopus (440)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22264789/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2011.11.024&amp;pmid=22264789" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-2" title="View in article">15.</a></div><div>Cutillas, P.R.</div><div><strong>Targeted In-Depth Quantification of Signaling Using Label-Free Mass Spectrometry</strong></div><div><em>Methods Enzymol.</em> 2017; <strong>585</strong>:245-268</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/bs.mie.2016.09.021" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85008618868" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28109432/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fbs.mie.2016.09.021&amp;pmid=28109432" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">16.</a></div><div>Dan, H.C. ∙ Cooper, M.J. ∙ Cogswell, P.C. ...</div><div><strong>Akt-dependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK</strong></div><div><em>Genes Dev.</em> 2008; <strong>22</strong>:1490-1500</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/gad.1662308" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-44849117768" target="_blank" aria-label="Open Scopus in new tab">Scopus (512)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18519641/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fgad.1662308&amp;pmid=18519641" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17-1" title="View in article">17.</a></div><div>Dull, T. ∙ Zufferey, R. ∙ Kelly, M. ...</div><div><strong>A third-generation lentivirus vector with a conditional packaging system</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:8463-8471</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.11.8463-8471.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9765382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.11.8463-8471.1998&amp;pmid=9765382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">18.</a></div><div>Fang, W.B. ∙ Jokar, I. ∙ Zou, A. ...</div><div><strong>CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2012; <strong>287</strong>:36593-36608</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M112.365999" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84867771909" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22927430/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M112.365999&amp;pmid=22927430" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19" title="View in article">19.</a></div><div>Foo, S.S. ∙ Turner, C.J. ∙ Adams, S. ...</div><div><strong>Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly</strong></div><div><em>Cell.</em> 2006; <strong>124</strong>:161-173</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2005.10.034&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2005.10.034&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-30344440869" target="_blank" aria-label="Open Scopus in new tab">Scopus (393)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16413489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2005.10.034&amp;pmid=16413489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">20.</a></div><div>Furuhashi, M. ∙ Sjöblom, T. ∙ Abramsson, A. ...</div><div><strong>Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate</strong></div><div><em>Cancer Res.</em> 2004; <strong>64</strong>:2725-2733</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-03-1489" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-16544382996" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15087386/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-03-1489&amp;pmid=15087386" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">21.</a></div><div>Garmy-Susini, B. ∙ Jin, H. ∙ Zhu, Y. ...</div><div><strong>Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2005; <strong>115</strong>:1542-1551</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI23445" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-20444483652" target="_blank" aria-label="Open Scopus in new tab">Scopus (170)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15902308/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI23445&amp;pmid=15902308" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">22.</a></div><div>Georgouli, M. ∙ Herraiz, C. ∙ Crosas-Molist, E. ...</div><div><strong>Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment</strong></div><div><em>Cell.</em> 2019; <strong>176</strong>:757-774.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2018.12.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2018.12.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85061010359" target="_blank" aria-label="Open Scopus in new tab">Scopus (103)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30712866/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.12.038&amp;pmid=30712866" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">23.</a></div><div>Ghajar, C.M. ∙ Peinado, H. ∙ Mori, H. ...</div><div><strong>The perivascular niche regulates breast tumour dormancy</strong></div><div><em>Nat. Cell Biol.</em> 2013; <strong>15</strong>:807-817</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncb2767" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84880332704" target="_blank" aria-label="Open Scopus in new tab">Scopus (857)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23728425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncb2767&amp;pmid=23728425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">24.</a></div><div>Ghiabi, P. ∙ Jiang, J. ∙ Pasquier, J. ...</div><div><strong>Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e112424</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0112424" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84911395686" target="_blank" aria-label="Open Scopus in new tab">Scopus (67)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25380486/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0112424&amp;pmid=25380486" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">25.</a></div><div>Gilbert, L.A. ∙ Hemann, M.T.</div><div><strong>DNA damage-mediated induction of a chemoresistant niche</strong></div><div><em>Cell.</em> 2010; <strong>143</strong>:355-366</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2010.09.043&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77958501473" target="_blank" aria-label="Open Scopus in new tab">Scopus (362)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21029859/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2010.09.043&amp;pmid=21029859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">26.</a></div><div>Gruhler, A. ∙ Olsen, J.V. ∙ Mohammed, S. ...</div><div><strong>Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway</strong></div><div><em>Mol. Cell. Proteomics.</em> 2005; <strong>4</strong>:310-327</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/mcp.M400219-MCP200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-15944377809" target="_blank" aria-label="Open Scopus in new tab">Scopus (709)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15665377/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.M400219-MCP200&amp;pmid=15665377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">27.</a></div><div>Guan, J.L.</div><div><strong>Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer</strong></div><div><em>IUBMB Life.</em> 2010; <strong>62</strong>:268-276</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/iub.311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77951125212" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20101634/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fiub.311&amp;pmid=20101634" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Guerrouahen, B.S. ∙ Pasquier, J. ∙ Kaoud, N.A. ...</div><div><strong>Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer</strong></div><div><em>Mol. Cancer Ther.</em> 2014; <strong>13</strong>:3123-3136</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1535-7163.MCT-13-1053" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84917705793" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25319392/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1535-7163.MCT-13-1053&amp;pmid=25319392" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">29.</a></div><div>Hanahan, D.</div><div><strong>Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes</strong></div><div><em>Nature.</em> 1985; <strong>315</strong>:115-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/315115a0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0021888904" target="_blank" aria-label="Open Scopus in new tab">Scopus (1095)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2986015/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F315115a0&amp;pmid=2986015" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">30.</a></div><div>Hanahan, D. ∙ Weinberg, R.A.</div><div><strong>Hallmarks of cancer: the next generation</strong></div><div><em>Cell.</em> 2011; <strong>144</strong>:646-674</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79952284127" target="_blank" aria-label="Open Scopus in new tab">Scopus (49637)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21376230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2011.02.013&amp;pmid=21376230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">31.</a></div><div>Heldin, C.H.</div><div><strong>Targeting the PDGF signaling pathway in tumor treatment</strong></div><div><em>Cell Commun. Signal.</em> 2013; <strong>11</strong>:97</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1478-811X-11-97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84890467312" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24359404/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1478-811X-11-97&amp;pmid=24359404" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Ito, M. ∙ Nakano, T. ∙ Erdodi, F. ...</div><div><strong>Myosin phosphatase: structure, regulation and function</strong></div><div><em>Mol. Cell. Biochem.</em> 2004; <strong>259</strong>:197-209</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1023/B:MCBI.0000021373.14288.00" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-1942538405" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15124925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1023%2FB%3AMCBI.0000021373.14288.00&amp;pmid=15124925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">33.</a></div><div>Keskin, D. ∙ Kim, J. ∙ Cooke, V.G. ...</div><div><strong>Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2</strong></div><div><em>Cell Rep.</em> 2015; <strong>10</strong>:1066-1081</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.celrep.2015.01.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.celrep.2015.01.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84929142111" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25704811/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2015.01.035&amp;pmid=25704811" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-5" title="View in article">34.</a></div><div>LaBarbera, K.E. ∙ Hyldahl, R.D. ∙ O’Fallon, K.S. ...</div><div><strong>Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in&nbsp;vitro</strong></div><div><em>Physiol. Rep.</em> 2015; <strong>3</strong></div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.14814/phy2.12309" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85003571538" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25911453/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.14814%2Fphy2.12309&amp;pmid=25911453" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">35.</a></div><div>Larsen, M.R. ∙ Thingholm, T.E. ∙ Jensen, O.N. ...</div><div><strong>Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns</strong></div><div><em>Mol. Cell. Proteomics.</em> 2005; <strong>4</strong>:873-886</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/mcp.T500007-MCP200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-24944519450" target="_blank" aria-label="Open Scopus in new tab">Scopus (1361)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15858219/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.T500007-MCP200&amp;pmid=15858219" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">36.</a></div><div>Lu, J. ∙ Ye, X. ∙ Fan, F. ...</div><div><strong>Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1</strong></div><div><em>Cancer Cell.</em> 2013; <strong>23</strong>:171-185</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2012.12.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccr.2012.12.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84873728505" target="_blank" aria-label="Open Scopus in new tab">Scopus (363)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23375636/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.12.021&amp;pmid=23375636" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">37.</a></div><div>Mas-Moruno, C. ∙ Rechenmacher, F. ∙ Kessler, H.</div><div><strong>Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation</strong></div><div><em>Anticancer. Agents Med. Chem.</em> 2010; <strong>10</strong>:753-768</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2174/187152010794728639" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79952741178" target="_blank" aria-label="Open Scopus in new tab">Scopus (512)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21269250/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2174%2F187152010794728639&amp;pmid=21269250" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">38.</a></div><div>Mason, W.P.</div><div><strong>End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma</strong></div><div><em>Neuro-oncol.</em> 2015; <strong>17</strong>:634-635</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/neuonc/nov018" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84928911049" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25681307/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fneuonc%2Fnov018&amp;pmid=25681307" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39" title="View in article">39.</a></div><div>McComb, S. ∙ Aguadé-Gorgorió, J. ∙ Harder, L. ...</div><div><strong>Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:339ra70</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad2986" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84969626016" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27194728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad2986&amp;pmid=27194728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">40.</a></div><div>Montoya, A. ∙ Beltran, L. ∙ Casado, P. ...</div><div><strong>Characterization of a TiO<sub>2</sub> enrichment method for label-free quantitative phosphoproteomics</strong></div><div><em>Methods.</em> 2011; <strong>54</strong>:370-378</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.ymeth.2011.02.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-79961193839" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21316455/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ymeth.2011.02.004&amp;pmid=21316455" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41-1" title="View in article">41.</a></div><div>Morgan, E.A. ∙ Schneider, J.G. ∙ Baroni, T.E. ...</div><div><strong>Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit</strong></div><div><em>FASEB J.</em> 2010; <strong>24</strong>:1117-1127</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1096/fj.09-138420" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77951625288" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19933310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1096%2Ffj.09-138420&amp;pmid=19933310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">42.</a></div><div>O’Keeffe, M.B. ∙ Devlin, A.H. ∙ Burns, A.J. ...</div><div><strong>Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes</strong></div><div><em>Oncol. Res.</em> 2008; <strong>17</strong>:93-101</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3727/096504008785055530" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-47549086341" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18669161/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3727%2F096504008785055530&amp;pmid=18669161" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">43.</a></div><div>Orgaz, J.L. ∙ Crosas-Molist, E. ∙ Sadok, A. ...</div><div><strong>Myosin II reactivation and cytoskeletal remodelling as a hallmark and a vulnerability in melanoma resistance</strong></div><div><em>Cancer Cell.</em> 2020; <strong>37</strong>:85-103.e9</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2019.12.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2019.12.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85077365737" target="_blank" aria-label="Open Scopus in new tab">Scopus (95)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31935375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2019.12.003&amp;pmid=31935375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">44.</a></div><div>Pedrosa, A.R. ∙ Trindade, A. ∙ Carvalho, C. ...</div><div><strong>Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions</strong></div><div><em>Oncotarget.</em> 2015; <strong>6</strong>:24404-24423</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.18632/oncotarget.4380" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84943408033" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26213336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.18632%2Foncotarget.4380&amp;pmid=26213336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-5" title="View in article">45.</a></div><div>Perkins, N.D.</div><div><strong>The diverse and complex roles of NF-κB subunits in cancer</strong></div><div><em>Nat. Rev. Cancer.</em> 2012; <strong>12</strong>:121-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc3204" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84856213846" target="_blank" aria-label="Open Scopus in new tab">Scopus (747)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22257950/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc3204&amp;pmid=22257950" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Perkins, D.N. ∙ Pappin, D.J. ∙ Creasy, D.M. ...</div><div><strong>Probability-based protein identification by searching sequence databases using mass spectrometry data</strong></div><div><em>Electrophoresis.</em> 1999; <strong>20</strong>:3551-3567</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/(SICI)1522-2683(19991201)20:18%3C3551::AID-ELPS3551%3E3.0.CO;2-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0033434080" target="_blank" aria-label="Open Scopus in new tab">Scopus (7034)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10612281/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2F%28SICI%291522-2683%2819991201%2920%3A18%253C3551%3A%3AAID-ELPS3551%253E3.0.CO%3B2-2&amp;pmid=10612281" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">47.</a></div><div>Pietras, K. ∙ Rubin, K. ∙ Sjöblom, T. ...</div><div><strong>Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy</strong></div><div><em>Cancer Res.</em> 2002; <strong>62</strong>:5476-5484</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12359756/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=12359756" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">48.</a></div><div>Pikarsky, E. ∙ Porat, R.M. ∙ Stein, I. ...</div><div><strong>NF-kappaB functions as a tumour promoter in inflammation-associated cancer</strong></div><div><em>Nature.</em> 2004; <strong>431</strong>:461-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02924" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-4644324186" target="_blank" aria-label="Open Scopus in new tab">Scopus (2241)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15329734/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02924&amp;pmid=15329734" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-3" title="View in article">49.</a></div><div>Poulos, M.G. ∙ Ramalingam, P. ∙ Gutkin, M.C. ...</div><div><strong>Endothelial-specific inhibition of NF-κB enhances functional haematopoiesis</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:13829</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms13829" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85006954187" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28000664/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms13829&amp;pmid=28000664" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">50.</a></div><div>Raza, A. ∙ Franklin, M.J. ∙ Dudek, A.Z.</div><div><strong>Pericytes and vessel maturation during tumor angiogenesis and metastasis</strong></div><div><em>Am. J. Hematol.</em> 2010; <strong>85</strong>:593-598</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ajh.21745" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-77955496673" target="_blank" aria-label="Open Scopus in new tab">Scopus (307)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20540157/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fajh.21745&amp;pmid=20540157" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">51.</a></div><div>Reynolds, L.E. ∙ Wyder, L. ∙ Lively, J.C. ...</div><div><strong>Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins</strong></div><div><em>Nat. Med.</em> 2002; <strong>8</strong>:27-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm0102-27" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0036152857" target="_blank" aria-label="Open Scopus in new tab">Scopus (566)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11786903/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm0102-27&amp;pmid=11786903" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">52.</a></div><div>Reynolds, A.R. ∙ Reynolds, L.E. ∙ Nagel, T.E. ...</div><div><strong>Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice</strong></div><div><em>Cancer Res.</em> 2004; <strong>64</strong>:8643-8650</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-04-2760" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-9244231286" target="_blank" aria-label="Open Scopus in new tab">Scopus (142)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15574772/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-04-2760&amp;pmid=15574772" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">53.</a></div><div>Reynolds, A.R. ∙ Hart, I.R. ∙ Watson, A.R. ...</div><div><strong>Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors</strong></div><div><em>Nat. Med.</em> 2009; <strong>15</strong>:392-400</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.1941" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-64149106522" target="_blank" aria-label="Open Scopus in new tab">Scopus (405)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19305413/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.1941&amp;pmid=19305413" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54-1" title="View in article">54.</a></div><div>Reynolds, L.E. ∙ D’Amico, G. ∙ Lechertier, T. ...</div><div><strong>Dual role of pericyte α6β1-integrin in tumour blood vessels</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2017; <strong>130</strong>:1583-1595</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.197848" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85018256546" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28289267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.197848&amp;pmid=28289267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56" title="View in article">55.</a></div><div>Schneider, C.A. ∙ Rasband, W.S. ∙ Eliceiri, K.W.</div><div><strong>NIH Image to ImageJ: 25 years of image analysis</strong></div><div><em>Nat. Methods.</em> 2012; <strong>9</strong>:671-675</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2089" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84863205849" target="_blank" aria-label="Open Scopus in new tab">Scopus (43944)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22930834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2089&amp;pmid=22930834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">56.</a></div><div>Sennino, B. ∙ Falcón, B.L. ∙ McCauley, D. ...</div><div><strong>Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:7358-7367</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-07-0293" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-34547637867" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17671206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-07-0293&amp;pmid=17671206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58-1" title="View in article">57.</a></div><div>Sinha, D. ∙ Chong, L. ∙ George, J. ...</div><div><strong>Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients</strong></div><div><em>Clin. Cancer Res.</em> 2016; <strong>22</strong>:1813-1824</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-15-1931" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84964329283" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26589433/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-15-1931&amp;pmid=26589433" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">58.</a></div><div>Steri, V. ∙ Ellison, T.S. ∙ Gontarczyk, A.M. ...</div><div><strong>Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice</strong></div><div><em>Circ. Res.</em> 2014; <strong>114</strong>:79-91</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/CIRCRESAHA.114.301591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84892931092" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24103390/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FCIRCRESAHA.114.301591&amp;pmid=24103390" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">59.</a></div><div>Stratman, A.N. ∙ Malotte, K.M. ∙ Mahan, R.D. ...</div><div><strong>Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation</strong></div><div><em>Blood.</em> 2009; <strong>114</strong>:5091-5101</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2009-05-222364" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-73949086144" target="_blank" aria-label="Open Scopus in new tab">Scopus (448)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19822899/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2009-05-222364&amp;pmid=19822899" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">60.</a></div><div>Stupp, R. ∙ Ruegg, C.</div><div><strong>Integrin inhibitors reaching the clinic</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2007; <strong>25</strong>:1637-1638</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2006.09.8376" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-34249113455" target="_blank" aria-label="Open Scopus in new tab">Scopus (113)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17470853/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2006.09.8376&amp;pmid=17470853" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">61.</a></div><div>Tang, C.H. ∙ Tsai, C.C.</div><div><strong>CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway</strong></div><div><em>Biochem. Pharmacol.</em> 2012; <strong>83</strong>:335-344</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bcp.2011.11.013" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84455202302" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22138288/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bcp.2011.11.013&amp;pmid=22138288" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">62.</a></div><div>Tavora, B. ∙ Reynolds, L.E. ∙ Batista, S. ...</div><div><strong>Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</strong></div><div><em>Nature.</em> 2014; <strong>514</strong>:112-116</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature13541" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84906937038" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25079333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature13541&amp;pmid=25079333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">63.</a></div><div>Tucci, M. ∙ Stucci, S. ∙ Silvestris, F.</div><div><strong>Does cilengitide deserve another chance?</strong></div><div><em>Lancet Oncol.</em> 2014; <strong>15</strong>:e584-e585</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1470-2045%2814%2970462-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1470-2045%2814%2970462-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84925228193" target="_blank" aria-label="Open Scopus in new tab">Scopus (33)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25456376/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2814%2970462-0&amp;pmid=25456376" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">64.</a></div><div>Usatyuk, P.V. ∙ Fu, P. ∙ Mohan, V. ...</div><div><strong>Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2014; <strong>289</strong>:13476-13491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1074/jbc.M113.527556" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84900465261" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24634221/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M113.527556&amp;pmid=24634221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">65.</a></div><div>Vial, E. ∙ Sahai, E. ∙ Marshall, C.J.</div><div><strong>ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility</strong></div><div><em>Cancer Cell.</em> 2003; <strong>4</strong>:67-79</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1535-6108%2803%2900162-4&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2FS1535-6108%2803%2900162-4&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-0042349229" target="_blank" aria-label="Open Scopus in new tab">Scopus (348)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12892714/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1535-6108%2803%2900162-4&amp;pmid=12892714" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68-1" title="View in article">66.</a></div><div>Vicente-Manzanares, M. ∙ Ma, X. ∙ Adelstein, R.S. ...</div><div><strong>Non-muscle myosin II takes centre stage in cell adhesion and migration</strong></div><div><em>Nat. Rev. Mol. Cell Biol.</em> 2009; <strong>10</strong>:778-790</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrm2786" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-70350454867" target="_blank" aria-label="Open Scopus in new tab">Scopus (1461)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19851336/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrm2786&amp;pmid=19851336" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69-1" title="View in article">67.</a></div><div>Vizcaíno, J.A. ∙ Csordas, A. ∙ del-Toro, N. ...</div><div><strong>2016 update of the PRIDE database and its related tools</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:D447-D456</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv1145" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84976871411" target="_blank" aria-label="Open Scopus in new tab">Scopus (2916)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26527722/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv1145&amp;pmid=26527722" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">68.</a></div><div>Wang, Z. ∙ Ahmad, A. ∙ Li, Y. ...</div><div><strong>Emerging roles of PDGF-D signaling pathway in tumor development and progression</strong></div><div><em>Biochim. Biophys. Acta.</em> 2010; <strong>1806</strong>:122-130</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20434526/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=20434526" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72" title="View in article">69.</a></div><div>Wiederschain, D. ∙ Wee, S. ∙ Chen, L. ...</div><div><strong>Single-vector inducible lentiviral RNAi system for oncology target validation</strong></div><div><em>Cell Cycle.</em> 2009; <strong>8</strong>:498-504</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4161/cc.8.3.7701" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-59449092185" target="_blank" aria-label="Open Scopus in new tab">Scopus (321)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19177017/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4161%2Fcc.8.3.7701&amp;pmid=19177017" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">70.</a></div><div>Wieland, E. ∙ Rodriguez-Vita, J. ∙ Liebler, S.S. ...</div><div><strong>Endothelial Notch1 Activity Facilitates Metastasis</strong></div><div><em>Cancer Cell.</em> 2017; <strong>31</strong>:355-367</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2017.01.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2017.01.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85013625323" target="_blank" aria-label="Open Scopus in new tab">Scopus (222)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28238683/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2017.01.007&amp;pmid=28238683" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">71.</a></div><div>Wilkes, E.H. ∙ Casado, P. ∙ Rajeeve, V. ...</div><div><strong>Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability</strong></div><div><em>Mol. Cell. Proteomics.</em> 2017; <strong>16</strong>:1694-1704</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1074%2Fmcp.O116.064360&amp;cf=fulltext&amp;site=mcpro-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1074%2Fmcp.O116.064360&amp;cf=pdf&amp;site=mcpro-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-85029166644" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28674151/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fmcp.O116.064360&amp;pmid=28674151" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75" title="View in article">72.</a></div><div>Wong, P.P. ∙ Demircioglu, F. ∙ Ghazaly, E. ...</div><div><strong>Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread</strong></div><div><em>Cancer Cell.</em> 2015; <strong>27</strong>:123-137</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2014.10.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=10.1016%2Fj.ccell.2014.10.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84922180322" target="_blank" aria-label="Open Scopus in new tab">Scopus (168)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25584895/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2014.10.015&amp;pmid=25584895" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">73.</a></div><div>Xian, X. ∙ Håkansson, J. ∙ Ståhlberg, A. ...</div><div><strong>Pericytes limit tumor cell metastasis</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2006; <strong>116</strong>:642-651</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI25705" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-33644643376" target="_blank" aria-label="Open Scopus in new tab">Scopus (300)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16470244/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI25705&amp;pmid=16470244" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">74.</a></div><div>Xing, Y. ∙ Zhao, S. ∙ Zhou, B.P. ...</div><div><strong>Metabolic reprogramming of the tumour microenvironment</strong></div><div><em>FEBS J.</em> 2015; <strong>282</strong>:3892-3898</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/febs.13402" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84944273587" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26255648/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Ffebs.13402&amp;pmid=26255648" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">75.</a></div><div>Yonenaga, Y. ∙ Mori, A. ∙ Onodera, H. ...</div><div><strong>Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients</strong></div><div><em>Oncology.</em> 2005; <strong>69</strong>:159-166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1159/000087840" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-25444491756" target="_blank" aria-label="Open Scopus in new tab">Scopus (158)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16127287/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1159%2F000087840&amp;pmid=16127287" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">76.</a></div><div>You, W.K. ∙ Yotsumoto, F. ∙ Sakimura, K. ...</div><div><strong>NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function</strong></div><div><em>Angiogenesis.</em> 2014; <strong>17</strong>:61-76</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10456-013-9378-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.003&amp;key=2-s2.0-84892816761" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23925489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10456-013-9378-1&amp;pmid=23925489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (13)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/2cb90f37-4ea3-424d-8369-6aaa079c7ec0/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/82373254-e6cb-4254-b2ac-ab44f02f9fe3/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/0522b333-2d4c-437d-bb7f-309299627726/main.assets/figs2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/216dc664-19c8-4d9a-a337-5ed793e445e6/main.assets/gr2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/a92528ce-fcb8-498b-b12c-22479360130c/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/443dc136-10f9-429d-aa4b-19ebb2aaf45d/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/ffc25762-52a2-4bc1-a3b4-170a5fe525f9/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/2b806d41-0630-483f-982c-0b76302911b7/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/986f651e-d443-4896-b67e-ca391618b281/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/46ed39ae-5d39-42df-a8f3-52faa54c849a/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/dcb777de-4a15-4a2e-af6a-b2c41c16fa2a/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/206153ef-28e1-4868-9c94-019b2be8656c/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/asset/e9aca48a-d787-426b-bf36-ed59766db2f6/main.assets/gr7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel js--loaded" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3Apii%5C%3AS0092867419X00136%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3Apii%5C%3AS0092867420301471" data-pb-mode-enabled="false">
                <li class="publication-list__box publication-list__box-axel">
                    <ul class="rlist axel-list__box">
                        
                        
            <li class="plum-x-wrapper">
                <div class="plum-x plum-x--axel">
                    <div class="plum-x__items">
                        
                    <div class="plum-x__item plum-x-citation">
                        <div class="plum-x__item-num">65</div>
                        <div class="plum-x__item-title">Citations</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-capture">
                        <div class="plum-x__item-num">140</div>
                        <div class="plum-x__item-title">Captures</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-socialMedia">
                        <div class="plum-x__item-num">362</div>
                        <div class="plum-x__item-title">Social Media</div>
                    </div>    
                
                    </div>
                    <div class="plum-x__details">
                        <div class="plum-x__logo">
                            <img src="/products/marlin/releasedAssets/images/plumx-logo.png" alt="Plum X logo">
                        </div>
                        <a class="plum-x__view-details" href="https://plu.mx/plum/a/?doi=10.1016/j.cell.2020.02.003&amp;theme=plum-jbs-theme&amp;hideUsage=true" target="_blank">
                            <span>View details</span>
                            <span class="sr-only">opens in a new tab</span>
                            <i class="icon-external-arrow" aria-hidden="true"></i>
                        </a>
                    </div>
                </div>  
            </li>
        
                    </ul>
                </li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (2)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/attachment/0f9005fd-c2e2-4b4d-a60c-193fc88285c4/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (47.68 KB)</span></a><div class="core-description">Table S1. Construction of CRISPR/Cas9-EGFP Plasmids, Related to Figure&nbsp;6</div></div></div><div class="core-supplementary-material" data-category="video"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.02.003/attachment/ed7665c9-e891-4ee7-b52c-3bb8d973c39c/mmc2.mp4" download="mmc2.mp4"><span id="mmc2-link">Video (234.48 MB)</span></a><div class="core-description">Video S1. 360 Video of How Mural Cell-β3-Integrin Regulates Tumor Growth, Related to Figure 7</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867420301471" class="ux3DeferredOnScrollWidget axel-related-articles__body" data-show-more="true"></div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2020.02.003","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.02.003/asset/2cb90f37-4ea3-424d-8369-6aaa079c7ec0/main.assets/gr1.jpg" height="959" width="689" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/3c25bf3a-b886-43f0-97dc-45e5786ac148/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.02.003/asset/82373254-e6cb-4254-b2ac-ab44f02f9fe3/main.assets/figs1.jpg" height="861" width="678" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/b3783937-17f2-4c16-8419-8d998100b99f/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.02.003/asset/0522b333-2d4c-437d-bb7f-309299627726/main.assets/figs2.jpg" height="942" width="670" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/30e4124a-e00f-4f01-83be-e9810de1170d/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.02.003/asset/216dc664-19c8-4d9a-a337-5ed793e445e6/main.assets/gr2.jpg" height="952" width="715" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/58568896-52b0-48b3-8351-b28c03d33a60/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.02.003/asset/a92528ce-fcb8-498b-b12c-22479360130c/main.assets/gr3.jpg" height="950" width="645" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/39b4eae0-22e6-4d86-ba7d-b3df50e1f5cd/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.02.003/asset/443dc136-10f9-429d-aa4b-19ebb2aaf45d/main.assets/figs3.jpg" height="952" width="689" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/14107f96-10f0-4080-ba3f-56de8984222e/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.02.003/asset/ffc25762-52a2-4bc1-a3b4-170a5fe525f9/main.assets/gr4.jpg" height="943" width="693" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/6553f85f-9ccd-46d4-a29b-1a47d21115ee/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.02.003/asset/2b806d41-0630-483f-982c-0b76302911b7/main.assets/figs4.jpg" height="887" width="675" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/94e000cf-008e-48b5-a0cd-7aaada7231e3/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.02.003/asset/986f651e-d443-4896-b67e-ca391618b281/main.assets/gr5.jpg" height="940" width="703" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/bed39d45-1136-4f1e-b54c-e0b71b3dc1e6/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.02.003/asset/46ed39ae-5d39-42df-a8f3-52faa54c849a/main.assets/figs5.jpg" height="787" width="678" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/b57e4a22-c3f8-48dd-bcd4-32fd48d367aa/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.02.003/asset/dcb777de-4a15-4a2e-af6a-b2c41c16fa2a/main.assets/gr6.jpg" height="754" width="767" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/e7712134-cb4a-4ddb-ad67-64652009f3be/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.02.003/asset/206153ef-28e1-4868-9c94-019b2be8656c/main.assets/figs6.jpg" height="865" width="662" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/cab1a7a4-75f0-4b19-bd58-8ad5389ab5f2/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.02.003/asset/e9aca48a-d787-426b-bf36-ed59766db2f6/main.assets/gr7.jpg" height="812" width="754" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/1ae8da14-5c87-4323-bcf0-f5e9bee6a7f6/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.02.003/asset/2cb90f37-4ea3-424d-8369-6aaa079c7ec0/main.assets/gr1.jpg" height="959" width="689" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/3c25bf3a-b886-43f0-97dc-45e5786ac148/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.02.003/asset/82373254-e6cb-4254-b2ac-ab44f02f9fe3/main.assets/figs1.jpg" height="861" width="678" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/b3783937-17f2-4c16-8419-8d998100b99f/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.02.003/asset/0522b333-2d4c-437d-bb7f-309299627726/main.assets/figs2.jpg" height="942" width="670" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/30e4124a-e00f-4f01-83be-e9810de1170d/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.02.003/asset/216dc664-19c8-4d9a-a337-5ed793e445e6/main.assets/gr2.jpg" height="952" width="715" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/58568896-52b0-48b3-8351-b28c03d33a60/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.02.003/asset/a92528ce-fcb8-498b-b12c-22479360130c/main.assets/gr3.jpg" height="950" width="645" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/39b4eae0-22e6-4d86-ba7d-b3df50e1f5cd/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.02.003/asset/443dc136-10f9-429d-aa4b-19ebb2aaf45d/main.assets/figs3.jpg" height="952" width="689" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/14107f96-10f0-4080-ba3f-56de8984222e/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.02.003/asset/ffc25762-52a2-4bc1-a3b4-170a5fe525f9/main.assets/gr4.jpg" height="943" width="693" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/6553f85f-9ccd-46d4-a29b-1a47d21115ee/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.02.003/asset/2b806d41-0630-483f-982c-0b76302911b7/main.assets/figs4.jpg" height="887" width="675" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/94e000cf-008e-48b5-a0cd-7aaada7231e3/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.02.003/asset/986f651e-d443-4896-b67e-ca391618b281/main.assets/gr5.jpg" height="940" width="703" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/bed39d45-1136-4f1e-b54c-e0b71b3dc1e6/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.02.003/asset/46ed39ae-5d39-42df-a8f3-52faa54c849a/main.assets/figs5.jpg" height="787" width="678" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/b57e4a22-c3f8-48dd-bcd4-32fd48d367aa/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.02.003/asset/dcb777de-4a15-4a2e-af6a-b2c41c16fa2a/main.assets/gr6.jpg" height="754" width="767" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/e7712134-cb4a-4ddb-ad67-64652009f3be/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.02.003/asset/206153ef-28e1-4868-9c94-019b2be8656c/main.assets/figs6.jpg" height="865" width="662" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/cab1a7a4-75f0-4b19-bd58-8ad5389ab5f2/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.02.003/asset/e9aca48a-d787-426b-bf36-ed59766db2f6/main.assets/gr7.jpg" height="812" width="754" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.003/asset/1ae8da14-5c87-4323-bcf0-f5e9bee6a7f6/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30147-1';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749586683369","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"181","issueNumber":"6","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867420301471","coverDate":"202006","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Cancer Burden Is Controlled by Mural Cellx3b23Integrin Regulated Crosstalk with Tumor Cells","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94db8e39d979428d',t:'MTc0OTU4NjY4Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94db8e39d979428d&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2020.02.003&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>